{
"company_details": [
{
"company_id": "0001300524",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001300524.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001300524.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001300524.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001300524_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001300524_main_keyfigs.svg",
"name": "American International Holdings CORP",
"rank": 1,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001300524.svg",
"report_text": "The relative strengths and weaknesses of American International Holdings CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of American International Holdings CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 160% points.The greatest weakness of American International Holdings CORP is the variable Other Revenues, reducing the Economic Capital Ratio by 28% points.
The company's Economic Capital Ratio, given in the ranking table, is 307%, being 144% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001300524_2013_American_International_Holdings_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-67.2",
"Stockholders Equity": "-94.5",
"ECR before LimitedLiability": "-33.7",
"Property Plant and Equipment": "-22.5",
"Intangible Assets": "-50.5",
"Other Liabilities": "17.5",
"Liabilities": "23.9",
"Long Term Liabilities": "33.5",
"Liabilities, Current": "-54.7",
"Expenses": "-39.4",
"Revenues": "52.7",
"Net Income": "29.9",
"Other Expenses": "-342",
"Operating Costs and Expenses": "15.8",
"Labor Expense": "25.4",
"General and Administrative Expense": "64.1",
"Cost of Goods and Services Sold": "48.3",
"Other Revenues": "52.7",
"Other Net Income": "-50.7",
"Comprehensive Net Income": "30.4",
"Economic Capital Ratio": "-40.4"
},
"2012": {
"Assets": "-3.13",
"Stockholders Equity": "160",
"ECR before LimitedLiability": "158",
"Assets, Current": "-10.2",
"Liabilities, Current": "33.0",
"Liabilities": "62.9",
"Long Term Liabilities": "24.0",
"Other Liabilities": "15.9",
"Research And Development Expense": "1.91",
"Expenses": "41.4",
"Revenues": "-27.5",
"Net Income": "16.3",
"Other Expenses": "18.4",
"General and Administrative Expense": "2.16",
"Goodwill Impairment Loss": "1.38",
"Operating Costs and Expenses": "3.78",
"Cost of Goods and Services Sold": "4.90",
"Labor Expense": "7.86",
"Other Revenues": "-27.5",
"Comprehensive Net Income": "16.5",
"Economic Capital Ratio": "144"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001300524_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "3,577",
"Assets, Non-Current": "6.5",
"Cost of Goods and Services Sold": "-5,276",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "-6,270",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,880",
"Long Term Liabilities": "50",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "23,150",
"Other Liabilities": "0",
"Other Net Income": "-41",
"Other Revenues": "11,293",
"Property Plant and Equipment": "1,701",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,285",
"Liabilities": "3,929",
"Expenses": "11,603",
"Revenues": "11,293",
"Stockholders Equity": "1,356",
"Net Income": "-351",
"Comprehensive Net Income": "-351",
"BaseVar": "16,076",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "120%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "2,513",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "162",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "24",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "263",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,513",
"Liabilities": "24",
"Expenses": "162",
"Revenues": "0",
"Stockholders Equity": "2,489",
"Net Income": "101",
"Comprehensive Net Income": "101",
"BaseVar": "1,481",
"ECR before LimitedLiability": "292%",
"Economic Capital Ratio": "307%"
}
}
},
"top_rated": true,
"trend": 51.0,
"value": 3.071844947358948,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001300524.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001300524.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001300524.svg"
},
{
"company_id": "0000895930",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000895930.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000895930.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000895930_main_keyfigs.svg",
"name": "Amsurg CORP",
"rank": 2,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000895930.svg",
"report_text": "The relative strengths and weaknesses of Amsurg CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Amsurg CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 121% points.The greatest weakness of Amsurg CORP is the variable Revenues, reducing the Economic Capital Ratio by 43% points.
The company's Economic Capital Ratio, given in the ranking table, is 291%, being 128% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000895930_2013_Amsurg_CORP.pdf",
"shrinked_graph_json": {
"2010": {
"Assets": "2.73",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "103",
"Intangible Assets": "7.64",
"Other Liabilities": "22.2",
"Liabilities": "89.9",
"Liabilities, Current": "26.2",
"Long Term Liabilities": "60.7",
"Other Expenses": "15.2",
"Expenses": "7.92",
"Revenues": "-42.0",
"Net Income": "12.6",
"Cost of Goods and Services Sold": "13.6",
"General and Administrative Expense": "6.31",
"Labor Expense": "-18.3",
"Operating Costs and Expenses": "-8.44",
"Other Revenues": "-42.0",
"Comprehensive Net Income": "-3.07",
"Other Net Income": "42.3",
"Other Compr. Net Income": "-16.2",
"Economic Capital Ratio": "105"
},
"2011": {
"Assets": "6.83",
"Stockholders Equity": "120",
"ECR before LimitedLiability": "138",
"Intangible Assets": "17.0",
"Other Liabilities": "14.7",
"Liabilities": "78.9",
"Long Term Liabilities": "43.2",
"Liabilities, Current": "36.8",
"Expenses": "29.7",
"Revenues": "-45.6",
"Net Income": "34.1",
"Other Expenses": "18.0",
"Operating Costs and Expenses": "-9.07",
"Labor Expense": "-11.6",
"General and Administrative Expense": "19.1",
"Cost of Goods and Services Sold": "7.52",
"Other Revenues": "-45.6",
"Other Net Income": "45.0",
"Comprehensive Net Income": "21.8",
"Other Compr. Net Income": "-13.5",
"Economic Capital Ratio": "131"
},
"2012": {
"Assets": "7.48",
"Stockholders Equity": "121",
"ECR before LimitedLiability": "142",
"Intangible Assets": "21.4",
"Liabilities, Current": "37.7",
"Liabilities": "77.5",
"Long Term Liabilities": "33.6",
"Other Liabilities": "22.7",
"Expenses": "28.6",
"Revenues": "-42.7",
"Net Income": "30.6",
"Other Expenses": "14.2",
"General and Administrative Expense": "18.7",
"Operating Costs and Expenses": "-8.72",
"Cost of Goods and Services Sold": "7.42",
"Labor Expense": "-9.68",
"Other Revenues": "-42.7",
"Other Net Income": "40.5",
"Comprehensive Net Income": "19.8",
"Other Compr. Net Income": "-11.8",
"Economic Capital Ratio": "128"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000895930_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "132,956",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "24,910",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "905,858",
"Labor Expense": "213,274",
"Liabilities, Current": "43,563",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "148,878",
"Other Assets": "7,897",
"Other Compr. Net Income": "-129,337",
"Other Expenses": "141,759",
"Other Liabilities": "0",
"Other Net Income": "709,317",
"Other Revenues": "0",
"Property Plant and Equipment": "119,167",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,165,878",
"Liabilities": "43,563",
"Expenses": "528,821",
"Revenues": "0",
"Stockholders Equity": "1,122,315",
"Net Income": "180,496",
"Comprehensive Net Income": "51,159",
"BaseVar": "1,288,458",
"ECR before LimitedLiability": "278%",
"Economic Capital Ratio": "295%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "173,215",
"Assets, Non-Current": "10,522",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "26,175",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,244,723",
"Labor Expense": "243,094",
"Liabilities, Current": "63,654",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "171,759",
"Other Assets": "0",
"Other Compr. Net Income": "-139,602",
"Other Expenses": "155,195",
"Other Liabilities": "0",
"Other Net Income": "786,337",
"Other Revenues": "0",
"Property Plant and Equipment": "144,558",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,573,018",
"Liabilities": "63,654",
"Expenses": "596,223",
"Revenues": "0",
"Stockholders Equity": "1,509,364",
"Net Income": "190,114",
"Comprehensive Net Income": "50,512",
"BaseVar": "1,579,417",
"ECR before LimitedLiability": "274%",
"Economic Capital Ratio": "292%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "192,181",
"Assets, Non-Current": "11,274",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "30,078",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,674,519",
"Labor Expense": "291,713",
"Liabilities, Current": "84,413",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "194,293",
"Other Assets": "0",
"Other Compr. Net Income": "-161,080",
"Other Expenses": "191,643",
"Other Liabilities": "0",
"Other Net Income": "931,370",
"Other Revenues": "0",
"Property Plant and Equipment": "166,612",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,044,586",
"Liabilities": "84,413",
"Expenses": "707,727",
"Revenues": "0",
"Stockholders Equity": "1,960,173",
"Net Income": "223,643",
"Comprehensive Net Income": "62,563",
"BaseVar": "1,964,588",
"ECR before LimitedLiability": "273%",
"Economic Capital Ratio": "291%"
}
}
},
"top_rated": true,
"trend": -1.0,
"value": 2.91446930265018,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000895930.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000895930.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000895930.svg"
},
{
"company_id": "0000352915",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000352915.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000352915.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000352915.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000352915_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000352915_main_keyfigs.svg",
"name": "Universal Health Services Inc",
"rank": 3,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000352915.svg",
"report_text": "The relative strengths and weaknesses of Universal Health Services Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Universal Health Services Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 79% points.The greatest weakness of Universal Health Services Inc is the variable Labor Expense, reducing the Economic Capital Ratio by 43% points.
The company's Economic Capital Ratio, given in the ranking table, is 269%, being 105% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000352915_2013_Universal_Health_Services_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Assets": "3.86",
"Liabilities": "72.2",
"Stockholders Equity": "68.2",
"ECR before LimitedLiability": "73.3",
"Property Plant and Equipment": "8.34",
"Assets, Non-Current": "17.0",
"Other Assets": "-9.32",
"Other Liabilities": "20.5",
"Long Term Liabilities": "56.6",
"Other Expenses": "17.7",
"Expenses": "-16.1",
"Revenues": "-42.2",
"Net Income": "-6.14",
"Cost of Goods and Services Sold": "13.5",
"General and Administrative Expense": "6.28",
"Labor Expense": "-34.0",
"Operating Costs and Expenses": "-19.9",
"Other Revenues": "-42.2",
"Comprehensive Net Income": "-4.95",
"Other Net Income": "46.7",
"Economic Capital Ratio": "75.1"
},
"2011": {
"Other Liabilities": "18.0",
"Liabilities": "84.0",
"Stockholders Equity": "67.5",
"ECR before LimitedLiability": "115",
"Long Term Liabilities": "51.4",
"Liabilities, Current": "31.3",
"Expenses": "-6.31",
"Net Income": "29.5",
"Other Expenses": "23.2",
"Operating Costs and Expenses": "-29.6",
"Labor Expense": "-46.2",
"General and Administrative Expense": "24.9",
"Cost of Goods and Services Sold": "9.88",
"Other Revenues": "-61.7",
"Revenues": "-61.7",
"Other Assets": "-8.66",
"Property Plant and Equipment": "6.09",
"Assets, Non-Current": "15.1",
"Other Net Income": "86.3",
"Comprehensive Net Income": "29.8",
"Economic Capital Ratio": "108"
},
"2012": {
"Liabilities, Current": "30.3",
"Liabilities": "78.9",
"Property Plant and Equipment": "7.38",
"Stockholders Equity": "73.3",
"ECR before LimitedLiability": "119",
"Long Term Liabilities": "38.9",
"Other Liabilities": "26.4",
"Other Revenues": "57.8",
"Revenues": "57.8",
"Net Income": "26.4",
"Assets, Current": "-5.24",
"Other Assets": "-9.04",
"Assets, Non-Current": "16.5",
"Comprehensive Net Income": "26.2",
"Other Expenses": "26.2",
"General and Administrative Expense": "23.5",
"Other Net Income": "-34.7",
"Operating Costs and Expenses": "-29.3",
"Cost of Goods and Services Sold": "9.33",
"Labor Expense": "-43.3",
"Economic Capital Ratio": "105"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000352915_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "1,331,116",
"Assets, Non-Current": "2,943,853",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "223,915",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,589,914",
"Labor Expense": "2,423,102",
"Liabilities, Current": "826,299",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "1,738,381",
"Other Assets": "-2,589,914",
"Other Compr. Net Income": "0",
"Other Expenses": "906,992",
"Other Liabilities": "0",
"Other Net Income": "5,568,185",
"Other Revenues": "0",
"Property Plant and Equipment": "3,252,967",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,527,936",
"Liabilities": "826,299",
"Expenses": "5,292,390",
"Revenues": "0",
"Stockholders Equity": "6,701,637",
"Net Income": "275,795",
"Comprehensive Net Income": "275,795",
"BaseVar": "9,607,405",
"ECR before LimitedLiability": "239%",
"Economic Capital Ratio": "266%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "1,364,905",
"Assets, Non-Current": "3,012,360",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "295,228",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,627,602",
"Labor Expense": "3,394,967",
"Liabilities, Current": "836,933",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "2,207,491",
"Other Assets": "-2,627,602",
"Other Compr. Net Income": "0",
"Other Expenses": "1,153,642",
"Other Liabilities": "0",
"Other Net Income": "7,500,198",
"Other Revenues": "0",
"Property Plant and Equipment": "3,287,980",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,665,245",
"Liabilities": "836,933",
"Expenses": "7,051,328",
"Revenues": "0",
"Stockholders Equity": "6,828,312",
"Net Income": "448,870",
"Comprehensive Net Income": "448,870",
"BaseVar": "11,526,852",
"ECR before LimitedLiability": "243%",
"Economic Capital Ratio": "269%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,407,496",
"Assets, Non-Current": "3,411,112",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "302,426",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,036,765",
"Labor Expense": "3,440,917",
"Liabilities, Current": "894,058",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "2,175,743",
"Other Assets": "-3,036,765",
"Other Compr. Net Income": "-38,580",
"Other Expenses": "553,267",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "6,961,400",
"Property Plant and Equipment": "3,382,235",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,200,843",
"Liabilities": "894,058",
"Expenses": "6,472,353",
"Revenues": "6,961,400",
"Stockholders Equity": "7,306,785",
"Net Income": "489,047",
"Comprehensive Net Income": "450,467",
"BaseVar": "11,283,617",
"ECR before LimitedLiability": "243%",
"Economic Capital Ratio": "269%"
}
}
},
"top_rated": true,
"trend": 1.0,
"value": 2.685072732937495,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000352915.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000352915.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000352915.svg"
},
{
"company_id": "0001022079",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001022079.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001022079.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001022079.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001022079_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001022079_main_keyfigs.svg",
"name": "Quest Diagnostics INC",
"rank": 4,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001022079.svg",
"report_text": "The relative strengths and weaknesses of Quest Diagnostics INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Quest Diagnostics INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 76% points.The greatest weakness of Quest Diagnostics INC is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 58% points.
The company's Economic Capital Ratio, given in the ranking table, is 268%, being 104% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001022079_2013_Quest_Diagnostics_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Assets": "10.8",
"Stockholders Equity": "79.5",
"ECR before LimitedLiability": "71.5",
"Intangible Assets": "9.50",
"Liabilities, Current": "10.4",
"Liabilities": "52.4",
"Long Term Liabilities": "42.0",
"Other Liabilities": "4.28",
"Other Expenses": "16.3",
"Expenses": "7.55",
"Revenues": "36.8",
"Net Income": "1.97",
"General and Administrative Expense": "-16.0",
"Cost of Goods and Services Sold": "-12.9",
"Labor Expense": "5.30",
"Operating Costs and Expenses": "12.5",
"Depreciation, Depletion, Amortization": "1.15",
"Other Revenues": "36.8",
"Comprehensive Net Income": "1.97",
"Other Net Income": "-47.2",
"Economic Capital Ratio": "71.9"
},
"2010": {
"Other Liabilities": "21.1",
"Liabilities": "69.8",
"Assets, Current": "-2.44",
"Stockholders Equity": "52.8",
"ECR before LimitedLiability": "69.0",
"Liabilities, Current": "-4.04",
"Long Term Liabilities": "58.1",
"Other Expenses": "27.5",
"Expenses": "-16.4",
"Cost of Goods and Services Sold": "-53.7",
"General and Administrative Expense": "-19.4",
"Labor Expense": "10.5",
"Operating Costs and Expenses": "11.5",
"Depreciation, Depletion, Amortization": "1.89",
"Other Revenues": "63.7",
"Revenues": "63.7",
"Property Plant and Equipment": "-4.82",
"Intangible Assets": "13.5",
"Economic Capital Ratio": "70.8",
"Other Compr. Net Income": "1.23",
"Other Net Income": "-56.5"
},
"2011": {
"Assets": "6.63",
"Liabilities": "56.5",
"Stockholders Equity": "61.0",
"ECR before LimitedLiability": "95.1",
"Property Plant and Equipment": "-6.00",
"Assets, Current": "-5.90",
"Intangible Assets": "33.5",
"Other Liabilities": "14.1",
"Long Term Liabilities": "41.6",
"Liabilities, Current": "6.50",
"Expenses": "6.49",
"Revenues": "48.3",
"Net Income": "24.5",
"Other Expenses": "26.7",
"Operating Costs and Expenses": "8.11",
"Labor Expense": "12.7",
"Cost of Goods and Services Sold": "-52.2",
"Other Revenues": "48.3",
"Other Net Income": "-33.4",
"Comprehensive Net Income": "24.7",
"Economic Capital Ratio": "88.5"
},
"2012": {
"Property Plant and Equipment": "-3.63",
"Assets": "4.99",
"Liabilities": "74.4",
"Stockholders Equity": "75.7",
"ECR before LimitedLiability": "119",
"Intangible Assets": "23.3",
"Assets, Current": "-5.01",
"Liabilities, Current": "26.7",
"Long Term Liabilities": "37.4",
"Other Liabilities": "25.4",
"Expenses": "4.82",
"Revenues": "53.1",
"Net Income": "26.0",
"Other Expenses": "26.7",
"Operating Costs and Expenses": "6.90",
"Cost of Goods and Services Sold": "-57.7",
"Labor Expense": "14.3",
"Other Revenues": "53.1",
"Other Net Income": "-36.4",
"Comprehensive Net Income": "26.2",
"Economic Capital Ratio": "104"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001022079_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "1,679,425",
"Assets, Non-Current": "150,663",
"Cost of Goods and Services Sold": "4,321,475",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,747,618",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "5,907,609",
"Labor Expense": "0",
"Liabilities, Current": "1,059,212",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "487,513",
"Other Liabilities": "0",
"Other Net Income": "-132,415",
"Other Revenues": "7,455,243",
"Property Plant and Equipment": "825,946",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,563,643",
"Liabilities": "1,059,212",
"Expenses": "6,556,606",
"Revenues": "7,455,243",
"Stockholders Equity": "7,504,431",
"Net Income": "766,222",
"Comprehensive Net Income": "766,222",
"BaseVar": "11,883,560",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "268%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "1,605,417",
"Assets, Non-Current": "189,494",
"Cost of Goods and Services Sold": "4,317,247",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,707,673",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "5,898,343",
"Labor Expense": "0",
"Liabilities, Current": "1,214,268",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "474,001",
"Other Liabilities": "0",
"Other Net Income": "-112,987",
"Other Revenues": "7,368,925",
"Property Plant and Equipment": "834,376",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,527,630",
"Liabilities": "1,214,268",
"Expenses": "6,498,921",
"Revenues": "7,368,925",
"Stockholders Equity": "7,313,362",
"Net Income": "757,017",
"Comprehensive Net Income": "757,017",
"BaseVar": "11,861,366",
"ECR before LimitedLiability": "233%",
"Economic Capital Ratio": "261%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "1,401,260",
"Assets, Non-Current": "280,971",
"Cost of Goods and Services Sold": "4,395,333",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,814,315",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "6,831,377",
"Labor Expense": "0",
"Liabilities, Current": "1,561,159",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "654,794",
"Other Liabilities": "0",
"Other Net Income": "-140,398",
"Other Revenues": "7,510,490",
"Property Plant and Equipment": "799,771",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "9,313,379",
"Liabilities": "1,561,159",
"Expenses": "6,864,442",
"Revenues": "7,510,490",
"Stockholders Equity": "7,752,220",
"Net Income": "505,650",
"Comprehensive Net Income": "505,650",
"BaseVar": "12,694,934",
"ECR before LimitedLiability": "216%",
"Economic Capital Ratio": "249%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,560,997",
"Assets, Non-Current": "204,631",
"Cost of Goods and Services Sold": "4,364,699",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,745,200",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "6,408,020",
"Labor Expense": "0",
"Liabilities, Current": "1,047,603",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "354,384",
"Other Compr. Net Income": "-14,026",
"Other Expenses": "473,763",
"Other Liabilities": "0",
"Other Net Income": "-206,766",
"Other Revenues": "7,382,562",
"Property Plant and Equipment": "755,831",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "9,283,863",
"Liabilities": "1,047,603",
"Expenses": "6,583,662",
"Revenues": "7,382,562",
"Stockholders Equity": "8,236,260",
"Net Income": "592,134",
"Comprehensive Net Income": "578,108",
"BaseVar": "12,259,241",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "268%"
}
}
},
"top_rated": true,
"trend": 7.0,
"value": 2.6812924683315793,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001022079.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001022079.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001022079.svg"
},
{
"company_id": "0001043000",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001043000.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001043000.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001043000.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001043000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001043000_main_keyfigs.svg",
"name": "Sonida Senior Living INC",
"rank": 5,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001043000.svg",
"report_text": "The relative strengths and weaknesses of Sonida Senior Living INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Sonida Senior Living INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 97% points.The greatest weakness of Sonida Senior Living INC is the variable Other Expenses, reducing the Economic Capital Ratio by 29% points.
The company's Economic Capital Ratio, given in the ranking table, is 265%, being 101% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001043000_2013_Sonida_Senior_Living_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "12.3",
"Stockholders Equity": "97.2",
"ECR before LimitedLiability": "116",
"Property Plant and Equipment": "38.9",
"Intangible Assets": "-5.62",
"Other Liabilities": "13.9",
"Liabilities": "66.4",
"Long Term Liabilities": "40.8",
"Liabilities, Current": "22.5",
"Expenses": "11.1",
"Revenues": "33.4",
"Net Income": "17.7",
"Other Expenses": "-36.0",
"Operating Costs and Expenses": "7.52",
"Labor Expense": "11.8",
"General and Administrative Expense": "15.3",
"Cost of Goods and Services Sold": "7.49",
"Other Revenues": "33.4",
"Other Net Income": "-29.2",
"Comprehensive Net Income": "17.9",
"Economic Capital Ratio": "109"
},
"2012": {
"Property Plant and Equipment": "55.0",
"Assets": "15.6",
"Liabilities": "59.5",
"Stockholders Equity": "97.1",
"ECR before LimitedLiability": "115",
"Intangible Assets": "-5.67",
"Assets, Current": "-5.66",
"Liabilities, Current": "18.7",
"Long Term Liabilities": "30.1",
"Other Liabilities": "20.3",
"Expenses": "12.3",
"Revenues": "25.5",
"Net Income": "13.7",
"Other Expenses": "-28.9",
"General and Administrative Expense": "14.6",
"Cost of Goods and Services Sold": "7.07",
"Labor Expense": "11.3",
"Other Revenues": "25.5",
"Other Net Income": "-25.9",
"Comprehensive Net Income": "14.0",
"Economic Capital Ratio": "101"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001043000_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "60,999",
"Assets, Non-Current": "29,016",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "18,299",
"General and Administrative Expense": "13,198",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "40,213",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "6,852",
"Other Compr. Net Income": "0",
"Other Expenses": "228,493",
"Other Liabilities": "0",
"Other Net Income": "-487",
"Other Revenues": "263,502",
"Property Plant and Equipment": "365,459",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "462,326",
"Liabilities": "40,213",
"Expenses": "259,990",
"Revenues": "263,502",
"Stockholders Equity": "422,113",
"Net Income": "3,025",
"Comprehensive Net Income": "3,025",
"BaseVar": "513,259",
"ECR before LimitedLiability": "245%",
"Economic Capital Ratio": "270%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "56,442",
"Assets, Non-Current": "42,917",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "35,130",
"General and Administrative Expense": "16,114",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "62,154",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "10,424",
"Other Compr. Net Income": "0",
"Other Expenses": "262,628",
"Other Liabilities": "0",
"Other Net Income": "217",
"Other Revenues": "310,536",
"Property Plant and Equipment": "527,159",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "636,942",
"Liabilities": "62,154",
"Expenses": "313,872",
"Revenues": "310,536",
"Stockholders Equity": "574,788",
"Net Income": "-3,119",
"Comprehensive Net Income": "-3,119",
"BaseVar": "661,860",
"ECR before LimitedLiability": "238%",
"Economic Capital Ratio": "265%"
}
}
},
"top_rated": true,
"trend": -2.0,
"value": 2.645663903650976,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001043000.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001043000.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001043000.svg"
},
{
"company_id": "0001091312",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001091312.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001091312.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001091312_main_keyfigs.svg",
"name": "Symbion INC TN",
"rank": 6,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001091312.svg",
"report_text": "The relative strengths and weaknesses of Symbion INC TN are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Symbion INC TN compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 94% points.The greatest weakness of Symbion INC TN is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 42% points.
The company's Economic Capital Ratio, given in the ranking table, is 261%, being 98% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001091312_2013_Symbion_INC_TN.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "14.9",
"Stockholders Equity": "110",
"ECR before LimitedLiability": "121",
"Intangible Assets": "22.4",
"Other Liabilities": "12.9",
"Liabilities": "63.8",
"Long Term Liabilities": "38.4",
"Liabilities, Current": "22.6",
"Expenses": "17.3",
"Revenues": "23.8",
"Net Income": "16.4",
"Research And Development Expense": "2.10",
"Other Expenses": "52.9",
"Operating Costs and Expenses": "-13.0",
"Labor Expense": "-6.84",
"General and Administrative Expense": "14.3",
"Cost of Goods and Services Sold": "-40.9",
"Other Revenues": "23.8",
"Other Net Income": "-26.4",
"Comprehensive Net Income": "16.6",
"Economic Capital Ratio": "115"
},
"2012": {
"Assets": "15.8",
"Stockholders Equity": "94.0",
"ECR before LimitedLiability": "112",
"Intangible Assets": "30.2",
"Liabilities, Current": "17.2",
"Liabilities": "58.2",
"Long Term Liabilities": "30.0",
"Other Liabilities": "20.1",
"Expenses": "16.0",
"Revenues": "26.0",
"Net Income": "17.7",
"Other Expenses": "54.3",
"General and Administrative Expense": "14.6",
"Operating Costs and Expenses": "-15.7",
"Cost of Goods and Services Sold": "-42.5",
"Labor Expense": "-6.78",
"Other Revenues": "26.0",
"Other Net Income": "-26.0",
"Comprehensive Net Income": "13.2",
"Other Compr. Net Income": "-4.74",
"Economic Capital Ratio": "97.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001091312_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "159,862",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "316,978",
"Depreciation, Depletion, Amortization": "20,263",
"General and Administrative Expense": "22,723",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "657,064",
"Labor Expense": "123,085",
"Liabilities, Current": "70,841",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "137,202",
"Other Assets": "31,363",
"Other Compr. Net Income": "0",
"Other Expenses": "-182,325",
"Other Liabilities": "0",
"Other Net Income": "207",
"Other Revenues": "444,653",
"Property Plant and Equipment": "129,805",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "978,094",
"Liabilities": "70,841",
"Expenses": "437,926",
"Revenues": "444,653",
"Stockholders Equity": "907,253",
"Net Income": "6,934",
"Comprehensive Net Income": "6,934",
"BaseVar": "965,860",
"ECR before LimitedLiability": "252%",
"Economic Capital Ratio": "275%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "173,095",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "365,270",
"Depreciation, Depletion, Amortization": "21,923",
"General and Administrative Expense": "26,901",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "680,609",
"Labor Expense": "140,985",
"Liabilities, Current": "106,019",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "161,718",
"Other Assets": "31,345",
"Other Compr. Net Income": "-38,798",
"Other Expenses": "-235,770",
"Other Liabilities": "0",
"Other Net Income": "122",
"Other Revenues": "507,993",
"Property Plant and Equipment": "132,154",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,017,203",
"Liabilities": "106,019",
"Expenses": "481,027",
"Revenues": "507,993",
"Stockholders Equity": "911,184",
"Net Income": "27,088",
"Comprehensive Net Income": "-11,710",
"BaseVar": "1,075,581",
"ECR before LimitedLiability": "233%",
"Economic Capital Ratio": "261%"
}
}
},
"top_rated": true,
"trend": -4.0,
"value": 2.6137670650404576,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001091312.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001091312.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001091312.svg"
},
{
"company_id": "0000806517",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000806517.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000806517.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000806517.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000806517_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000806517_main_keyfigs.svg",
"name": "Psychemedics CORP",
"rank": 7,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000806517.svg",
"report_text": "The relative strengths and weaknesses of Psychemedics CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Psychemedics CORP compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 83% points.The greatest weakness of Psychemedics CORP is the variable Other Revenues, reducing the Economic Capital Ratio by 54% points.
The company's Economic Capital Ratio, given in the ranking table, is 256%, being 93% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000806517_2013_Psychemedics_CORP.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "21.7",
"Liabilities": "60.0",
"Stockholders Equity": "44.0",
"ECR before LimitedLiability": "107",
"Long Term Liabilities": "36.9",
"Other Liabilities": "9.72",
"Expenses": "6.16",
"Revenues": "-53.7",
"Net Income": "41.8",
"Other Expenses": "18.3",
"General and Administrative Expense": "-9.75",
"Selling and Marketing Expense": "-37.6",
"Operating Costs and Expenses": "7.04",
"Cost of Goods and Services Sold": "9.10",
"Labor Expense": "14.5",
"Other Revenues": "-53.7",
"Intangible Assets": "-8.52",
"Assets, Current": "13.4",
"Other Net Income": "82.7",
"Comprehensive Net Income": "42.2",
"Economic Capital Ratio": "92.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000806517_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "9,574",
"Assets, Non-Current": "345",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "3,947",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,083",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,958",
"Other Liabilities": "815",
"Other Net Income": "14,254",
"Other Revenues": "0",
"Property Plant and Equipment": "4,201",
"Research And Development Expense": "826",
"Selling and Marketing Expense": "4,544"
},
"output_variables": {
"Assets": "14,121",
"Liabilities": "2,898",
"Expenses": "11,274",
"Revenues": "0",
"Stockholders Equity": "11,223",
"Net Income": "2,980",
"Comprehensive Net Income": "2,980",
"BaseVar": "21,273",
"ECR before LimitedLiability": "226%",
"Economic Capital Ratio": "256%"
}
}
},
"top_rated": true,
"trend": null,
"value": 2.5638838321935724,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000806517.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000806517.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000806517.svg"
},
{
"company_id": "0001294632",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001294632.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001294632.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001294632_main_keyfigs.svg",
"name": "Iasis Healthcare LLC",
"rank": 8,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001294632.svg",
"report_text": "The relative strengths and weaknesses of Iasis Healthcare LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Iasis Healthcare LLC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 80% points.The greatest weakness of Iasis Healthcare LLC is the variable Other Revenues, reducing the Economic Capital Ratio by 57% points.
The company's Economic Capital Ratio, given in the ranking table, is 255%, being 92% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001294632_2013_Iasis_Healthcare_LLC.pdf",
"shrinked_graph_json": {
"2011": {
"Other Liabilities": "17.0",
"Liabilities": "76.7",
"Stockholders Equity": "52.9",
"ECR before LimitedLiability": "98.1",
"Long Term Liabilities": "49.2",
"Liabilities, Current": "23.1",
"Expenses": "-11.7",
"Revenues": "-61.1",
"Net Income": "23.7",
"Research And Development Expense": "2.99",
"Other Expenses": "-21.3",
"Operating Costs and Expenses": "-10.2",
"Labor Expense": "-23.0",
"General and Administrative Expense": "24.7",
"Cost of Goods and Services Sold": "9.76",
"Other Revenues": "-61.1",
"Property Plant and Equipment": "7.81",
"Assets, Current": "-4.89",
"Other Net Income": "88.2",
"Comprehensive Net Income": "24.0",
"Economic Capital Ratio": "91.4"
},
"2012": {
"Liabilities, Current": "27.0",
"Liabilities": "77.3",
"Stockholders Equity": "59.1",
"ECR before LimitedLiability": "106",
"Long Term Liabilities": "38.8",
"Other Liabilities": "26.4",
"Research And Development Expense": "3.78",
"Expenses": "-10.8",
"Revenues": "-57.3",
"Net Income": "20.9",
"Other Expenses": "-8.99",
"General and Administrative Expense": "24.3",
"Operating Costs and Expenses": "-14.9",
"Cost of Goods and Services Sold": "9.65",
"Labor Expense": "-29.6",
"Other Revenues": "-57.3",
"Property Plant and Equipment": "9.83",
"Assets, Current": "-6.43",
"Other Net Income": "80.5",
"Comprehensive Net Income": "21.3",
"Economic Capital Ratio": "91.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001294632_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "606,918",
"Assets, Non-Current": "63,509",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "104,241",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "808,651",
"Labor Expense": "818,742",
"Liabilities, Current": "381,802",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "431,070",
"Other Assets": "32,779",
"Other Compr. Net Income": "0",
"Other Expenses": "1,388,487",
"Other Liabilities": "0",
"Other Net Income": "2,781,600",
"Other Revenues": "0",
"Property Plant and Equipment": "1,167,920",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,679,777",
"Liabilities": "381,802",
"Expenses": "2,742,540",
"Revenues": "0",
"Stockholders Equity": "2,297,975",
"Net Income": "39,060",
"Comprehensive Net Income": "39,060",
"BaseVar": "4,292,860",
"ECR before LimitedLiability": "220%",
"Economic Capital Ratio": "252%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "593,876",
"Assets, Non-Current": "68,498",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "114,358",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "818,424",
"Labor Expense": "938,471",
"Liabilities, Current": "352,902",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "470,733",
"Other Assets": "29,161",
"Other Compr. Net Income": "0",
"Other Expenses": "983,208",
"Other Liabilities": "0",
"Other Net Income": "2,538,358",
"Other Revenues": "0",
"Property Plant and Equipment": "1,171,657",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,681,616",
"Liabilities": "352,902",
"Expenses": "2,506,770",
"Revenues": "0",
"Stockholders Equity": "2,328,714",
"Net Income": "31,588",
"Comprehensive Net Income": "31,588",
"BaseVar": "4,039,823",
"ECR before LimitedLiability": "225%",
"Economic Capital Ratio": "255%"
}
}
},
"top_rated": true,
"trend": 1.0,
"value": 2.552281403405068,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001294632.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001294632.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001294632.svg"
},
{
"company_id": "0000744825",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000744825.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000744825.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000744825.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000744825_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000744825_main_keyfigs.svg",
"name": "American Shared Hospital Services",
"rank": 9,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000744825.svg",
"report_text": "The relative strengths and weaknesses of American Shared Hospital Services are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of American Shared Hospital Services compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 104% points.The greatest weakness of American Shared Hospital Services is the variable Other Net Income, reducing the Economic Capital Ratio by 19% points.
The company's Economic Capital Ratio, given in the ranking table, is 255%, being 91% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000744825_2013_American_Shared_Hospital_Services.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "29.9",
"Liabilities": "33.5",
"Stockholders Equity": "100",
"ECR before LimitedLiability": "102",
"Property Plant and Equipment": "43.9",
"Intangible Assets": "-5.98",
"Other Liabilities": "9.64",
"Long Term Liabilities": "29.3",
"Expenses": "26.5",
"Revenues": "-22.7",
"Net Income": "14.5",
"Other Expenses": "28.7",
"Depreciation, Depletion, Amortization": "-8.66",
"Operating Costs and Expenses": "5.36",
"Labor Expense": "8.41",
"General and Administrative Expense": "6.97",
"Cost of Goods and Services Sold": "-19.2",
"Other Revenues": "-22.7",
"Other Net Income": "9.22",
"Comprehensive Net Income": "14.7",
"Economic Capital Ratio": "95.0"
},
"2012": {
"Property Plant and Equipment": "51.1",
"Assets": "33.2",
"Stockholders Equity": "104",
"ECR before LimitedLiability": "106",
"Intangible Assets": "-5.32",
"Liabilities, Current": "-4.28",
"Liabilities": "31.1",
"Long Term Liabilities": "22.0",
"Other Liabilities": "14.6",
"Research And Development Expense": "2.00",
"Expenses": "27.4",
"Other Net Income": "-18.6",
"Net Income": "11.8",
"Depreciation, Depletion, Amortization": "-9.00",
"Other Expenses": "25.3",
"General and Administrative Expense": "6.22",
"Operating Costs and Expenses": "3.96",
"Cost of Goods and Services Sold": "-12.5",
"Labor Expense": "8.22",
"Comprehensive Net Income": "12.0",
"Economic Capital Ratio": "91.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000744825_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "17,615",
"Assets, Non-Current": "997",
"Cost of Goods and Services Sold": "14,224",
"Depreciation, Depletion, Amortization": "6,127",
"General and Administrative Expense": "4,041",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "9,944",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "2,656",
"Other Compr. Net Income": "0",
"Other Expenses": "-3,552",
"Other Liabilities": "0",
"Other Net Income": "17,237",
"Other Revenues": "5,092",
"Property Plant and Equipment": "53,267",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "74,535",
"Liabilities": "9,944",
"Expenses": "20,840",
"Revenues": "5,092",
"Stockholders Equity": "64,591",
"Net Income": "1,489",
"Comprehensive Net Income": "1,489",
"BaseVar": "63,824",
"ECR before LimitedLiability": "225%",
"Economic Capital Ratio": "256%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "15,956",
"Assets, Non-Current": "1,003",
"Cost of Goods and Services Sold": "10,118",
"Depreciation, Depletion, Amortization": "5,965",
"General and Administrative Expense": "4,045",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "9,653",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "2,687",
"Other Compr. Net Income": "0",
"Other Expenses": "-3,703",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "17,238",
"Property Plant and Equipment": "53,677",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "73,323",
"Liabilities": "9,653",
"Expenses": "16,425",
"Revenues": "17,238",
"Stockholders Equity": "63,670",
"Net Income": "813",
"Comprehensive Net Income": "813",
"BaseVar": "58,320",
"ECR before LimitedLiability": "224%",
"Economic Capital Ratio": "255%"
}
}
},
"top_rated": true,
"trend": -1.0,
"value": 2.551247108479799,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000744825.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000744825.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000744825.svg"
},
{
"company_id": "0001138476",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001138476.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001138476.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001138476.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001138476_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001138476_main_keyfigs.svg",
"name": "Pacific Health CARE Organization INC",
"rank": 10,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001138476.svg",
"report_text": "The relative strengths and weaknesses of Pacific Health CARE Organization INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Pacific Health CARE Organization INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 168% points.The greatest weakness of Pacific Health CARE Organization INC is the variable Labor Expense, reducing the Economic Capital Ratio by 71% points.
The company's Economic Capital Ratio, given in the ranking table, is 255%, being 91% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001138476_2013_Pacific_Health_CARE_Organization_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-27.7",
"Liabilities": "127",
"Stockholders Equity": "-59.4",
"ECR before LimitedLiability": "87.1",
"Property Plant and Equipment": "-16.9",
"Assets, Current": "12.6",
"Intangible Assets": "-20.1",
"Other Liabilities": "26.6",
"Long Term Liabilities": "78.1",
"Liabilities, Current": "46.1",
"Expenses": "-76.0",
"Revenues": "164",
"Net Income": "58.9",
"Research And Development Expense": "5.31",
"Operating Costs and Expenses": "-20.2",
"Labor Expense": "-103",
"Cost of Goods and Services Sold": "17.3",
"Other Revenues": "164",
"Other Net Income": "-71.4",
"Comprehensive Net Income": "59.4",
"Economic Capital Ratio": "80.4"
},
"2012": {
"Property Plant and Equipment": "-10.7",
"Assets": "-19.3",
"Stockholders Equity": "-42.9",
"ECR before LimitedLiability": "105",
"Intangible Assets": "-13.8",
"Liabilities, Current": "40.5",
"Liabilities": "113",
"Long Term Liabilities": "59.5",
"Other Liabilities": "39.1",
"Expenses": "-50.7",
"Revenues": "168",
"Net Income": "68.5",
"Other Expenses": "-18.0",
"General and Administrative Expense": "14.5",
"Operating Costs and Expenses": "-14.5",
"Cost of Goods and Services Sold": "16.0",
"Labor Expense": "-71.2",
"Other Revenues": "168",
"Other Net Income": "-62.1",
"Comprehensive Net Income": "69.2",
"Economic Capital Ratio": "90.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001138476_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "980",
"Assets, Non-Current": "8.2",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "14",
"General and Administrative Expense": "392",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "1,132",
"Liabilities, Current": "257",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "359",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "735",
"Other Liabilities": "7.1",
"Other Net Income": "-1.5",
"Other Revenues": "2,832",
"Property Plant and Equipment": "71",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,059",
"Liabilities": "264",
"Expenses": "2,632",
"Revenues": "2,832",
"Stockholders Equity": "796",
"Net Income": "198",
"Comprehensive Net Income": "198",
"BaseVar": "3,394",
"ECR before LimitedLiability": "204%",
"Economic Capital Ratio": "241%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,873",
"Assets, Non-Current": "8.2",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "29",
"General and Administrative Expense": "491",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "1,655",
"Liabilities, Current": "520",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "487",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,454",
"Other Liabilities": "21",
"Other Net Income": "0.32",
"Other Revenues": "4,827",
"Property Plant and Equipment": "168",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,049",
"Liabilities": "542",
"Expenses": "4,116",
"Revenues": "4,827",
"Stockholders Equity": "1,507",
"Net Income": "711",
"Comprehensive Net Income": "711",
"BaseVar": "5,767",
"ECR before LimitedLiability": "224%",
"Economic Capital Ratio": "255%"
}
}
},
"top_rated": true,
"trend": 4.0,
"value": 2.5452467119248356,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001138476.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001138476.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001138476.svg"
},
{
"company_id": "0000931059",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000931059.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000931059.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000931059.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000931059_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000931059_main_keyfigs.svg",
"name": "Rennova Health Inc",
"rank": 11,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000931059.svg",
"report_text": "The relative strengths and weaknesses of Rennova Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Rennova Health Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 128% points.The greatest weakness of Rennova Health Inc is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 28% points.
The company's Economic Capital Ratio, given in the ranking table, is 254%, being 90% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000931059_2013_Rennova_Health_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "14.7",
"Assets": "79.9",
"Liabilities": "12.9",
"Stockholders Equity": "112",
"ECR before LimitedLiability": "58.3",
"Property Plant and Equipment": "-7.67",
"Assets, Current": "125",
"Intangible Assets": "-9.17",
"Other Liabilities": "6.52",
"Long Term Liabilities": "20.6",
"Liabilities, Current": "-16.2",
"Expenses": "28.7",
"Revenues": "-23.4",
"Net Income": "-22.7",
"Other Expenses": "18.0",
"Labor Expense": "6.45",
"General and Administrative Expense": "-8.58",
"Other Revenues": "-23.4",
"Other Net Income": "-28.3",
"Comprehensive Net Income": "-22.7",
"Economic Capital Ratio": "51.7"
},
"2012": {
"Property Plant and Equipment": "-4.57",
"Assets": "41.3",
"Liabilities": "45.6",
"Stockholders Equity": "128",
"ECR before LimitedLiability": "105",
"Intangible Assets": "-5.44",
"Assets, Current": "113",
"Liabilities, Current": "14.6",
"Long Term Liabilities": "22.0",
"Other Liabilities": "14.6",
"Expenses": "16.2",
"Revenues": "-27.6",
"Net Income": "-11.6",
"Other Expenses": "19.3",
"General and Administrative Expense": "-28.1",
"Operating Costs and Expenses": "3.97",
"Cost of Goods and Services Sold": "5.14",
"Labor Expense": "8.24",
"Other Revenues": "-27.6",
"Comprehensive Net Income": "-11.0",
"Economic Capital Ratio": "90.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000931059_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "9,043",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,883",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,792",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "2,046",
"Other Compr. Net Income": "-18",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-1,263",
"Other Revenues": "16",
"Property Plant and Equipment": "112",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "11,201",
"Liabilities": "1,792",
"Expenses": "1,883",
"Revenues": "16",
"Stockholders Equity": "9,409",
"Net Income": "-3,130",
"Comprehensive Net Income": "-3,148",
"BaseVar": "8,086",
"ECR before LimitedLiability": "162%",
"Economic Capital Ratio": "212%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "8,294",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,615",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "582",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "312",
"Other Compr. Net Income": "25",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "1,086",
"Other Revenues": "100",
"Property Plant and Equipment": "56",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,662",
"Liabilities": "582",
"Expenses": "2,615",
"Revenues": "100",
"Stockholders Equity": "8,080",
"Net Income": "-1,429",
"Comprehensive Net Income": "-1,404",
"BaseVar": "6,535",
"ECR before LimitedLiability": "223%",
"Economic Capital Ratio": "254%"
}
}
},
"top_rated": true,
"trend": 12.0,
"value": 2.5414217519634867,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000931059.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000931059.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000931059.svg"
},
{
"company_id": "0001522138",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001522138.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001522138.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001522138_main_keyfigs.svg",
"name": "Capella Healthcare Inc",
"rank": 12,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001522138.svg",
"report_text": "The relative strengths and weaknesses of Capella Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Capella Healthcare Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 74% points.The greatest weakness of Capella Healthcare Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 54% points.
The company's Economic Capital Ratio, given in the ranking table, is 253%, being 90% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001522138_2013_Capella_Healthcare_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "4.46",
"Stockholders Equity": "72.1",
"ECR before LimitedLiability": "105",
"Property Plant and Equipment": "15.7",
"Intangible Assets": "-4.43",
"Other Liabilities": "16.1",
"Liabilities": "75.6",
"Long Term Liabilities": "46.6",
"Liabilities, Current": "26.1",
"Expenses": "-5.86",
"Revenues": "-56.0",
"Net Income": "18.2",
"Other Expenses": "5.64",
"Operating Costs and Expenses": "-8.01",
"Labor Expense": "-43.0",
"General and Administrative Expense": "22.8",
"Cost of Goods and Services Sold": "9.01",
"Other Revenues": "-56.0",
"Other Net Income": "71.5",
"Comprehensive Net Income": "18.4",
"Economic Capital Ratio": "98.1"
},
"2012": {
"Liabilities, Current": "25.6",
"Liabilities": "74.1",
"Stockholders Equity": "64.2",
"ECR before LimitedLiability": "104",
"Long Term Liabilities": "37.1",
"Other Liabilities": "25.2",
"Research And Development Expense": "3.60",
"Expenses": "-8.97",
"Revenues": "-54.5",
"Net Income": "16.8",
"Depreciation, Depletion, Amortization": "-3.45",
"General and Administrative Expense": "23.2",
"Operating Costs and Expenses": "-11.9",
"Cost of Goods and Services Sold": "9.22",
"Labor Expense": "-39.4",
"Other Revenues": "-54.5",
"Property Plant and Equipment": "19.8",
"Assets, Current": "-5.76",
"Other Net Income": "72.6",
"Comprehensive Net Income": "17.2",
"Economic Capital Ratio": "89.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001522138_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "211,000",
"Assets, Non-Current": "29,900",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "33,700",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "117,300",
"Labor Expense": "332,100",
"Liabilities, Current": "86,100",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "103,100",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "208,400",
"Other Liabilities": "0",
"Other Net Income": "664,000",
"Other Revenues": "0",
"Property Plant and Equipment": "426,500",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "784,700",
"Liabilities": "86,100",
"Expenses": "677,300",
"Revenues": "0",
"Stockholders Equity": "698,600",
"Net Income": "-13,300",
"Comprehensive Net Income": "-13,300",
"BaseVar": "1,106,050",
"ECR before LimitedLiability": "230%",
"Economic Capital Ratio": "259%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "194,800",
"Assets, Non-Current": "29,300",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "39,600",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "146,700",
"Labor Expense": "350,400",
"Liabilities, Current": "106,800",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "126,700",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "228,100",
"Other Liabilities": "0",
"Other Net Income": "732,000",
"Other Revenues": "0",
"Property Plant and Equipment": "473,600",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "844,400",
"Liabilities": "106,800",
"Expenses": "744,800",
"Revenues": "0",
"Stockholders Equity": "737,600",
"Net Income": "-12,800",
"Comprehensive Net Income": "-12,800",
"BaseVar": "1,214,000",
"ECR before LimitedLiability": "222%",
"Economic Capital Ratio": "253%"
}
}
},
"top_rated": true,
"trend": -6.0,
"value": 2.5348779091619367,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001522138.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001522138.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001522138.svg"
},
{
"company_id": "0001131324",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001131324.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001131324.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001131324.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001131324_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001131324_main_keyfigs.svg",
"name": "Genomic Health INC",
"rank": 13,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001131324.svg",
"report_text": "The relative strengths and weaknesses of Genomic Health INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Genomic Health INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 113% points.The greatest weakness of Genomic Health INC is the variable Selling and Marketing Expense, reducing the Economic Capital Ratio by 78% points.
The company's Economic Capital Ratio, given in the ranking table, is 250%, being 86% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001131324_2013_Genomic_Health_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Other Liabilities": "19.6",
"Liabilities": "86.9",
"Stockholders Equity": "21.9",
"ECR before LimitedLiability": "90.7",
"Long Term Liabilities": "56.0",
"Liabilities, Current": "25.4",
"Selling and Marketing Expense": "-72.7",
"Expenses": "-27.0",
"Revenues": "102",
"Net Income": "32.2",
"Research And Development Expense": "-30.4",
"Other Expenses": "23.0",
"Operating Costs and Expenses": "11.6",
"Labor Expense": "18.2",
"Cost of Goods and Services Sold": "11.6",
"Other Revenues": "102",
"Assets, Current": "34.7",
"Intangible Assets": "-14.1",
"Other Net Income": "-46.0",
"Comprehensive Net Income": "32.5",
"Economic Capital Ratio": "84.0"
},
"2012": {
"Assets": "-12.3",
"Stockholders Equity": "18.2",
"ECR before LimitedLiability": "100",
"Intangible Assets": "-12.8",
"Assets, Current": "16.8",
"Liabilities, Current": "38.3",
"Liabilities": "99.4",
"Long Term Liabilities": "48.8",
"Other Liabilities": "33.5",
"Research And Development Expense": "-35.2",
"Expenses": "-38.1",
"Revenues": "113",
"Net Income": "31.9",
"Other Expenses": "19.7",
"Selling and Marketing Expense": "-77.5",
"Cost of Goods and Services Sold": "12.8",
"Labor Expense": "20.4",
"Other Revenues": "113",
"Other Net Income": "-48.4",
"Comprehensive Net Income": "32.5",
"Economic Capital Ratio": "86.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001131324_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "128,995",
"Assets, Non-Current": "4,560",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "40,543",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "26,139",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "34,261",
"Other Liabilities": "0",
"Other Net Income": "16",
"Other Revenues": "206,111",
"Property Plant and Equipment": "9,443",
"Research And Development Expense": "39,864",
"Selling and Marketing Expense": "83,613"
},
"output_variables": {
"Assets": "142,998",
"Liabilities": "26,139",
"Expenses": "198,281",
"Revenues": "206,111",
"Stockholders Equity": "116,859",
"Net Income": "7,846",
"Comprehensive Net Income": "7,846",
"BaseVar": "286,772",
"ECR before LimitedLiability": "210%",
"Economic Capital Ratio": "245%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "130,209",
"Assets, Non-Current": "9,421",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "47,064",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "25,340",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "45",
"Other Expenses": "37,440",
"Other Liabilities": "0",
"Other Net Income": "237",
"Other Revenues": "235,173",
"Property Plant and Equipment": "14,104",
"Research And Development Expense": "49,104",
"Selling and Marketing Expense": "93,553"
},
"output_variables": {
"Assets": "153,734",
"Liabilities": "25,340",
"Expenses": "227,161",
"Revenues": "235,173",
"Stockholders Equity": "128,394",
"Net Income": "8,249",
"Comprehensive Net Income": "8,294",
"BaseVar": "320,845",
"ECR before LimitedLiability": "217%",
"Economic Capital Ratio": "250%"
}
}
},
"top_rated": true,
"trend": -1.0,
"value": 2.4995433733357273,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001131324.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001131324.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001131324.svg"
},
{
"company_id": "0000731012",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000731012.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000731012.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000731012.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000731012_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000731012_main_keyfigs.svg",
"name": "Healthcare Services Group Inc",
"rank": 14,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000731012.svg",
"report_text": "The relative strengths and weaknesses of Healthcare Services Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Healthcare Services Group Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 87% points.The greatest weakness of Healthcare Services Group Inc is the variable Liabilities, Current, reducing the Economic Capital Ratio by 31% points.
The company's Economic Capital Ratio, given in the ranking table, is 247%, being 84% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000731012_2013_Healthcare_Services_Group_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "49.9",
"Assets": "29.0",
"Liabilities": "21.3",
"Stockholders Equity": "99.0",
"ECR before LimitedLiability": "72.3",
"Other Assets": "3.90",
"Intangible Assets": "-4.32",
"Other Liabilities": "11.4",
"Liabilities, Current": "-30.1",
"Long Term Liabilities": "33.3",
"Other Expenses": "9.01",
"Expenses": "30.9",
"Revenues": "-21.9",
"Net Income": "9.88",
"Cost of Goods and Services Sold": "7.28",
"General and Administrative Expense": "3.37",
"Labor Expense": "5.40",
"Operating Costs and Expenses": "5.94",
"Other Revenues": "-21.9",
"Comprehensive Net Income": "10.5",
"Economic Capital Ratio": "74.1"
},
"2011": {
"Other Assets": "3.65",
"Assets": "34.8",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "108",
"Assets, Current": "48.3",
"Other Liabilities": "8.19",
"Liabilities": "16.3",
"Long Term Liabilities": "25.2",
"Liabilities, Current": "-20.6",
"Expenses": "41.3",
"Revenues": "-26.3",
"Net Income": "25.8",
"Other Expenses": "11.0",
"Operating Costs and Expenses": "4.45",
"Labor Expense": "6.98",
"General and Administrative Expense": "11.3",
"Cost of Goods and Services Sold": "4.43",
"Other Revenues": "-26.3",
"Other Net Income": "8.56",
"Comprehensive Net Income": "26.0",
"Economic Capital Ratio": "101"
},
"2012": {
"Property Plant and Equipment": "-3.62",
"Assets": "38.0",
"Liabilities": "6.30",
"Stockholders Equity": "87.3",
"ECR before LimitedLiability": "98.0",
"Assets, Current": "52.4",
"Other Assets": "4.96",
"Liabilities, Current": "-30.6",
"Long Term Liabilities": "18.9",
"Other Liabilities": "12.5",
"Expenses": "38.4",
"Revenues": "-25.1",
"Net Income": "24.0",
"Other Expenses": "7.87",
"General and Administrative Expense": "11.3",
"Cost of Goods and Services Sold": "4.44",
"Labor Expense": "7.13",
"Other Revenues": "-25.1",
"Other Net Income": "8.88",
"Comprehensive Net Income": "24.1",
"Economic Capital Ratio": "83.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000731012_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "221,775",
"Assets, Non-Current": "42",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "16,955",
"Labor Expense": "0",
"Liabilities, Current": "40,531",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "32,506",
"Other Compr. Net Income": "0",
"Other Expenses": "19,678",
"Other Liabilities": "0",
"Other Net Income": "54,119",
"Other Revenues": "0",
"Property Plant and Equipment": "6,656",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "277,934",
"Liabilities": "40,531",
"Expenses": "19,678",
"Revenues": "0",
"Stockholders Equity": "237,403",
"Net Income": "34,441",
"Comprehensive Net Income": "34,441",
"BaseVar": "196,131",
"ECR before LimitedLiability": "238%",
"Economic Capital Ratio": "265%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "232,121",
"Assets, Non-Current": "40",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "16,955",
"Labor Expense": "0",
"Liabilities, Current": "45,387",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "30,816",
"Other Compr. Net Income": "0",
"Other Expenses": "19,656",
"Other Liabilities": "0",
"Other Net Income": "57,812",
"Other Revenues": "0",
"Property Plant and Equipment": "9,763",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "289,695",
"Liabilities": "45,387",
"Expenses": "19,656",
"Revenues": "0",
"Stockholders Equity": "244,308",
"Net Income": "38,156",
"Comprehensive Net Income": "38,156",
"BaseVar": "206,275",
"ECR before LimitedLiability": "234%",
"Economic Capital Ratio": "262%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "267,846",
"Assets, Non-Current": "38",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "16,955",
"Labor Expense": "0",
"Liabilities, Current": "67,664",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "36,072",
"Other Compr. Net Income": "-216",
"Other Expenses": "26,050",
"Other Liabilities": "0",
"Other Net Income": "70,264",
"Other Revenues": "0",
"Property Plant and Equipment": "10,272",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "331,183",
"Liabilities": "67,664",
"Expenses": "26,050",
"Revenues": "0",
"Stockholders Equity": "263,519",
"Net Income": "44,214",
"Comprehensive Net Income": "43,998",
"BaseVar": "247,688",
"ECR before LimitedLiability": "214%",
"Economic Capital Ratio": "247%"
}
}
},
"top_rated": true,
"trend": -9.0,
"value": 2.474823988384418,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000731012.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000731012.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000731012.svg"
},
{
"company_id": "0000885978",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000885978.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000885978.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000885978.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000885978_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000885978_main_keyfigs.svg",
"name": "U S Physical Therapy INC NV",
"rank": 15,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000885978.svg",
"report_text": "The relative strengths and weaknesses of U S Physical Therapy INC NV are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of U S Physical Therapy INC NV compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 103% points.The greatest weakness of U S Physical Therapy INC NV is the variable Labor Expense, reducing the Economic Capital Ratio by 77% points.
The company's Economic Capital Ratio, given in the ranking table, is 246%, being 83% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000885978_2013_U_S_Physical_Therapy_INC_NV.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-11.4",
"Stockholders Equity": "8.44",
"ECR before LimitedLiability": "84.8",
"Property Plant and Equipment": "-10.9",
"Intangible Assets": "13.7",
"Other Liabilities": "16.8",
"Liabilities": "70.2",
"Long Term Liabilities": "22.3",
"Liabilities, Current": "41.2",
"Expenses": "-14.3",
"Revenues": "96.8",
"Net Income": "43.7",
"Other Expenses": "-10.2",
"Operating Costs and Expenses": "10.9",
"Labor Expense": "-72.9",
"General and Administrative Expense": "27.6",
"Cost of Goods and Services Sold": "10.9",
"Other Revenues": "96.8",
"Other Net Income": "-38.7",
"Comprehensive Net Income": "44.0",
"Economic Capital Ratio": "78.1"
},
"2012": {
"Property Plant and Equipment": "-9.05",
"Assets": "-11.0",
"Liabilities": "82.3",
"Stockholders Equity": "14.0",
"ECR before LimitedLiability": "97.0",
"Intangible Assets": "16.8",
"Assets, Current": "-9.92",
"Liabilities, Current": "48.2",
"Long Term Liabilities": "18.9",
"Other Liabilities": "29.4",
"Expenses": "-22.0",
"Revenues": "103",
"Net Income": "40.1",
"Other Expenses": "-17.4",
"General and Administrative Expense": "29.3",
"Cost of Goods and Services Sold": "11.6",
"Labor Expense": "-77.2",
"Other Revenues": "103",
"Other Net Income": "-43.9",
"Comprehensive Net Income": "40.6",
"Economic Capital Ratio": "82.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000885978_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "45,667",
"Assets, Non-Current": "2,043",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "102,353",
"Labor Expense": "125,117",
"Liabilities, Current": "16,324",
"Long Term Liabilities": "24,407",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "87,551",
"Other Liabilities": "941",
"Other Net Income": "5,445",
"Other Revenues": "237,006",
"Property Plant and Equipment": "13,189",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "163,252",
"Liabilities": "41,672",
"Expenses": "212,668",
"Revenues": "237,006",
"Stockholders Equity": "121,580",
"Net Income": "29,783",
"Comprehensive Net Income": "29,783",
"BaseVar": "330,022",
"ECR before LimitedLiability": "201%",
"Economic Capital Ratio": "239%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "45,322",
"Assets, Non-Current": "1,042",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "112,334",
"Labor Expense": "132,824",
"Liabilities, Current": "16,307",
"Long Term Liabilities": "19,854",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "93,052",
"Other Liabilities": "894",
"Other Net Income": "6.0",
"Other Revenues": "252,088",
"Property Plant and Equipment": "13,016",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "171,714",
"Liabilities": "37,055",
"Expenses": "225,876",
"Revenues": "252,088",
"Stockholders Equity": "134,659",
"Net Income": "26,218",
"Comprehensive Net Income": "26,218",
"BaseVar": "343,370",
"ECR before LimitedLiability": "212%",
"Economic Capital Ratio": "246%"
}
}
},
"top_rated": true,
"trend": 0.0,
"value": 2.4643824461384747,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000885978.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000885978.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000885978.svg"
},
{
"company_id": "0000704415",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000704415.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000704415.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000704415.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000704415_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000704415_main_keyfigs.svg",
"name": "Tivity Health INC",
"rank": 16,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000704415.svg",
"report_text": "The relative strengths and weaknesses of Tivity Health INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Tivity Health INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 107% points.The greatest weakness of Tivity Health INC is the variable Liabilities, Current, reducing the Economic Capital Ratio by 27% points.
The company's Economic Capital Ratio, given in the ranking table, is 243%, being 79% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000704415_2013_Tivity_Health_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "77.8",
"Stockholders Equity": "109",
"ECR before LimitedLiability": "63.0",
"Property Plant and Equipment": "5.87",
"Intangible Assets": "55.2",
"Other Liabilities": "6.35",
"Liabilities": "9.26",
"Long Term Liabilities": "20.0",
"Liabilities, Current": "-19.8",
"Expenses": "43.7",
"Revenues": "-22.6",
"Net Income": "-16.4",
"Other Expenses": "14.8",
"Operating Costs and Expenses": "3.92",
"Labor Expense": "6.18",
"General and Administrative Expense": "10.1",
"Cost of Goods and Services Sold": "3.91",
"Other Revenues": "-22.6",
"Other Net Income": "-38.4",
"Comprehensive Net Income": "-16.3",
"Economic Capital Ratio": "56.4"
},
"2012": {
"Property Plant and Equipment": "6.15",
"Assets": "59.7",
"Stockholders Equity": "107",
"ECR before LimitedLiability": "93.5",
"Intangible Assets": "36.4",
"Liabilities, Current": "-26.7",
"Liabilities": "3.02",
"Long Term Liabilities": "15.4",
"Other Liabilities": "10.2",
"Expenses": "37.7",
"Revenues": "-20.3",
"Net Income": "8.65",
"Other Expenses": "12.7",
"General and Administrative Expense": "9.25",
"Operating Costs and Expenses": "2.80",
"Cost of Goods and Services Sold": "3.63",
"Labor Expense": "5.83",
"Other Revenues": "-20.3",
"Other Net Income": "-10.6",
"Comprehensive Net Income": "8.94",
"Economic Capital Ratio": "79.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000704415_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "127,531",
"Assets, Non-Current": "10,797",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "428,389",
"Labor Expense": "0",
"Liabilities, Current": "118,757",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "15,386",
"Other Liabilities": "0",
"Other Net Income": "-142,307",
"Other Revenues": "0",
"Property Plant and Equipment": "142,188",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "708,905",
"Liabilities": "118,757",
"Expenses": "15,386",
"Revenues": "0",
"Stockholders Equity": "590,148",
"Net Income": "-157,693",
"Comprehensive Net Income": "-157,693",
"BaseVar": "492,678",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "217%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "141,809",
"Assets, Non-Current": "21,042",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "428,923",
"Labor Expense": "0",
"Liabilities, Current": "128,258",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "860",
"Other Expenses": "6,722",
"Other Liabilities": "0",
"Other Net Income": "14,746",
"Other Revenues": "0",
"Property Plant and Equipment": "156,494",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "748,268",
"Liabilities": "128,258",
"Expenses": "6,722",
"Revenues": "0",
"Stockholders Equity": "620,010",
"Net Income": "8,024",
"Comprehensive Net Income": "8,884",
"BaseVar": "449,427",
"ECR before LimitedLiability": "207%",
"Economic Capital Ratio": "243%"
}
}
},
"top_rated": true,
"trend": 5.0,
"value": 2.429579658456632,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000704415.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000704415.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000704415.svg"
},
{
"company_id": "0000860730",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000860730.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000860730.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000860730.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000860730_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000860730_main_keyfigs.svg",
"name": "HCA Healthcare Inc",
"rank": 17,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000860730.svg",
"report_text": "The relative strengths and weaknesses of HCA Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of HCA Healthcare Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 88% points.The greatest weakness of HCA Healthcare Inc is the variable Liabilities, Current, reducing the Economic Capital Ratio by 37% points.
The company's Economic Capital Ratio, given in the ranking table, is 234%, being 71% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000860730_2013_HCA_Healthcare_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "12.2",
"Assets": "48.2",
"Stockholders Equity": "92.0",
"ECR before LimitedLiability": "89.7",
"Property Plant and Equipment": "23.3",
"Assets, Current": "6.17",
"Intangible Assets": "-5.66",
"Expenses": "41.0",
"Net Income": "20.6",
"Other Expenses": "13.9",
"Operating Costs and Expenses": "3.90",
"Labor Expense": "6.13",
"General and Administrative Expense": "9.95",
"Cost of Goods and Services Sold": "3.89",
"Other Revenues": "-22.9",
"Revenues": "-22.9",
"Other Liabilities": "6.85",
"Long Term Liabilities": "21.3",
"Liabilities, Current": "-36.9",
"Comprehensive Net Income": "20.7",
"Economic Capital Ratio": "83.0"
},
"2012": {
"Property Plant and Equipment": "26.7",
"Assets": "52.6",
"Liabilities": "-3.43",
"Stockholders Equity": "88.5",
"ECR before LimitedLiability": "85.0",
"Intangible Assets": "-5.99",
"Assets, Current": "5.40",
"Other Assets": "14.1",
"Liabilities, Current": "-36.7",
"Long Term Liabilities": "16.1",
"Other Liabilities": "10.6",
"Expenses": "38.6",
"Revenues": "-21.8",
"Net Income": "15.7",
"Other Expenses": "11.3",
"General and Administrative Expense": "9.94",
"Cost of Goods and Services Sold": "3.90",
"Labor Expense": "6.26",
"Other Revenues": "-21.8",
"Comprehensive Net Income": "14.3",
"Economic Capital Ratio": "70.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000860730_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "7,233,000",
"Assets, Non-Current": "742,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,554,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "6,089,000",
"Other Compr. Net Income": "0",
"Other Expenses": "719,000",
"Other Liabilities": "0",
"Other Net Income": "3,561,000",
"Other Revenues": "0",
"Property Plant and Equipment": "12,834,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "26,898,000",
"Liabilities": "5,554,000",
"Expenses": "719,000",
"Revenues": "0",
"Stockholders Equity": "21,344,000",
"Net Income": "2,842,000",
"Comprehensive Net Income": "2,842,000",
"BaseVar": "18,366,000",
"ECR before LimitedLiability": "208%",
"Economic Capital Ratio": "244%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,763,000",
"Assets, Non-Current": "783,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "6,172,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "6,344,000",
"Other Compr. Net Income": "-418,000",
"Other Expenses": "888,000",
"Other Liabilities": "0",
"Other Net Income": "2,894,000",
"Other Revenues": "0",
"Property Plant and Equipment": "13,185,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "28,075,000",
"Liabilities": "6,172,000",
"Expenses": "888,000",
"Revenues": "0",
"Stockholders Equity": "21,903,000",
"Net Income": "2,006,000",
"Comprehensive Net Income": "1,588,000",
"BaseVar": "19,223,500",
"ECR before LimitedLiability": "195%",
"Economic Capital Ratio": "234%"
}
}
},
"top_rated": true,
"trend": -4.0,
"value": 2.344621987679554,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000860730.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000860730.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000860730.svg"
},
{
"company_id": "0001060009",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001060009.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001060009.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001060009_main_keyfigs.svg",
"name": "Kindred Healthcare INC",
"rank": 18,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001060009.svg",
"report_text": "The relative strengths and weaknesses of Kindred Healthcare INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Kindred Healthcare INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 134% points.The greatest weakness of Kindred Healthcare INC is the variable Labor Expense, reducing the Economic Capital Ratio by 88% points.
The company's Economic Capital Ratio, given in the ranking table, is 233%, being 70% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001060009_2013_Kindred_Healthcare_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-11.3",
"Stockholders Equity": "20.8",
"ECR before LimitedLiability": "76.7",
"Property Plant and Equipment": "-4.34",
"Assets, Current": "-6.56",
"Other Liabilities": "17.5",
"Liabilities": "76.1",
"Long Term Liabilities": "51.3",
"Liabilities, Current": "16.4",
"Expenses": "-25.2",
"Revenues": "-66.9",
"Net Income": "22.9",
"Other Expenses": "20.6",
"Operating Costs and Expenses": "-21.1",
"Labor Expense": "-78.0",
"General and Administrative Expense": "27.4",
"Cost of Goods and Services Sold": "10.7",
"Other Revenues": "-66.9",
"Other Net Income": "118",
"Comprehensive Net Income": "23.2",
"Economic Capital Ratio": "70.0"
},
"2012": {
"Assets": "-14.9",
"Stockholders Equity": "13.5",
"ECR before LimitedLiability": "83.8",
"Assets, Current": "-11.4",
"Liabilities, Current": "27.0",
"Liabilities": "87.3",
"Long Term Liabilities": "44.3",
"Other Liabilities": "30.1",
"Research And Development Expense": "4.63",
"Expenses": "-35.7",
"Revenues": "-71.1",
"Net Income": "23.1",
"Other Expenses": "16.1",
"General and Administrative Expense": "30.1",
"Operating Costs and Expenses": "-24.3",
"Cost of Goods and Services Sold": "11.9",
"Labor Expense": "-87.9",
"Other Revenues": "-71.1",
"Other Net Income": "134",
"Comprehensive Net Income": "23.6",
"Economic Capital Ratio": "69.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001060009_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "1,233,282",
"Assets, Non-Current": "198,469",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "165,594",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,531,862",
"Labor Expense": "3,255,815",
"Liabilities, Current": "848,923",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "1,164,480",
"Other Assets": "115,839",
"Other Compr. Net Income": "0",
"Other Expenses": "992,145",
"Other Liabilities": "0",
"Other Net Income": "5,524,315",
"Other Revenues": "0",
"Property Plant and Equipment": "1,059,041",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,138,493",
"Liabilities": "848,923",
"Expenses": "5,578,034",
"Revenues": "0",
"Stockholders Equity": "3,289,570",
"Net Income": "-53,719",
"Comprehensive Net Income": "-53,719",
"BaseVar": "8,044,882",
"ECR before LimitedLiability": "189%",
"Economic Capital Ratio": "231%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,273,766",
"Assets, Non-Current": "219,466",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "201,068",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,481,033",
"Labor Expense": "3,672,475",
"Liabilities, Current": "835,331",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "1,233,134",
"Other Assets": "120,555",
"Other Compr. Net Income": "-1,456",
"Other Expenses": "1,106,985",
"Other Liabilities": "0",
"Other Net Income": "6,174,338",
"Other Revenues": "0",
"Property Plant and Equipment": "1,143,126",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,237,946",
"Liabilities": "835,331",
"Expenses": "6,213,662",
"Revenues": "0",
"Stockholders Equity": "3,402,615",
"Net Income": "-39,324",
"Comprehensive Net Income": "-40,780",
"BaseVar": "8,731,366",
"ECR before LimitedLiability": "193%",
"Economic Capital Ratio": "233%"
}
}
},
"top_rated": true,
"trend": 0.0,
"value": 2.332076612498335,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001060009.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001060009.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001060009.svg"
},
{
"company_id": "0001047335",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001047335.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001047335.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001047335.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001047335_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001047335_main_keyfigs.svg",
"name": "National Healthcare CORP",
"rank": 19,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001047335.svg",
"report_text": "The relative strengths and weaknesses of National Healthcare CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of National Healthcare CORP compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 61% points.The greatest weakness of National Healthcare CORP is the variable Revenues, reducing the Economic Capital Ratio by 43% points.
The company's Economic Capital Ratio, given in the ranking table, is 230%, being 66% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001047335_2013_National_Healthcare_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Other Liabilities": "13.2",
"Liabilities": "42.3",
"Stockholders Equity": "36.3",
"ECR before LimitedLiability": "74.6",
"Long Term Liabilities": "39.5",
"Liabilities, Current": "-10.7",
"Expenses": "3.27",
"Net Income": "25.9",
"Other Expenses": "25.9",
"Operating Costs and Expenses": "-16.8",
"Labor Expense": "-42.5",
"General and Administrative Expense": "20.5",
"Cost of Goods and Services Sold": "7.99",
"Other Revenues": "-45.6",
"Revenues": "-45.6",
"Property Plant and Equipment": "16.0",
"Assets, Current": "5.30",
"Intangible Assets": "-12.5",
"Other Net Income": "66.7",
"Comprehensive Net Income": "26.2",
"Economic Capital Ratio": "67.9"
},
"2012": {
"Liabilities, Current": "-7.76",
"Liabilities": "42.7",
"Stockholders Equity": "37.9",
"ECR before LimitedLiability": "80.5",
"Long Term Liabilities": "31.1",
"Other Liabilities": "20.8",
"Expenses": "3.14",
"Net Income": "23.0",
"Other Expenses": "22.0",
"General and Administrative Expense": "20.4",
"Operating Costs and Expenses": "-17.4",
"Cost of Goods and Services Sold": "8.01",
"Labor Expense": "-38.8",
"Other Revenues": "-42.9",
"Revenues": "-42.9",
"Property Plant and Equipment": "15.2",
"Intangible Assets": "-11.4",
"Assets, Current": "3.73",
"Other Net Income": "60.8",
"Comprehensive Net Income": "25.0",
"Economic Capital Ratio": "66.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001047335_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "362,186",
"Assets, Non-Current": "73,835",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "28,901",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "20,320",
"Labor Expense": "428,672",
"Liabilities, Current": "215,907",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "198,439",
"Other Assets": "-20,320",
"Other Compr. Net Income": "0",
"Other Expenses": "73,986",
"Other Liabilities": "0",
"Other Net Income": "773,537",
"Other Revenues": "20,533",
"Property Plant and Equipment": "429,651",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "865,672",
"Liabilities": "215,907",
"Expenses": "729,998",
"Revenues": "20,533",
"Stockholders Equity": "649,765",
"Net Income": "64,072",
"Comprehensive Net Income": "64,072",
"BaseVar": "1,302,824",
"ECR before LimitedLiability": "186%",
"Economic Capital Ratio": "229%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "414,979",
"Assets, Non-Current": "84,295",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "29,792",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "17,600",
"Labor Expense": "426,934",
"Liabilities, Current": "226,495",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "198,691",
"Other Assets": "-17,600",
"Other Compr. Net Income": "14,106",
"Other Expenses": "73,133",
"Other Liabilities": "0",
"Other Net Income": "761,262",
"Other Revenues": "25,245",
"Property Plant and Equipment": "420,907",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "920,181",
"Liabilities": "226,495",
"Expenses": "728,550",
"Revenues": "25,245",
"Stockholders Equity": "693,686",
"Net Income": "57,957",
"Comprehensive Net Income": "72,063",
"BaseVar": "1,337,920",
"ECR before LimitedLiability": "188%",
"Economic Capital Ratio": "230%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 2.299124652895616,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001047335.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001047335.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001047335.svg"
},
{
"company_id": "0000792641",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000792641.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000792641.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000792641_main_keyfigs.svg",
"name": "BIO Reference Laboratories INC",
"rank": 20,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000792641.svg",
"report_text": "The relative strengths and weaknesses of BIO Reference Laboratories INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of BIO Reference Laboratories INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 68% points.The greatest weakness of BIO Reference Laboratories INC is the variable Liabilities, Current, reducing the Economic Capital Ratio by 31% points.
The company's Economic Capital Ratio, given in the ranking table, is 229%, being 65% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000792641_2013_BIO_Reference_Laboratories_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "-6.79",
"Assets": "46.1",
"Liabilities": "-21.0",
"Stockholders Equity": "57.5",
"ECR before LimitedLiability": "60.9",
"Assets, Current": "59.8",
"Assets, Non-Current": "5.84",
"Other Liabilities": "6.60",
"Long Term Liabilities": "12.9",
"Liabilities, Current": "-47.7",
"Expenses": "38.2",
"Revenues": "-23.7",
"Net Income": "22.1",
"Other Expenses": "8.07",
"Operating Costs and Expenses": "4.11",
"Labor Expense": "6.47",
"General and Administrative Expense": "10.5",
"Other Revenues": "-23.7",
"Other Net Income": "7.58",
"Comprehensive Net Income": "22.2",
"Economic Capital Ratio": "54.2"
},
"2012": {
"Assets": "40.5",
"Liabilities": "-7.52",
"Stockholders Equity": "68.4",
"ECR before LimitedLiability": "79.5",
"Assets, Current": "44.3",
"Other Assets": "-5.14",
"Assets, Non-Current": "5.39",
"Liabilities, Current": "-31.1",
"Long Term Liabilities": "7.75",
"Other Liabilities": "11.7",
"Expenses": "36.6",
"Revenues": "-24.4",
"Net Income": "22.9",
"Other Expenses": "5.81",
"General and Administrative Expense": "11.1",
"Cost of Goods and Services Sold": "4.36",
"Labor Expense": "7.01",
"Other Revenues": "-24.4",
"Other Net Income": "9.69",
"Comprehensive Net Income": "23.0",
"Economic Capital Ratio": "65.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000792641_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "206,780",
"Assets, Non-Current": "32,912",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "30,312",
"Labor Expense": "0",
"Liabilities, Current": "82,514",
"Long Term Liabilities": "10,978",
"Operating Costs and Expenses": "0",
"Other Assets": "-30,312",
"Other Compr. Net Income": "0",
"Other Expenses": "28,487",
"Other Liabilities": "0",
"Other Net Income": "64,846",
"Other Revenues": "0",
"Property Plant and Equipment": "43,567",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "283,259",
"Liabilities": "93,492",
"Expenses": "28,487",
"Revenues": "0",
"Stockholders Equity": "189,767",
"Net Income": "36,359",
"Comprehensive Net Income": "36,359",
"BaseVar": "235,042",
"ECR before LimitedLiability": "165%",
"Economic Capital Ratio": "215%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "223,577",
"Assets, Non-Current": "38,808",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "29,731",
"Labor Expense": "0",
"Liabilities, Current": "71,952",
"Long Term Liabilities": "13,626",
"Operating Costs and Expenses": "0",
"Other Assets": "-29,731",
"Other Compr. Net Income": "0",
"Other Expenses": "32,360",
"Other Liabilities": "0",
"Other Net Income": "74,516",
"Other Revenues": "0",
"Property Plant and Equipment": "50,440",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "312,825",
"Liabilities": "85,578",
"Expenses": "32,360",
"Revenues": "0",
"Stockholders Equity": "227,247",
"Net Income": "42,156",
"Comprehensive Net Income": "42,156",
"BaseVar": "252,640",
"ECR before LimitedLiability": "187%",
"Economic Capital Ratio": "229%"
}
}
},
"top_rated": false,
"trend": 2.0,
"value": 2.2895315783555565,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000792641.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000792641.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000792641.svg"
},
{
"company_id": "0000893949",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000893949.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000893949.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000893949.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000893949_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000893949_main_keyfigs.svg",
"name": "Pediatrix Medical Group Inc",
"rank": 21,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000893949.svg",
"report_text": "The relative strengths and weaknesses of Pediatrix Medical Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Pediatrix Medical Group Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 57% points.The greatest weakness of Pediatrix Medical Group Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 39% points.
The company's Economic Capital Ratio, given in the ranking table, is 227%, being 64% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000893949_2013_Pediatrix_Medical_Group_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-5.23",
"Assets": "6.34",
"Liabilities": "22.2",
"Stockholders Equity": "29.7",
"ECR before LimitedLiability": "28.9",
"Property Plant and Equipment": "-10.7",
"Intangible Assets": "35.6",
"Other Liabilities": "6.46",
"Liabilities, Current": "-9.19",
"Long Term Liabilities": "24.1",
"Other Revenues": "-32.1",
"Revenues": "-32.1",
"Net Income": "1.69",
"Other Expenses": "-26.8",
"Comprehensive Net Income": "2.60",
"Cost of Goods and Services Sold": "10.7",
"General and Administrative Expense": "-2.85",
"Labor Expense": "7.92",
"Operating Costs and Expenses": "8.72",
"Other Net Income": "32.9",
"Economic Capital Ratio": "30.7"
},
"2011": {
"Assets": "11.8",
"Stockholders Equity": "51.0",
"ECR before LimitedLiability": "79.9",
"Property Plant and Equipment": "-8.91",
"Intangible Assets": "46.4",
"Other Liabilities": "-12.2",
"Liabilities": "31.7",
"Long Term Liabilities": "27.2",
"Liabilities, Current": "16.1",
"Expenses": "14.5",
"Revenues": "-41.5",
"Net Income": "25.8",
"Other Expenses": "20.3",
"Operating Costs and Expenses": "6.90",
"Labor Expense": "-37.5",
"General and Administrative Expense": "9.57",
"Cost of Goods and Services Sold": "6.88",
"Other Revenues": "-41.5",
"Other Net Income": "50.0",
"Comprehensive Net Income": "26.0",
"Economic Capital Ratio": "73.2"
},
"2012": {
"Property Plant and Equipment": "-8.71",
"Assets": "12.2",
"Liabilities": "26.8",
"Stockholders Equity": "46.5",
"ECR before LimitedLiability": "77.9",
"Intangible Assets": "57.0",
"Assets, Current": "-9.83",
"Liabilities, Current": "20.6",
"Long Term Liabilities": "10.5",
"Expenses": "13.8",
"Revenues": "-38.6",
"Net Income": "23.0",
"Other Expenses": "17.3",
"General and Administrative Expense": "9.92",
"Operating Costs and Expenses": "5.23",
"Cost of Goods and Services Sold": "6.78",
"Labor Expense": "-33.9",
"Other Revenues": "-38.6",
"Other Net Income": "46.0",
"Comprehensive Net Income": "23.3",
"Economic Capital Ratio": "63.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000893949_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "296,009",
"Assets, Non-Current": "70,151",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "154,267",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,601,319",
"Labor Expense": "0",
"Liabilities, Current": "320,847",
"Long Term Liabilities": "195,223",
"Operating Costs and Expenses": "0",
"Other Assets": "27,393",
"Other Compr. Net Income": "0",
"Other Expenses": "1,046,035",
"Other Liabilities": "74,122",
"Other Net Income": "1,402,993",
"Other Revenues": "0",
"Property Plant and Equipment": "42,774",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,037,646",
"Liabilities": "590,192",
"Expenses": "1,200,302",
"Revenues": "0",
"Stockholders Equity": "1,447,454",
"Net Income": "202,691",
"Comprehensive Net Income": "202,691",
"BaseVar": "2,615,566",
"ECR before LimitedLiability": "175%",
"Economic Capital Ratio": "221%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "337,273",
"Assets, Non-Current": "83,092",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "25,292",
"General and Administrative Expense": "170,356",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,746,762",
"Labor Expense": "970,396",
"Liabilities, Current": "254,301",
"Long Term Liabilities": "83,544",
"Operating Costs and Expenses": "0",
"Other Assets": "44,991",
"Other Compr. Net Income": "0",
"Other Expenses": "205,702",
"Other Liabilities": "203,787",
"Other Net Income": "1,589,743",
"Other Revenues": "0",
"Property Plant and Equipment": "60,530",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,272,648",
"Liabilities": "541,632",
"Expenses": "1,371,746",
"Revenues": "0",
"Stockholders Equity": "1,731,016",
"Net Income": "217,997",
"Comprehensive Net Income": "217,997",
"BaseVar": "2,887,884",
"ECR before LimitedLiability": "194%",
"Economic Capital Ratio": "234%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "359,044",
"Assets, Non-Current": "118,290",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "30,816",
"General and Administrative Expense": "193,540",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,165,672",
"Labor Expense": "1,130,913",
"Liabilities, Current": "268,338",
"Long Term Liabilities": "200,951",
"Operating Costs and Expenses": "0",
"Other Assets": "47,593",
"Other Compr. Net Income": "0",
"Other Expenses": "222,332",
"Other Liabilities": "245,680",
"Other Net Income": "1,818,508",
"Other Revenues": "0",
"Property Plant and Equipment": "59,738",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,750,337",
"Liabilities": "714,969",
"Expenses": "1,577,601",
"Revenues": "0",
"Stockholders Equity": "2,035,368",
"Net Income": "240,907",
"Comprehensive Net Income": "240,907",
"BaseVar": "3,430,708",
"ECR before LimitedLiability": "184%",
"Economic Capital Ratio": "227%"
}
}
},
"top_rated": false,
"trend": -5.0,
"value": 2.2738546873196968,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000893949.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000893949.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000893949.svg"
},
{
"company_id": "0000019411",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000019411.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000019411.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000019411.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000019411_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000019411_main_keyfigs.svg",
"name": "Magellan Health INC",
"rank": 22,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000019411.svg",
"report_text": "The relative strengths and weaknesses of Magellan Health INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Magellan Health INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 128% points.The greatest weakness of Magellan Health INC is the variable Other Expenses, reducing the Economic Capital Ratio by 171% points.
The company's Economic Capital Ratio, given in the ranking table, is 213%, being 49% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000019411_2013_Magellan_Health_INC.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "5.49",
"Assets": "-32.3",
"Liabilities": "80.2",
"Stockholders Equity": "-50.4",
"ECR before LimitedLiability": "18.7",
"Property Plant and Equipment": "-19.2",
"Intangible Assets": "-21.2",
"Other Liabilities": "10.5",
"Long Term Liabilities": "74.5",
"Other Expenses": "-148",
"Expenses": "-70.2",
"Revenues": "126",
"Net Income": "-7.40",
"Cost of Goods and Services Sold": "20.5",
"General and Administrative Expense": "9.41",
"Labor Expense": "15.1",
"Operating Costs and Expenses": "16.7",
"Other Revenues": "126",
"Comprehensive Net Income": "-5.66",
"Other Net Income": "-77.3",
"Economic Capital Ratio": "20.5"
},
"2011": {
"Assets": "-33.0",
"Liabilities": "76.2",
"Stockholders Equity": "-42.6",
"ECR before LimitedLiability": "49.1",
"Property Plant and Equipment": "-20.6",
"Assets, Non-Current": "-5.37",
"Intangible Assets": "-10.8",
"Long Term Liabilities": "59.0",
"Liabilities, Current": "20.5",
"Expenses": "-39.9",
"Revenues": "119",
"Net Income": "40.5",
"Other Expenses": "-149",
"Operating Costs and Expenses": "13.2",
"Labor Expense": "20.9",
"General and Administrative Expense": "34.6",
"Cost of Goods and Services Sold": "13.1",
"Other Revenues": "119",
"Other Net Income": "-49.2",
"Comprehensive Net Income": "41.0",
"Economic Capital Ratio": "42.4"
},
"2012": {
"Property Plant and Equipment": "-17.4",
"Assets": "-31.9",
"Stockholders Equity": "-41.9",
"ECR before LimitedLiability": "63.2",
"Intangible Assets": "-10.6",
"Liabilities, Current": "30.1",
"Liabilities": "89.6",
"Long Term Liabilities": "49.4",
"Other Liabilities": "20.4",
"Expenses": "-49.3",
"Revenues": "128",
"Net Income": "39.2",
"Other Expenses": "-171",
"General and Administrative Expense": "36.3",
"Operating Costs and Expenses": "10.8",
"Cost of Goods and Services Sold": "14.0",
"Labor Expense": "22.5",
"Other Revenues": "128",
"Other Net Income": "-51.0",
"Comprehensive Net Income": "39.8",
"Economic Capital Ratio": "49.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000019411_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "858,487",
"Assets, Non-Current": "2,396",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "54,682",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "480,936",
"Labor Expense": "0",
"Liabilities, Current": "390,169",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "95,799",
"Other Compr. Net Income": "-105",
"Other Expenses": "2,775,899",
"Other Liabilities": "120,248",
"Other Net Income": "0",
"Other Revenues": "2,969,240",
"Property Plant and Equipment": "111,814",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,549,432",
"Liabilities": "510,417",
"Expenses": "2,830,581",
"Revenues": "2,969,240",
"Stockholders Equity": "1,039,015",
"Net Income": "138,659",
"Comprehensive Net Income": "138,554",
"BaseVar": "3,929,888",
"ECR before LimitedLiability": "160%",
"Economic Capital Ratio": "211%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "732,709",
"Assets, Non-Current": "10,952",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "58,623",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "471,528",
"Labor Expense": "0",
"Liabilities, Current": "369,550",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "7,956",
"Other Compr. Net Income": "-159",
"Other Expenses": "2,611,154",
"Other Liabilities": "126,343",
"Other Net Income": "0",
"Other Revenues": "2,799,400",
"Property Plant and Equipment": "118,022",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,341,167",
"Liabilities": "495,893",
"Expenses": "2,669,777",
"Revenues": "2,799,400",
"Stockholders Equity": "845,274",
"Net Income": "129,623",
"Comprehensive Net Income": "129,464",
"BaseVar": "3,653,198",
"ECR before LimitedLiability": "148%",
"Economic Capital Ratio": "203%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "871,418",
"Assets, Non-Current": "9,730",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "60,488",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "461,874",
"Labor Expense": "0",
"Liabilities, Current": "393,202",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "32,563",
"Other Compr. Net Income": "115",
"Other Expenses": "2,995,882",
"Other Liabilities": "101,598",
"Other Net Income": "0",
"Other Revenues": "3,207,397",
"Property Plant and Equipment": "136,548",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,512,133",
"Liabilities": "494,800",
"Expenses": "3,056,370",
"Revenues": "3,207,397",
"Stockholders Equity": "1,017,333",
"Net Income": "151,027",
"Comprehensive Net Income": "151,142",
"BaseVar": "4,135,408",
"ECR before LimitedLiability": "162%",
"Economic Capital Ratio": "213%"
}
}
},
"top_rated": false,
"trend": 3.0,
"value": 2.1269020791035533,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000019411.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000019411.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000019411.svg"
},
{
"company_id": "0001410471",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001410471.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001410471.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001410471_main_keyfigs.svg",
"name": "IPC Healthcare Inc",
"rank": 23,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001410471.svg",
"report_text": "The relative strengths and weaknesses of IPC Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of IPC Healthcare Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 87% points.The greatest weakness of IPC Healthcare Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 67% points.
The company's Economic Capital Ratio, given in the ranking table, is 208%, being 45% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001410471_2013_IPC_Healthcare_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-16.5",
"Liabilities": "61.3",
"ECR before LimitedLiability": "63.9",
"Property Plant and Equipment": "-16.9",
"Assets, Current": "-6.09",
"Assets, Non-Current": "-4.09",
"Intangible Assets": "11.6",
"Other Liabilities": "-7.62",
"Long Term Liabilities": "49.9",
"Liabilities, Current": "21.1",
"Expenses": "-18.8",
"Net Income": "34.1",
"Other Expenses": "-76.2",
"Operating Costs and Expenses": "10.6",
"Labor Expense": "16.7",
"Cost of Goods and Services Sold": "10.6",
"Other Revenues": "101",
"Revenues": "101",
"Other Net Income": "-40.6",
"Comprehensive Net Income": "34.4",
"Economic Capital Ratio": "57.2"
},
"2012": {
"Property Plant and Equipment": "-16.1",
"Assets": "-15.8",
"Liabilities": "49.4",
"ECR before LimitedLiability": "59.0",
"Intangible Assets": "22.1",
"Assets, Current": "-12.0",
"Assets, Non-Current": "-4.88",
"Liabilities, Current": "21.4",
"Long Term Liabilities": "36.3",
"Other Liabilities": "-6.79",
"Expenses": "-14.7",
"Net Income": "29.1",
"Other Expenses": "-67.4",
"Operating Costs and Expenses": "7.71",
"Cost of Goods and Services Sold": "10.0",
"Labor Expense": "16.1",
"Other Revenues": "86.9",
"Revenues": "86.9",
"Other Net Income": "-35.7",
"Comprehensive Net Income": "29.6",
"Economic Capital Ratio": "44.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001410471_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "107,594",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "3,192",
"General and Administrative Expense": "73,259",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "175,500",
"Labor Expense": "0",
"Liabilities, Current": "59,459",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "16,708",
"Other Compr. Net Income": "0",
"Other Expenses": "351,764",
"Other Liabilities": "32,803",
"Other Net Income": "17",
"Other Revenues": "457,467",
"Property Plant and Equipment": "5,112",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "304,914",
"Liabilities": "92,262",
"Expenses": "428,215",
"Revenues": "457,467",
"Stockholders Equity": "212,652",
"Net Income": "29,269",
"Comprehensive Net Income": "29,269",
"BaseVar": "641,438",
"ECR before LimitedLiability": "170%",
"Economic Capital Ratio": "218%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "122,829",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "3,911",
"General and Administrative Expense": "83,679",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "242,142",
"Labor Expense": "0",
"Liabilities, Current": "73,766",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "17,324",
"Other Compr. Net Income": "0",
"Other Expenses": "403,323",
"Other Liabilities": "57,921",
"Other Net Income": "14",
"Other Revenues": "523,485",
"Property Plant and Equipment": "5,763",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "388,058",
"Liabilities": "131,687",
"Expenses": "490,913",
"Revenues": "523,485",
"Stockholders Equity": "256,371",
"Net Income": "32,586",
"Comprehensive Net Income": "32,586",
"BaseVar": "767,078",
"ECR before LimitedLiability": "156%",
"Economic Capital Ratio": "208%"
}
}
},
"top_rated": false,
"trend": -3.0,
"value": 2.0842588275271443,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001410471.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001410471.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001410471.svg"
},
{
"company_id": "0001367832",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001367832.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001367832.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001367832_main_keyfigs.svg",
"name": "Aurora Diagnostics Holdings LLC",
"rank": 24,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001367832.svg",
"report_text": "The relative strengths and weaknesses of Aurora Diagnostics Holdings LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Aurora Diagnostics Holdings LLC compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 160% points.The greatest weakness of Aurora Diagnostics Holdings LLC is the variable Operating Costs and Expenses, reducing the Economic Capital Ratio by 123% points.
The company's Economic Capital Ratio, given in the ranking table, is 208%, being 44% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001367832_2013_Aurora_Diagnostics_Holdings_LLC.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "-20.2",
"Assets": "19.6",
"Liabilities": "55.6",
"Stockholders Equity": "99.0",
"ECR before LimitedLiability": "104",
"Assets, Non-Current": "156",
"Intangible Assets": "63.6",
"Other Liabilities": "12.1",
"Long Term Liabilities": "35.9",
"Liabilities, Current": "14.7",
"Expenses": "18.2",
"Revenues": "21.0",
"Net Income": "8.21",
"Other Expenses": "46.7",
"Operating Costs and Expenses": "-57.7",
"Labor Expense": "10.5",
"Cost of Goods and Services Sold": "6.68",
"Other Revenues": "21.0",
"Other Net Income": "-33.4",
"Comprehensive Net Income": "8.41",
"Economic Capital Ratio": "97.4"
},
"2012": {
"Liabilities, Current": "20.9",
"Liabilities": "67.1",
"Stockholders Equity": "66.7",
"ECR before LimitedLiability": "58.1",
"Long Term Liabilities": "31.7",
"Other Liabilities": "21.0",
"Expenses": "-19.9",
"Net Income": "-28.5",
"Other Expenses": "119",
"Goodwill Impairment Loss": "-46.9",
"Operating Costs and Expenses": "-123",
"Labor Expense": "14.0",
"Other Revenues": "33.0",
"Revenues": "33.0",
"Intangible Assets": "107",
"Assets, Current": "-17.0",
"Other Assets": "-39.1",
"Assets, Non-Current": "160",
"Other Net Income": "-41.6",
"Comprehensive Net Income": "-28.1",
"Economic Capital Ratio": "43.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001367832_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "56,096",
"Assets, Non-Current": "538,561",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "65,547",
"Goodwill Impairment Loss": "24,471",
"Intangible Assets": "525,243",
"Labor Expense": "0",
"Liabilities, Current": "59,228",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "278,520",
"Other Assets": "-525,243",
"Other Compr. Net Income": "0",
"Other Expenses": "-90,758",
"Other Liabilities": "0",
"Other Net Income": "-32,580",
"Other Revenues": "277,494",
"Property Plant and Equipment": "12,306",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "606,963",
"Liabilities": "59,228",
"Expenses": "277,780",
"Revenues": "277,494",
"Stockholders Equity": "547,735",
"Net Income": "-32,866",
"Comprehensive Net Income": "-32,866",
"BaseVar": "627,022",
"ECR before LimitedLiability": "229%",
"Economic Capital Ratio": "258%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "48,481",
"Assets, Non-Current": "349,469",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "64,230",
"Goodwill Impairment Loss": "168,498",
"Intangible Assets": "341,619",
"Labor Expense": "0",
"Liabilities, Current": "52,607",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "407,318",
"Other Assets": "-341,619",
"Other Compr. Net Income": "0",
"Other Expenses": "-237,837",
"Other Liabilities": "0",
"Other Net Income": "-36,531",
"Other Revenues": "277,886",
"Property Plant and Equipment": "11,155",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "409,105",
"Liabilities": "52,607",
"Expenses": "402,209",
"Revenues": "277,886",
"Stockholders Equity": "356,498",
"Net Income": "-160,854",
"Comprehensive Net Income": "-160,854",
"BaseVar": "589,169",
"ECR before LimitedLiability": "154%",
"Economic Capital Ratio": "208%"
}
}
},
"top_rated": false,
"trend": -17.0,
"value": 2.0753960688621533,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001367832.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001367832.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001367832.svg"
},
{
"company_id": "0001539778",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001539778.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001539778.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001539778.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001539778_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001539778_main_keyfigs.svg",
"name": "Rayont INC",
"rank": 25,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001539778.svg",
"report_text": "The relative strengths and weaknesses of Rayont INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Rayont INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 120% points.The greatest weakness of Rayont INC is the variable Other Liabilities, reducing the Economic Capital Ratio by 32% points.
The company's Economic Capital Ratio, given in the ranking table, is 207%, being 43% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001539778_2013_Rayont_INC.pdf",
"shrinked_graph_json": {
"2012": {
"Property Plant and Equipment": "-11.8",
"Assets": "25.5",
"Liabilities": "34.8",
"Stockholders Equity": "72.7",
"ECR before LimitedLiability": "57.6",
"Intangible Assets": "-13.3",
"Assets, Current": "120",
"Liabilities, Current": "36.6",
"Long Term Liabilities": "24.2",
"Other Liabilities": "-31.7",
"Other Revenues": "10.1",
"Revenues": "10.1",
"Net Income": "-16.6",
"Comprehensive Net Income": "-16.3",
"Other Expenses": "-17.4",
"General and Administrative Expense": "-16.4",
"Other Net Income": "-22.8",
"Operating Costs and Expenses": "5.00",
"Cost of Goods and Services Sold": "6.48",
"Labor Expense": "10.4",
"Economic Capital Ratio": "43.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001539778_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "421",
"Assets, Non-Current": "16",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "130",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1.6",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "166",
"Other Liabilities": "80",
"Other Net Income": "0",
"Other Revenues": "178",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "437",
"Liabilities": "82",
"Expenses": "295",
"Revenues": "178",
"Stockholders Equity": "355",
"Net Income": "-117",
"Comprehensive Net Income": "-117",
"BaseVar": "496",
"ECR before LimitedLiability": "153%",
"Economic Capital Ratio": "207%"
}
}
},
"top_rated": false,
"trend": null,
"value": 2.070400152673133,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001539778.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001539778.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001539778.svg"
},
{
"company_id": "0001124140",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001124140.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001124140.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001124140.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001124140_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001124140_main_keyfigs.svg",
"name": "Exact Sciences CORP",
"rank": 26,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001124140.svg",
"report_text": "The relative strengths and weaknesses of Exact Sciences CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Exact Sciences CORP compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 149% points.The greatest weakness of Exact Sciences CORP is the variable Net Income, reducing the Economic Capital Ratio by 47% points.
The company's Economic Capital Ratio, given in the ranking table, is 206%, being 42% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001124140_2013_Exact_Sciences_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "64.8",
"Liabilities": "34.9",
"Stockholders Equity": "133",
"ECR before LimitedLiability": "77.9",
"Property Plant and Equipment": "-5.73",
"Assets, Current": "163",
"Intangible Assets": "-7.84",
"Other Liabilities": "7.68",
"Long Term Liabilities": "23.8",
"Liabilities, Current": "5.75",
"Expenses": "10.5",
"Revenues": "-21.0",
"Net Income": "-27.5",
"Research And Development Expense": "-27.7",
"Other Expenses": "19.7",
"Operating Costs and Expenses": "4.55",
"Labor Expense": "7.14",
"Other Revenues": "-21.0",
"Other Net Income": "-17.1",
"Comprehensive Net Income": "-27.4",
"Economic Capital Ratio": "71.2"
},
"2012": {
"Property Plant and Equipment": "-7.56",
"Assets": "71.6",
"Liabilities": "35.1",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "56.3",
"Intangible Assets": "-10.9",
"Assets, Current": "149",
"Liabilities, Current": "5.39",
"Long Term Liabilities": "19.1",
"Other Liabilities": "12.6",
"Research And Development Expense": "-43.9",
"Expenses": "-4.91",
"Revenues": "-23.2",
"Net Income": "-46.9",
"Other Expenses": "19.5",
"Cost of Goods and Services Sold": "5.07",
"Labor Expense": "8.17",
"Other Revenues": "-23.2",
"Other Net Income": "-17.8",
"Comprehensive Net Income": "-46.3",
"Economic Capital Ratio": "42.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001124140_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "94,395",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "24",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "8,137",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "7,977",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "4,163",
"Property Plant and Equipment": "2,558",
"Research And Development Expense": "21,968",
"Selling and Marketing Expense": "2,857"
},
"output_variables": {
"Assets": "96,953",
"Liabilities": "7,977",
"Expenses": "32,986",
"Revenues": "4,163",
"Stockholders Equity": "88,976",
"Net Income": "-28,823",
"Comprehensive Net Income": "-28,823",
"BaseVar": "71,040",
"ECR before LimitedLiability": "191%",
"Economic Capital Ratio": "232%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "108,714",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "9,900",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "11,455",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "313",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "4,144",
"Property Plant and Equipment": "3,405",
"Research And Development Expense": "42,131",
"Selling and Marketing Expense": "4,755"
},
"output_variables": {
"Assets": "112,119",
"Liabilities": "11,455",
"Expenses": "56,786",
"Revenues": "4,144",
"Stockholders Equity": "100,664",
"Net Income": "-52,642",
"Comprehensive Net Income": "-52,329",
"BaseVar": "92,408",
"ECR before LimitedLiability": "152%",
"Economic Capital Ratio": "206%"
}
}
},
"top_rated": false,
"trend": -9.0,
"value": 2.05766437498441,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001124140.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001124140.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001124140.svg"
},
{
"company_id": "0001507881",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001507881.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001507881.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001507881_main_keyfigs.svg",
"name": "USMD Holdings Inc",
"rank": 27,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001507881.svg",
"report_text": "The relative strengths and weaknesses of USMD Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of USMD Holdings Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 44% points.The greatest weakness of USMD Holdings Inc is the variable Other Liabilities, reducing the Economic Capital Ratio by 20% points.
The company's Economic Capital Ratio, given in the ranking table, is 205%, being 41% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001507881_2013_USMD_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "33.9",
"Assets": "-18.8",
"Liabilities": "-11.7",
"Stockholders Equity": "-37.0",
"ECR before LimitedLiability": "-114",
"Property Plant and Equipment": "-22.6",
"Assets, Non-Current": "-4.80",
"Intangible Assets": "-24.8",
"Long Term Liabilities": "3.01",
"Liabilities, Current": "-22.6",
"Expenses": "-21.2",
"Revenues": "-17.7",
"Net Income": "-44.0",
"Other Expenses": "-7.18",
"Operating Costs and Expenses": "-32.5",
"Labor Expense": "4.59",
"General and Administrative Expense": "7.36",
"Other Revenues": "-17.7",
"Other Net Income": "-11.4",
"Comprehensive Net Income": "-44.0",
"Economic Capital Ratio": "-121"
},
"2012": {
"Property Plant and Equipment": "-4.43",
"Assets": "26.4",
"Stockholders Equity": "44.1",
"Liabilities, Current": "12.4",
"ECR before LimitedLiability": "55.5",
"Intangible Assets": "39.3",
"Assets, Current": "-8.87",
"Other Assets": "12.2",
"Expenses": "24.9",
"Revenues": "11.7",
"Net Income": "18.1",
"Other Expenses": "17.3",
"General and Administrative Expense": "14.3",
"Cost of Goods and Services Sold": "5.55",
"Labor Expense": "-15.8",
"Other Revenues": "11.7",
"Long Term Liabilities": "6.32",
"Other Liabilities": "-20.2",
"Other Net Income": "-18.3",
"Comprehensive Net Income": "13.7",
"Economic Capital Ratio": "41.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001507881_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "44",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "125",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "125",
"Other Assets": "62",
"Other Compr. Net Income": "0",
"Other Expenses": "72",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "106",
"Liabilities": "125",
"Expenses": "197",
"Revenues": "0",
"Stockholders Equity": "-19",
"Net Income": "-197",
"Comprehensive Net Income": "-197",
"BaseVar": "214",
"ECR before LimitedLiability": "-194%",
"Economic Capital Ratio": "40%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "36,907",
"Assets, Non-Current": "386",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "3,302",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "147,047",
"Labor Expense": "62,694",
"Liabilities, Current": "25,952",
"Long Term Liabilities": "18,054",
"Operating Costs and Expenses": "15,711",
"Other Assets": "40,969",
"Other Compr. Net Income": "-11,650",
"Other Expenses": "10,292",
"Other Liabilities": "38,059",
"Other Net Income": "3,024",
"Other Revenues": "105,702",
"Property Plant and Equipment": "26,203",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "251,512",
"Liabilities": "82,065",
"Expenses": "91,999",
"Revenues": "105,702",
"Stockholders Equity": "169,447",
"Net Income": "16,727",
"Comprehensive Net Income": "5,077",
"BaseVar": "272,976",
"ECR before LimitedLiability": "150%",
"Economic Capital Ratio": "205%"
}
}
},
"top_rated": false,
"trend": 43.0,
"value": 2.049848838313129,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001507881.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001507881.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001507881.svg"
},
{
"company_id": "0001468328",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001468328.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001468328.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001468328.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001468328_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001468328_main_keyfigs.svg",
"name": "Addus Homecare Corp",
"rank": 28,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001468328.svg",
"report_text": "The relative strengths and weaknesses of Addus Homecare Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Addus Homecare Corp compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 38% points.The greatest weakness of Addus Homecare Corp is the variable Revenues, reducing the Economic Capital Ratio by 29% points.
The company's Economic Capital Ratio, given in the ranking table, is 199%, being 35% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001468328_2013_Addus_Homecare_Corp.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "20.9",
"Liabilities": "-14.3",
"Stockholders Equity": "18.6",
"ECR before LimitedLiability": "24.4",
"Property Plant and Equipment": "-14.9",
"Assets, Current": "34.5",
"Intangible Assets": "13.1",
"Other Liabilities": "8.50",
"Liabilities, Current": "-21.2",
"Expenses": "18.5",
"Revenues": "-32.9",
"Net Income": "12.6",
"Other Expenses": "29.6",
"Goodwill Impairment Loss": "-8.44",
"Operating Costs and Expenses": "6.04",
"Labor Expense": "9.57",
"General and Administrative Expense": "-25.2",
"Other Revenues": "-32.9",
"Other Net Income": "29.9",
"Comprehensive Net Income": "12.8",
"Economic Capital Ratio": "17.8"
},
"2012": {
"Property Plant and Equipment": "-9.79",
"Assets": "29.1",
"Liabilities": "-10.2",
"Stockholders Equity": "37.6",
"ECR before LimitedLiability": "49.2",
"Intangible Assets": "15.8",
"Assets, Current": "28.8",
"Liabilities, Current": "-23.0",
"Other Liabilities": "12.8",
"Expenses": "24.3",
"Revenues": "-28.7",
"Net Income": "15.9",
"Other Expenses": "17.7",
"General and Administrative Expense": "-16.2",
"Operating Costs and Expenses": "4.09",
"Cost of Goods and Services Sold": "5.30",
"Labor Expense": "8.56",
"Other Revenues": "-28.7",
"Other Net Income": "21.0",
"Comprehensive Net Income": "16.2",
"Economic Capital Ratio": "35.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001468328_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "88,861",
"Assets, Non-Current": "513",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "3,554",
"General and Administrative Expense": "66,926",
"Goodwill Impairment Loss": "15,989",
"Intangible Assets": "58,739",
"Labor Expense": "0",
"Liabilities, Current": "43,293",
"Long Term Liabilities": "24,958",
"Operating Costs and Expenses": "0",
"Other Assets": "4,089",
"Other Compr. Net Income": "0",
"Other Expenses": "-2,954",
"Other Liabilities": "0",
"Other Net Income": "81,534",
"Other Revenues": "0",
"Property Plant and Equipment": "2,490",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "154,692",
"Liabilities": "68,251",
"Expenses": "83,515",
"Revenues": "0",
"Stockholders Equity": "86,441",
"Net Income": "-1,981",
"Comprehensive Net Income": "-1,981",
"BaseVar": "193,996",
"ECR before LimitedLiability": "111%",
"Economic Capital Ratio": "178%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "87,836",
"Assets, Non-Current": "298",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "2,521",
"General and Administrative Expense": "46,362",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "56,906",
"Labor Expense": "0",
"Liabilities, Current": "39,190",
"Long Term Liabilities": "16,250",
"Operating Costs and Expenses": "0",
"Other Assets": "2,328",
"Other Compr. Net Income": "0",
"Other Expenses": "4,312",
"Other Liabilities": "0",
"Other Net Income": "60,830",
"Other Revenues": "0",
"Property Plant and Equipment": "2,489",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "149,857",
"Liabilities": "55,440",
"Expenses": "53,195",
"Revenues": "0",
"Stockholders Equity": "94,417",
"Net Income": "7,635",
"Comprehensive Net Income": "7,635",
"BaseVar": "159,661",
"ECR before LimitedLiability": "141%",
"Economic Capital Ratio": "199%"
}
}
},
"top_rated": false,
"trend": 1.0,
"value": 1.986928599378122,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001468328.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001468328.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001468328.svg"
},
{
"company_id": "0001552845",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001552845.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001552845.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001552845.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001552845_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001552845_main_keyfigs.svg",
"name": "Natur International Corp",
"rank": 29,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001552845.svg",
"report_text": "The relative strengths and weaknesses of Natur International Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Natur International Corp compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 165% points.The greatest weakness of Natur International Corp is the variable Expenses, reducing the Economic Capital Ratio by 182% points.
The company's Economic Capital Ratio, given in the ranking table, is 196%, being 32% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001552845_2013_Natur_International_Corp.pdf",
"shrinked_graph_json": {
"2012": {
"Property Plant and Equipment": "-35.8",
"Assets": "-60.1",
"Liabilities": "116",
"Expenses": "-182",
"Stockholders Equity": "-98.2",
"ECR before LimitedLiability": "46.3",
"Intangible Assets": "-37.1",
"Assets, Current": "-27.5",
"Other Assets": "33.3",
"Liabilities, Current": "88.8",
"Long Term Liabilities": "77.5",
"Other Liabilities": "52.1",
"Other Expenses": "-154",
"General and Administrative Expense": "31.3",
"Goodwill Impairment Loss": "-90.3",
"Cost of Goods and Services Sold": "24.1",
"Labor Expense": "-27.4",
"Other Revenues": "165",
"Revenues": "165",
"Economic Capital Ratio": "32.1",
"Other Net Income": "-85.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001552845_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "864",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "359",
"Goodwill Impairment Loss": "1,110",
"Intangible Assets": "80",
"Labor Expense": "783",
"Liabilities, Current": "222",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "424",
"Other Compr. Net Income": "0",
"Other Expenses": "2,716",
"Other Liabilities": "0",
"Other Net Income": "8.9",
"Other Revenues": "4,382",
"Property Plant and Equipment": "0.61",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,369",
"Liabilities": "222",
"Expenses": "4,968",
"Revenues": "4,382",
"Stockholders Equity": "1,146",
"Net Income": "-578",
"Comprehensive Net Income": "-578",
"BaseVar": "5,475",
"ECR before LimitedLiability": "136%",
"Economic Capital Ratio": "196%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.9574972120332241,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001552845.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001552845.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001552845.svg"
},
{
"company_id": "0001316645",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001316645.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001316645.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001316645_main_keyfigs.svg",
"name": "American Caresource Holdings Inc",
"rank": 30,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001316645.svg",
"report_text": "The relative strengths and weaknesses of American Caresource Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of American Caresource Holdings Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 118% points.The greatest weakness of American Caresource Holdings Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 158% points.
The company's Economic Capital Ratio, given in the ranking table, is 194%, being 30% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001316645_2013_American_Caresource_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-56.7",
"Expenses": "-107",
"Stockholders Equity": "-63.0",
"ECR before LimitedLiability": "25.0",
"Property Plant and Equipment": "-33.4",
"Assets, Current": "11.6",
"Intangible Assets": "-38.8",
"Other Liabilities": "25.4",
"Liabilities": "94.0",
"Long Term Liabilities": "77.6",
"Liabilities, Current": "43.2",
"Other Expenses": "-192",
"Goodwill Impairment Loss": "-20.3",
"Operating Costs and Expenses": "19.0",
"Labor Expense": "30.6",
"General and Administrative Expense": "12.0",
"Cost of Goods and Services Sold": "18.9",
"Other Revenues": "122",
"Revenues": "122",
"Economic Capital Ratio": "18.3",
"Other Net Income": "-65.7"
},
"2012": {
"Property Plant and Equipment": "-22.6",
"Assets": "-42.8",
"Liabilities": "107",
"Stockholders Equity": "-44.4",
"ECR before LimitedLiability": "44.7",
"Intangible Assets": "-28.1",
"Assets, Non-Current": "-8.46",
"Liabilities, Current": "32.1",
"Long Term Liabilities": "53.4",
"Other Liabilities": "35.5",
"Expenses": "-77.9",
"Revenues": "118",
"Net Income": "12.0",
"Other Expenses": "-158",
"Operating Costs and Expenses": "12.2",
"Cost of Goods and Services Sold": "15.8",
"Labor Expense": "25.8",
"Other Revenues": "118",
"Other Net Income": "-55.1",
"Comprehensive Net Income": "12.7",
"Economic Capital Ratio": "30.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001316645_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "16,197",
"Assets, Non-Current": "16",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "792",
"General and Administrative Expense": "6,240",
"Goodwill Impairment Loss": "4,361",
"Intangible Assets": "896",
"Labor Expense": "0",
"Liabilities, Current": "4,915",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "226",
"Other Compr. Net Income": "0",
"Other Expenses": "44,789",
"Other Liabilities": "0",
"Other Net Income": "39",
"Other Revenues": "48,906",
"Property Plant and Equipment": "1,829",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "19,164",
"Liabilities": "4,915",
"Expenses": "56,182",
"Revenues": "48,906",
"Stockholders Equity": "14,249",
"Net Income": "-7,237",
"Comprehensive Net Income": "-7,237",
"BaseVar": "64,603",
"ECR before LimitedLiability": "112%",
"Economic Capital Ratio": "179%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "13,433",
"Assets, Non-Current": "16",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "878",
"General and Administrative Expense": "6,293",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "768",
"Labor Expense": "0",
"Liabilities, Current": "4,443",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "222",
"Other Compr. Net Income": "0",
"Other Expenses": "30,822",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "34,902",
"Property Plant and Equipment": "1,593",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "16,032",
"Liabilities": "4,443",
"Expenses": "37,993",
"Revenues": "34,902",
"Stockholders Equity": "11,589",
"Net Income": "-3,091",
"Comprehensive Net Income": "-3,091",
"BaseVar": "46,685",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "194%"
}
}
},
"top_rated": false,
"trend": -2.0,
"value": 1.941478218905762,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001316645.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001316645.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001316645.svg"
},
{
"company_id": "0000019584",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000019584.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000019584.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000019584.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000019584_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000019584_main_keyfigs.svg",
"name": "Chemed CORP",
"rank": 31,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000019584.svg",
"report_text": "The relative strengths and weaknesses of Chemed CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Chemed CORP compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 97% points.The greatest weakness of Chemed CORP is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 102% points.
The company's Economic Capital Ratio, given in the ranking table, is 183%, being 20% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000019584_2013_Chemed_CORP.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-12.0",
"Assets": "-30.2",
"Liabilities": "40.9",
"Stockholders Equity": "-43.3",
"ECR before LimitedLiability": "-3.98",
"Property Plant and Equipment": "-18.7",
"Assets, Non-Current": "-3.86",
"Other Liabilities": "8.86",
"Liabilities, Current": "5.35",
"Long Term Liabilities": "28.3",
"Other Expenses": "32.6",
"Expenses": "-39.6",
"Revenues": "102",
"Net Income": "-4.16",
"Cost of Goods and Services Sold": "-86.6",
"General and Administrative Expense": "-14.7",
"Labor Expense": "12.6",
"Operating Costs and Expenses": "13.9",
"Other Revenues": "102",
"Comprehensive Net Income": "-2.73",
"Other Net Income": "-58.7",
"Economic Capital Ratio": "-2.17"
},
"2011": {
"Assets": "-30.0",
"Liabilities": "38.7",
"Stockholders Equity": "-38.6",
"ECR before LimitedLiability": "28.4",
"Property Plant and Equipment": "-20.1",
"Assets, Current": "-21.3",
"Assets, Non-Current": "-4.98",
"Intangible Assets": "17.5",
"Long Term Liabilities": "11.4",
"Liabilities, Current": "26.5",
"Expenses": "-18.8",
"Revenues": "95.8",
"Net Income": "37.2",
"Other Expenses": "39.5",
"Operating Costs and Expenses": "11.2",
"Labor Expense": "17.8",
"Cost of Goods and Services Sold": "-103",
"Other Revenues": "95.8",
"Other Net Income": "-39.3",
"Comprehensive Net Income": "37.6",
"Economic Capital Ratio": "21.7"
},
"2012": {
"Property Plant and Equipment": "-17.5",
"Assets": "-30.4",
"Liabilities": "41.6",
"Stockholders Equity": "-38.5",
"ECR before LimitedLiability": "34.0",
"Intangible Assets": "16.9",
"Assets, Current": "-24.2",
"Liabilities, Current": "29.8",
"Other Liabilities": "12.4",
"Expenses": "-21.3",
"Revenues": "96.6",
"Net Income": "34.3",
"Other Expenses": "33.5",
"General and Administrative Expense": "6.27",
"Operating Costs and Expenses": "8.58",
"Cost of Goods and Services Sold": "-102",
"Labor Expense": "18.5",
"Other Revenues": "96.6",
"Other Net Income": "-37.7",
"Comprehensive Net Income": "34.9",
"Economic Capital Ratio": "19.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000019584_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "196,797",
"Assets, Non-Current": "11,015",
"Cost of Goods and Services Sold": "906,016",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "201,964",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "514,753",
"Labor Expense": "0",
"Liabilities, Current": "149,342",
"Long Term Liabilities": "165,834",
"Operating Costs and Expenses": "0",
"Other Assets": "28,304",
"Other Compr. Net Income": "0",
"Other Expenses": "93,002",
"Other Liabilities": "52,936",
"Other Net Income": "2,268",
"Other Revenues": "1,280,545",
"Property Plant and Equipment": "79,292",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "830,161",
"Liabilities": "368,112",
"Expenses": "1,200,982",
"Revenues": "1,280,545",
"Stockholders Equity": "462,049",
"Net Income": "81,831",
"Comprehensive Net Income": "81,831",
"BaseVar": "1,841,034",
"ECR before LimitedLiability": "125%",
"Economic Capital Ratio": "188%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "150,753",
"Assets, Non-Current": "11,677",
"Cost of Goods and Services Sold": "970,484",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "202,260",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "518,895",
"Labor Expense": "0",
"Liabilities, Current": "145,400",
"Long Term Liabilities": "176,665",
"Operating Costs and Expenses": "0",
"Other Assets": "31,629",
"Other Compr. Net Income": "0",
"Other Expenses": "97,964",
"Other Liabilities": "60,156",
"Other Net Income": "717",
"Other Revenues": "1,355,970",
"Property Plant and Equipment": "82,951",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "795,905",
"Liabilities": "382,221",
"Expenses": "1,270,708",
"Revenues": "1,355,970",
"Stockholders Equity": "413,684",
"Net Income": "85,979",
"Comprehensive Net Income": "85,979",
"BaseVar": "1,902,760",
"ECR before LimitedLiability": "116%",
"Economic Capital Ratio": "182%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "197,671",
"Assets, Non-Current": "10,923",
"Cost of Goods and Services Sold": "1,033,321",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "208,656",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "523,009",
"Labor Expense": "0",
"Liabilities, Current": "156,822",
"Long Term Liabilities": "186,252",
"Operating Costs and Expenses": "1,126",
"Other Assets": "36,089",
"Other Compr. Net Income": "0",
"Other Expenses": "101,759",
"Other Liabilities": "63,261",
"Other Net Income": "4,123",
"Other Revenues": "1,430,043",
"Property Plant and Equipment": "91,934",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "859,626",
"Liabilities": "406,335",
"Expenses": "1,344,862",
"Revenues": "1,430,043",
"Stockholders Equity": "453,291",
"Net Income": "89,304",
"Comprehensive Net Income": "89,304",
"BaseVar": "2,022,494",
"ECR before LimitedLiability": "118%",
"Economic Capital Ratio": "183%"
}
}
},
"top_rated": false,
"trend": -5.0,
"value": 1.8341292933426916,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000019584.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000019584.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000019584.svg"
},
{
"company_id": "0000896262",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000896262.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000896262.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000896262.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000896262_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000896262_main_keyfigs.svg",
"name": "Amedisys INC",
"rank": 32,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000896262.svg",
"report_text": "The relative strengths and weaknesses of Amedisys INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Amedisys INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 112% points.The greatest weakness of Amedisys INC is the variable Other Expenses, reducing the Economic Capital Ratio by 92% points.
The company's Economic Capital Ratio, given in the ranking table, is 181%, being 17% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000896262_2013_Amedisys_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Liabilities, Current": "3.61",
"Liabilities": "11.3",
"Stockholders Equity": "6.14",
"ECR before LimitedLiability": "8.16",
"Long Term Liabilities": "9.40",
"Other Liabilities": "-1.69",
"Other Expenses": "-60.9",
"Expenses": "-3.17",
"Net Income": "1.31",
"General and Administrative Expense": "11.3",
"Cost of Goods and Services Sold": "57.3",
"Labor Expense": "-21.5",
"Operating Costs and Expenses": "12.9",
"Other Revenues": "-81.2",
"Revenues": "-81.2",
"Intangible Assets": "7.32",
"Assets, Current": "-4.89",
"Property Plant and Equipment": "-1.71",
"Comprehensive Net Income": "1.31",
"Other Net Income": "91.4",
"Economic Capital Ratio": "8.57"
},
"2010": {
"Assets, Current": "-7.22",
"Assets": "-16.2",
"Liabilities": "47.8",
"Stockholders Equity": "-9.62",
"ECR before LimitedLiability": "19.8",
"Property Plant and Equipment": "-12.4",
"Assets, Non-Current": "-2.37",
"Intangible Assets": "7.23",
"Other Liabilities": "11.5",
"Long Term Liabilities": "36.7",
"Other Expenses": "-50.4",
"Expenses": "-31.3",
"Revenues": "-45.4",
"Net Income": "-3.37",
"Cost of Goods and Services Sold": "15.2",
"General and Administrative Expense": "6.96",
"Labor Expense": "-16.3",
"Operating Costs and Expenses": "12.3",
"Other Revenues": "-45.4",
"Other Net Income": "76.5",
"Economic Capital Ratio": "21.7"
},
"2011": {
"Assets": "-52.4",
"Stockholders Equity": "-43.3",
"Economic Capital Ratio": "-17.8",
"Property Plant and Equipment": "-28.5",
"Assets, Current": "-30.1",
"Other Liabilities": "18.4",
"Liabilities": "55.7",
"Long Term Liabilities": "33.6",
"Liabilities, Current": "20.5",
"Expenses": "-62.9",
"Revenues": "-74.1",
"Net Income": "-16.2",
"Other Expenses": "-51.6",
"Goodwill Impairment Loss": "-65.1",
"Operating Costs and Expenses": "15.4",
"Labor Expense": "-19.8",
"General and Administrative Expense": "41.8",
"Cost of Goods and Services Sold": "15.3",
"Other Revenues": "-74.1",
"Other Net Income": "75.6",
"Comprehensive Net Income": "-15.8"
},
"2012": {
"Property Plant and Equipment": "-16.6",
"Assets": "-43.6",
"Stockholders Equity": "-49.5",
"ECR before LimitedLiability": "31.4",
"Assets, Current": "-29.3",
"Liabilities, Current": "26.0",
"Liabilities": "81.8",
"Long Term Liabilities": "30.7",
"Other Liabilities": "31.7",
"Expenses": "-56.4",
"Revenues": "-76.2",
"Net Income": "16.2",
"Other Expenses": "-91.8",
"General and Administrative Expense": "39.1",
"Goodwill Impairment Loss": "-17.7",
"Cost of Goods and Services Sold": "14.6",
"Labor Expense": "-22.6",
"Other Revenues": "-76.2",
"Other Net Income": "112",
"Comprehensive Net Income": "19.0",
"Economic Capital Ratio": "17.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000896262_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "218,036",
"Assets, Non-Current": "17,865",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "28,312",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "844,531",
"Labor Expense": "327,738",
"Liabilities, Current": "229,306",
"Long Term Liabilities": "177,311",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,012,832",
"Other Liabilities": "29,399",
"Other Net Income": "1,505,105",
"Other Revenues": "0",
"Property Plant and Equipment": "91,919",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,172,351",
"Liabilities": "436,016",
"Expenses": "1,368,882",
"Revenues": "0",
"Stockholders Equity": "736,335",
"Net Income": "136,223",
"Comprehensive Net Income": "136,223",
"BaseVar": "2,241,177",
"ECR before LimitedLiability": "150%",
"Economic Capital Ratio": "205%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "293,930",
"Assets, Non-Current": "22,536",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "34,589",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "844,805",
"Labor Expense": "357,502",
"Liabilities, Current": "216,304",
"Long Term Liabilities": "151,520",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,121,027",
"Other Liabilities": "52,286",
"Other Net Income": "1,626,391",
"Other Revenues": "0",
"Property Plant and Equipment": "138,554",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,299,825",
"Liabilities": "420,110",
"Expenses": "1,513,118",
"Revenues": "0",
"Stockholders Equity": "879,715",
"Net Income": "113,273",
"Comprehensive Net Income": "113,273",
"BaseVar": "2,429,722",
"ECR before LimitedLiability": "162%",
"Economic Capital Ratio": "212%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "232,016",
"Assets, Non-Current": "24,322",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "579,955",
"Intangible Assets": "384,762",
"Labor Expense": "333,190",
"Liabilities, Current": "221,734",
"Long Term Liabilities": "116,403",
"Operating Costs and Expenses": "0",
"Other Assets": "68,649",
"Other Compr. Net Income": "0",
"Other Expenses": "924,653",
"Other Liabilities": "0",
"Other Net Income": "1,455,456",
"Other Revenues": "0",
"Property Plant and Equipment": "148,536",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "858,285",
"Liabilities": "338,137",
"Expenses": "1,837,798",
"Revenues": "0",
"Stockholders Equity": "520,148",
"Net Income": "-382,342",
"Comprehensive Net Income": "-382,342",
"BaseVar": "2,244,838",
"ECR before LimitedLiability": "62%",
"Economic Capital Ratio": "143%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "205,788",
"Assets, Non-Current": "18,650",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "162,103",
"Intangible Assets": "256,644",
"Labor Expense": "339,528",
"Liabilities, Current": "204,787",
"Long Term Liabilities": "71,575",
"Operating Costs and Expenses": "0",
"Other Assets": "92,804",
"Other Compr. Net Income": "14,997",
"Other Expenses": "1,077,082",
"Other Liabilities": "0",
"Other Net Income": "1,480,130",
"Other Revenues": "0",
"Property Plant and Equipment": "156,709",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "730,595",
"Liabilities": "276,362",
"Expenses": "1,578,713",
"Revenues": "0",
"Stockholders Equity": "454,233",
"Net Income": "-98,583",
"Comprehensive Net Income": "-83,586",
"BaseVar": "2,040,398",
"ECR before LimitedLiability": "114%",
"Economic Capital Ratio": "181%"
}
}
},
"top_rated": false,
"trend": 8.0,
"value": 1.808732395015007,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000896262.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000896262.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000896262.svg"
},
{
"company_id": "0001159281",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001159281.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001159281.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001159281.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001159281_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001159281_main_keyfigs.svg",
"name": "Alerislife Inc",
"rank": 33,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001159281.svg",
"report_text": "The relative strengths and weaknesses of Alerislife Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Alerislife Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 106% points.The greatest weakness of Alerislife Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 73% points.
The company's Economic Capital Ratio, given in the ranking table, is 180%, being 16% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001159281_2013_Alerislife_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-43.7",
"Stockholders Equity": "-65.5",
"ECR before LimitedLiability": "21.9",
"Assets, Current": "-25.4",
"Intangible Assets": "-33.2",
"Other Liabilities": "18.3",
"Liabilities": "55.5",
"Long Term Liabilities": "26.0",
"Liabilities, Current": "14.1",
"Expenses": "-35.3",
"Revenues": "97.8",
"Net Income": "44.5",
"Other Expenses": "-34.9",
"Operating Costs and Expenses": "13.6",
"Labor Expense": "-60.7",
"General and Administrative Expense": "26.3",
"Cost of Goods and Services Sold": "13.5",
"Other Revenues": "97.8",
"Other Net Income": "-46.0",
"Comprehensive Net Income": "44.9",
"Economic Capital Ratio": "15.2"
},
"2012": {
"Assets": "-48.6",
"Liabilities": "78.9",
"Stockholders Equity": "-72.9",
"ECR before LimitedLiability": "30.2",
"Intangible Assets": "-32.8",
"Assets, Current": "-33.7",
"Other Assets": "12.1",
"Liabilities, Current": "25.3",
"Long Term Liabilities": "26.6",
"Other Liabilities": "33.1",
"Expenses": "-54.3",
"Revenues": "106",
"Net Income": "34.9",
"Other Expenses": "-57.2",
"General and Administrative Expense": "29.7",
"Cost of Goods and Services Sold": "15.3",
"Labor Expense": "-64.2",
"Other Revenues": "106",
"Other Net Income": "-50.1",
"Comprehensive Net Income": "37.9",
"Economic Capital Ratio": "16.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001159281_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "141,516",
"Assets, Non-Current": "56,419",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "21,127",
"General and Administrative Expense": "57,540",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "536,386",
"Liabilities, Current": "189,331",
"Long Term Liabilities": "113,952",
"Operating Costs and Expenses": "0",
"Other Assets": "32,477",
"Other Compr. Net Income": "0",
"Other Expenses": "603,985",
"Other Liabilities": "0",
"Other Net Income": "5,551",
"Other Revenues": "1,281,764",
"Property Plant and Equipment": "353,065",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "583,477",
"Liabilities": "303,283",
"Expenses": "1,219,038",
"Revenues": "1,281,764",
"Stockholders Equity": "280,194",
"Net Income": "68,277",
"Comprehensive Net Income": "68,277",
"BaseVar": "1,696,556",
"ECR before LimitedLiability": "107%",
"Economic Capital Ratio": "176%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "137,314",
"Assets, Non-Current": "9,797",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "25,064",
"General and Administrative Expense": "61,599",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "548,164",
"Liabilities, Current": "183,960",
"Long Term Liabilities": "80,591",
"Operating Costs and Expenses": "0",
"Other Assets": "88,633",
"Other Compr. Net Income": "11,916",
"Other Expenses": "707,211",
"Other Liabilities": "0",
"Other Net Income": "4,588",
"Other Revenues": "1,350,878",
"Property Plant and Equipment": "335,612",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "571,356",
"Liabilities": "264,551",
"Expenses": "1,342,038",
"Revenues": "1,350,878",
"Stockholders Equity": "306,805",
"Net Income": "13,428",
"Comprehensive Net Income": "25,344",
"BaseVar": "1,772,664",
"ECR before LimitedLiability": "113%",
"Economic Capital Ratio": "180%"
}
}
},
"top_rated": false,
"trend": -3.0,
"value": 1.7970151316497294,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001159281.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001159281.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001159281.svg"
},
{
"company_id": "0000890908",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000890908.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000890908.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000890908_main_keyfigs.svg",
"name": "Dynacq Healthcare INC",
"rank": 34,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000890908.svg",
"report_text": "The relative strengths and weaknesses of Dynacq Healthcare INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Dynacq Healthcare INC compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 67% points.The greatest weakness of Dynacq Healthcare INC is the variable Liabilities, Current, reducing the Economic Capital Ratio by 39% points.
The company's Economic Capital Ratio, given in the ranking table, is 175%, being 11% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000890908_2013_Dynacq_Healthcare_INC.pdf",
"shrinked_graph_json": {
"2012": {
"Assets": "62.7",
"Liabilities": "-11.8",
"Stockholders Equity": "58.8",
"ECR before LimitedLiability": "25.3",
"Intangible Assets": "-14.0",
"Assets, Current": "21.1",
"Other Assets": "66.8",
"Liabilities, Current": "-39.0",
"Long Term Liabilities": "12.6",
"Other Liabilities": "10.8",
"Expenses": "14.5",
"Revenues": "-25.9",
"Net Income": "-17.1",
"Other Expenses": "6.31",
"General and Administrative Expense": "12.9",
"Operating Costs and Expenses": "-6.08",
"Cost of Goods and Services Sold": "4.97",
"Labor Expense": "-8.18",
"Other Revenues": "-25.9",
"Comprehensive Net Income": "-16.9",
"Economic Capital Ratio": "11.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000890908_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "19,687",
"Assets, Non-Current": "256",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "551",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "7,177",
"Liabilities, Current": "14,242",
"Long Term Liabilities": "1,074",
"Operating Costs and Expenses": "4,399",
"Other Assets": "19,587",
"Other Compr. Net Income": "0",
"Other Expenses": "5,576",
"Other Liabilities": "87",
"Other Net Income": "5,504",
"Other Revenues": "0",
"Property Plant and Equipment": "6,656",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "46,185",
"Liabilities": "15,404",
"Expenses": "17,703",
"Revenues": "0",
"Stockholders Equity": "30,781",
"Net Income": "-12,199",
"Comprehensive Net Income": "-12,199",
"BaseVar": "42,398",
"ECR before LimitedLiability": "105%",
"Economic Capital Ratio": "175%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.7474551970130894,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000890908.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000890908.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000890908.svg"
},
{
"company_id": "0000929994",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000929994.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000929994.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000929994_main_keyfigs.svg",
"name": "Assisted Living Concepts INC",
"rank": 35,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000929994.svg",
"report_text": "The relative strengths and weaknesses of Assisted Living Concepts INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Assisted Living Concepts INC compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 99% points.The greatest weakness of Assisted Living Concepts INC is the variable Revenues, reducing the Economic Capital Ratio by 31% points.
The company's Economic Capital Ratio, given in the ranking table, is 171%, being 7.2% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000929994_2013_Assisted_Living_Concepts_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "23.2",
"Stockholders Equity": "39.8",
"ECR before LimitedLiability": "51.9",
"Property Plant and Equipment": "119",
"Assets, Current": "-12.3",
"Intangible Assets": "-12.1",
"Expenses": "21.1",
"Revenues": "-32.3",
"Net Income": "18.2",
"Other Expenses": "-12.2",
"Depreciation, Depletion, Amortization": "-3.00",
"Operating Costs and Expenses": "5.66",
"Labor Expense": "8.93",
"General and Administrative Expense": "11.7",
"Cost of Goods and Services Sold": "5.64",
"Other Revenues": "-32.3",
"Long Term Liabilities": "-15.5",
"Liabilities, Current": "17.0",
"Other Net Income": "29.5",
"Comprehensive Net Income": "18.3",
"Economic Capital Ratio": "45.2"
},
"2012": {
"Property Plant and Equipment": "99.2",
"Assets": "24.6",
"Liabilities": "-19.3",
"Stockholders Equity": "17.2",
"ECR before LimitedLiability": "21.4",
"Intangible Assets": "-16.9",
"Assets, Current": "-19.5",
"Liabilities, Current": "-23.8",
"Long Term Liabilities": "-6.42",
"Other Liabilities": "10.2",
"Expenses": "18.3",
"Revenues": "-31.0",
"Net Income": "7.41",
"Other Expenses": "-16.1",
"General and Administrative Expense": "11.8",
"Cost of Goods and Services Sold": "6.02",
"Labor Expense": "9.75",
"Other Revenues": "-31.0",
"Other Net Income": "22.9",
"Comprehensive Net Income": "7.65",
"Economic Capital Ratio": "7.25"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000929994_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "20,271",
"Assets, Non-Current": "2,025",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "23,103",
"General and Administrative Expense": "13,361",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "9,028",
"Labor Expense": "0",
"Liabilities, Current": "36,005",
"Long Term Liabilities": "94,810",
"Operating Costs and Expenses": "0",
"Other Assets": "1,996",
"Other Compr. Net Income": "0",
"Other Expenses": "174,596",
"Other Liabilities": "25,518",
"Other Net Income": "234,464",
"Other Revenues": "956",
"Property Plant and Equipment": "430,733",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "464,053",
"Liabilities": "156,333",
"Expenses": "211,060",
"Revenues": "956",
"Stockholders Equity": "307,720",
"Net Income": "24,360",
"Comprehensive Net Income": "24,360",
"BaseVar": "533,433",
"ECR before LimitedLiability": "152%",
"Economic Capital Ratio": "206%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "31,423",
"Assets, Non-Current": "398",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "24,915",
"General and Administrative Expense": "19,822",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "154,284",
"Long Term Liabilities": "75,141",
"Operating Costs and Expenses": "0",
"Other Assets": "2,035",
"Other Compr. Net Income": "-137",
"Other Expenses": "210,051",
"Other Liabilities": "8,701",
"Other Net Income": "228,663",
"Other Revenues": "0",
"Property Plant and Equipment": "481,913",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "515,769",
"Liabilities": "238,126",
"Expenses": "254,788",
"Revenues": "0",
"Stockholders Equity": "277,643",
"Net Income": "-26,125",
"Comprehensive Net Income": "-26,262",
"BaseVar": "618,742",
"ECR before LimitedLiability": "100%",
"Economic Capital Ratio": "171%"
}
}
},
"top_rated": false,
"trend": -11.0,
"value": 1.7090151028343161,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000929994.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000929994.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000929994.svg"
},
{
"company_id": "0001003130",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001003130.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001003130.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001003130_main_keyfigs.svg",
"name": "LCA Vision INC",
"rank": 36,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001003130.svg",
"report_text": "The relative strengths and weaknesses of LCA Vision INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of LCA Vision INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 93% points.The greatest weakness of LCA Vision INC is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 72% points.
The company's Economic Capital Ratio, given in the ranking table, is 169%, being 5.6% points above the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001003130_2013_LCA_Vision_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-29.4",
"Liabilities": "52.7",
"Stockholders Equity": "-24.6",
"ECR before LimitedLiability": "27.0",
"Property Plant and Equipment": "-17.4",
"Assets, Current": "32.7",
"Intangible Assets": "-28.6",
"Other Liabilities": "16.0",
"Long Term Liabilities": "50.0",
"Liabilities, Current": "-13.8",
"Selling and Marketing Expense": "-30.2",
"Expenses": "-30.7",
"Revenues": "94.0",
"Net Income": "17.1",
"Operating Costs and Expenses": "11.5",
"Labor Expense": "18.4",
"Cost of Goods and Services Sold": "-51.1",
"Other Revenues": "94.0",
"Other Net Income": "-39.0",
"Comprehensive Net Income": "17.4",
"Economic Capital Ratio": "20.3"
},
"2012": {
"Property Plant and Equipment": "-24.7",
"Assets": "-49.7",
"Liabilities": "80.5",
"Stockholders Equity": "-57.3",
"ECR before LimitedLiability": "19.8",
"Intangible Assets": "-35.2",
"Assets, Current": "7.41",
"Assets, Non-Current": "-9.22",
"Long Term Liabilities": "48.7",
"Other Liabilities": "32.1",
"Expenses": "-60.7",
"Revenues": "93.4",
"Net Income": "13.4",
"General and Administrative Expense": "10.8",
"Selling and Marketing Expense": "-41.2",
"Operating Costs and Expenses": "11.8",
"Cost of Goods and Services Sold": "-72.3",
"Labor Expense": "25.3",
"Other Revenues": "93.4",
"Other Net Income": "-47.8",
"Comprehensive Net Income": "14.3",
"Economic Capital Ratio": "5.61"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001003130_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "52,473",
"Assets, Non-Current": "1,652",
"Cost of Goods and Services Sold": "43,048",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "13,942",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "25,772",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "1,671",
"Other Compr. Net Income": "0",
"Other Expenses": "30,601",
"Other Liabilities": "0",
"Other Net Income": "1,088",
"Other Revenues": "102,983",
"Property Plant and Equipment": "10,637",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "22,678"
},
"output_variables": {
"Assets": "66,433",
"Liabilities": "25,772",
"Expenses": "110,269",
"Revenues": "102,983",
"Stockholders Equity": "40,661",
"Net Income": "-6,198",
"Comprehensive Net Income": "-6,198",
"BaseVar": "153,272",
"ECR before LimitedLiability": "114%",
"Economic Capital Ratio": "181%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "41,028",
"Assets, Non-Current": "501",
"Cost of Goods and Services Sold": "44,348",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "13,442",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "19,976",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "1,059",
"Other Compr. Net Income": "94",
"Other Expenses": "30,060",
"Other Liabilities": "0",
"Other Net Income": "895",
"Other Revenues": "101,493",
"Property Plant and Equipment": "6,380",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "23,055"
},
"output_variables": {
"Assets": "48,968",
"Liabilities": "19,976",
"Expenses": "110,905",
"Revenues": "101,493",
"Stockholders Equity": "28,992",
"Net Income": "-8,517",
"Comprehensive Net Income": "-8,423",
"BaseVar": "141,166",
"ECR before LimitedLiability": "98%",
"Economic Capital Ratio": "169%"
}
}
},
"top_rated": false,
"trend": -9.0,
"value": 1.6926295418818036,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001003130.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001003130.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001003130.svg"
},
{
"company_id": "0001089815",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001089815.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001089815.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001089815.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001089815_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001089815_main_keyfigs.svg",
"name": "Elite Health Systems Inc",
"rank": 37,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001089815.svg",
"report_text": "The relative strengths and weaknesses of Elite Health Systems Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Elite Health Systems Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 77% points.The greatest weakness of Elite Health Systems Inc is the variable Liabilities, Current, reducing the Economic Capital Ratio by 70% points.
The company's Economic Capital Ratio, given in the ranking table, is 162%, being 1.6% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001089815_2013_Elite_Health_Systems_Inc.pdf",
"shrinked_graph_json": {
"2012": {
"Property Plant and Equipment": "-16.2",
"Assets": "15.7",
"Liabilities": "-39.9",
"Stockholders Equity": "-8.30",
"ECR before LimitedLiability": "12.6",
"Intangible Assets": "-18.2",
"Assets, Current": "76.9",
"Liabilities, Current": "-69.9",
"Long Term Liabilities": "20.1",
"Research And Development Expense": "2.37",
"Expenses": "29.5",
"Revenues": "-31.2",
"Net Income": "26.3",
"Other Expenses": "2.06",
"General and Administrative Expense": "-2.13",
"Operating Costs and Expenses": "4.72",
"Cost of Goods and Services Sold": "6.14",
"Labor Expense": "9.96",
"Other Revenues": "-31.2",
"Other Net Income": "32.2",
"Comprehensive Net Income": "26.6",
"Economic Capital Ratio": "-1.57"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001089815_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "5,047",
"Assets, Non-Current": "246",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,034",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,863",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,236",
"Other Liabilities": "362",
"Other Net Income": "2,999",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,293",
"Liabilities": "3,225",
"Expenses": "2,270",
"Revenues": "0",
"Stockholders Equity": "2,068",
"Net Income": "729",
"Comprehensive Net Income": "729",
"BaseVar": "6,894",
"ECR before LimitedLiability": "88%",
"Economic Capital Ratio": "162%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.6208538204656961,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001089815.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001089815.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001089815.svg"
},
{
"company_id": "0001301611",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001301611.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001301611.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001301611.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001301611_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001301611_main_keyfigs.svg",
"name": "Legacy Lifepoint Health INC",
"rank": 38,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001301611.svg",
"report_text": "The relative strengths and weaknesses of Legacy Lifepoint Health INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Legacy Lifepoint Health INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 47% points.The greatest weakness of Legacy Lifepoint Health INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 43% points.
The company's Economic Capital Ratio, given in the ranking table, is 162%, being 1.8% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001301611_2013_Legacy_Lifepoint_Health_INC.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-7.71",
"Assets": "-6.84",
"Liabilities": "-13.4",
"Stockholders Equity": "-19.9",
"ECR before LimitedLiability": "-27.6",
"Property Plant and Equipment": "13.3",
"Intangible Assets": "-5.11",
"Liabilities, Current": "11.6",
"Long Term Liabilities": "-24.7",
"Other Expenses": "4.68",
"Expenses": "-4.10",
"Revenues": "-32.2",
"Net Income": "-5.67",
"Cost of Goods and Services Sold": "12.0",
"General and Administrative Expense": "5.44",
"Labor Expense": "-19.3",
"Operating Costs and Expenses": "-4.06",
"Other Revenues": "-32.2",
"Comprehensive Net Income": "-4.69",
"Other Net Income": "34.7",
"Economic Capital Ratio": "-25.8"
},
"2011": {
"Assets": "8.03",
"Liabilities": "-22.3",
"Stockholders Equity": "-5.36",
"ECR before LimitedLiability": "10.0",
"Property Plant and Equipment": "18.2",
"Assets, Current": "-10.6",
"Intangible Assets": "9.97",
"Other Liabilities": "-7.76",
"Long Term Liabilities": "-37.0",
"Liabilities, Current": "20.0",
"Expenses": "18.0",
"Revenues": "-36.3",
"Net Income": "19.7",
"Other Expenses": "16.4",
"Operating Costs and Expenses": "-7.73",
"Labor Expense": "-18.0",
"General and Administrative Expense": "18.0",
"Cost of Goods and Services Sold": "6.83",
"Other Revenues": "-36.3",
"Other Net Income": "43.8",
"Comprehensive Net Income": "20.0",
"Economic Capital Ratio": "3.34"
},
"2012": {
"Property Plant and Equipment": "22.4",
"Assets": "3.45",
"Liabilities": "-19.6",
"Stockholders Equity": "-9.56",
"ECR before LimitedLiability": "12.4",
"Intangible Assets": "9.42",
"Assets, Current": "-16.2",
"Assets, Non-Current": "-4.42",
"Liabilities, Current": "21.7",
"Long Term Liabilities": "-42.7",
"Expenses": "14.5",
"Revenues": "-36.5",
"Net Income": "18.4",
"Other Expenses": "14.0",
"General and Administrative Expense": "19.0",
"Operating Costs and Expenses": "-10.2",
"Cost of Goods and Services Sold": "7.24",
"Labor Expense": "-18.7",
"Other Revenues": "-36.5",
"Other Net Income": "46.8",
"Comprehensive Net Income": "18.7",
"Economic Capital Ratio": "-1.81"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001301611_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "823,100",
"Assets, Non-Current": "9,700",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "148,500",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,623,800",
"Labor Expense": "1,270,300",
"Liabilities, Current": "324,300",
"Long Term Liabilities": "1,570,500",
"Operating Costs and Expenses": "605,200",
"Other Assets": "27,200",
"Other Compr. Net Income": "0",
"Other Expenses": "1,079,700",
"Other Liabilities": "351,000",
"Other Net Income": "3,262,300",
"Other Revenues": "0",
"Property Plant and Equipment": "1,668,600",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,152,400",
"Liabilities": "2,245,800",
"Expenses": "3,103,700",
"Revenues": "0",
"Stockholders Equity": "1,906,600",
"Net Income": "158,600",
"Comprehensive Net Income": "158,600",
"BaseVar": "6,382,100",
"ECR before LimitedLiability": "91%",
"Economic Capital Ratio": "165%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "840,000",
"Assets, Non-Current": "19,800",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "165,800",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,658,200",
"Labor Expense": "1,364,700",
"Liabilities, Current": "372,800",
"Long Term Liabilities": "1,595,400",
"Operating Costs and Expenses": "682,400",
"Other Assets": "21,700",
"Other Compr. Net Income": "1,200",
"Other Expenses": "647,700",
"Other Liabilities": "416,100",
"Other Net Income": "3,025,900",
"Other Revenues": "0",
"Property Plant and Equipment": "1,830,400",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,370,100",
"Liabilities": "2,384,300",
"Expenses": "2,860,600",
"Revenues": "0",
"Stockholders Equity": "1,985,800",
"Net Income": "165,300",
"Comprehensive Net Income": "166,500",
"BaseVar": "6,321,050",
"ECR before LimitedLiability": "90%",
"Economic Capital Ratio": "164%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "925,300",
"Assets, Non-Current": "47,800",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "193,100",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,696,300",
"Labor Expense": "1,554,500",
"Liabilities, Current": "444,900",
"Long Term Liabilities": "1,696,500",
"Operating Costs and Expenses": "799,100",
"Other Assets": "21,900",
"Other Compr. Net Income": "-3,500",
"Other Expenses": "689,500",
"Other Liabilities": "478,300",
"Other Net Income": "3,391,800",
"Other Revenues": "0",
"Property Plant and Equipment": "2,030,900",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,722,200",
"Liabilities": "2,619,700",
"Expenses": "3,236,200",
"Revenues": "0",
"Stockholders Equity": "2,102,500",
"Net Income": "155,600",
"Comprehensive Net Income": "152,100",
"BaseVar": "6,986,700",
"ECR before LimitedLiability": "87%",
"Economic Capital Ratio": "162%"
}
}
},
"top_rated": false,
"trend": -7.0,
"value": 1.6184326646429865,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001301611.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001301611.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001301611.svg"
},
{
"company_id": "0001520697",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001520697.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001520697.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001520697.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001520697_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001520697_main_keyfigs.svg",
"name": "Acadia Healthcare Company Inc",
"rank": 39,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001520697.svg",
"report_text": "The relative strengths and weaknesses of Acadia Healthcare Company Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Acadia Healthcare Company Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 52% points.The greatest weakness of Acadia Healthcare Company Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 80% points.
The company's Economic Capital Ratio, given in the ranking table, is 160%, being 3.8% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001520697_2013_Acadia_Healthcare_Company_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "10.4",
"Liabilities": "-59.3",
"Stockholders Equity": "-35.9",
"ECR before LimitedLiability": "-39.3",
"Property Plant and Equipment": "-6.63",
"Assets, Current": "-5.93",
"Intangible Assets": "27.3",
"Other Liabilities": "8.41",
"Long Term Liabilities": "-91.9",
"Liabilities, Current": "16.5",
"Expenses": "24.6",
"Revenues": "-38.4",
"Net Income": "8.39",
"Other Expenses": "15.0",
"Labor Expense": "-25.4",
"General and Administrative Expense": "19.8",
"Cost of Goods and Services Sold": "7.48",
"Other Revenues": "-38.4",
"Other Net Income": "27.2",
"Comprehensive Net Income": "8.62",
"Economic Capital Ratio": "-46.0"
},
"2012": {
"Property Plant and Equipment": "5.48",
"Assets": "27.4",
"Liabilities": "-38.4",
"Stockholders Equity": "3.62",
"ECR before LimitedLiability": "10.4",
"Intangible Assets": "52.4",
"Assets, Current": "-14.5",
"Liabilities, Current": "17.8",
"Long Term Liabilities": "-80.4",
"Other Liabilities": "12.2",
"Expenses": "27.5",
"Revenues": "-29.5",
"Net Income": "14.1",
"Other Expenses": "13.0",
"General and Administrative Expense": "15.2",
"Cost of Goods and Services Sold": "5.81",
"Labor Expense": "-13.4",
"Other Revenues": "-29.5",
"Other Net Income": "19.7",
"Comprehensive Net Income": "14.4",
"Economic Capital Ratio": "-3.84"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001520697_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "112,605",
"Assets, Non-Current": "16,366",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "4,288",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "195,047",
"Labor Expense": "156,561",
"Liabilities, Current": "40,668",
"Long Term Liabilities": "275,963",
"Operating Costs and Expenses": "20,472",
"Other Assets": "6,006",
"Other Compr. Net Income": "0",
"Other Expenses": "72,925",
"Other Liabilities": "0",
"Other Net Income": "219,354",
"Other Revenues": "0",
"Property Plant and Equipment": "82,972",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "412,996",
"Liabilities": "316,631",
"Expenses": "254,246",
"Revenues": "0",
"Stockholders Equity": "96,365",
"Net Income": "-34,892",
"Comprehensive Net Income": "-34,892",
"BaseVar": "601,614",
"ECR before LimitedLiability": "29%",
"Economic Capital Ratio": "115%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "140,981",
"Assets, Non-Current": "32,100",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "7,982",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "573,390",
"Labor Expense": "239,639",
"Liabilities, Current": "71,851",
"Long Term Liabilities": "478,014",
"Operating Costs and Expenses": "42,777",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "96,559",
"Other Liabilities": "998",
"Other Net Income": "407,360",
"Other Revenues": "0",
"Property Plant and Equipment": "236,942",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "983,413",
"Liabilities": "550,863",
"Expenses": "386,957",
"Revenues": "0",
"Stockholders Equity": "432,550",
"Net Income": "20,403",
"Comprehensive Net Income": "20,403",
"BaseVar": "1,164,296",
"ECR before LimitedLiability": "84%",
"Economic Capital Ratio": "160%"
}
}
},
"top_rated": false,
"trend": 15.0,
"value": 1.5981333564819242,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001520697.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001520697.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001520697.svg"
},
{
"company_id": "0000920148",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000920148.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000920148.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000920148.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000920148_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000920148_main_keyfigs.svg",
"name": "Laboratory Corp OF America Holdings",
"rank": 40,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000920148.svg",
"report_text": "The relative strengths and weaknesses of Laboratory Corp OF America Holdings are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Laboratory Corp OF America Holdings compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 54% points.The greatest weakness of Laboratory Corp OF America Holdings is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 40% points.
The company's Economic Capital Ratio, given in the ranking table, is 160%, being 3.9% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000920148_2013_Laboratory_Corp_OF_America_Holdings.pdf",
"shrinked_graph_json": {
"2009": {
"Assets": "9.99",
"Stockholders Equity": "-10.7",
"ECR before LimitedLiability": "-28.7",
"Intangible Assets": "11.8",
"Assets, Current": "-3.40",
"Liabilities, Current": "-26.2",
"Liabilities": "-35.2",
"Long Term Liabilities": "-10.7",
"Other Liabilities": "2.65",
"Other Expenses": "13.2",
"Expenses": "15.1",
"Revenues": "25.4",
"Net Income": "2.19",
"General and Administrative Expense": "-8.43",
"Cost of Goods and Services Sold": "-5.80",
"Labor Expense": "4.56",
"Operating Costs and Expenses": "11.0",
"Other Revenues": "25.4",
"Comprehensive Net Income": "2.19",
"Other Net Income": "-34.9",
"Economic Capital Ratio": "-28.3"
},
"2010": {
"Assets, Current": "-9.24",
"Assets": "-8.24",
"Liabilities": "-22.2",
"Stockholders Equity": "-27.7",
"ECR before LimitedLiability": "-32.2",
"Property Plant and Equipment": "-15.0",
"Assets, Non-Current": "-2.71",
"Intangible Assets": "27.6",
"Other Liabilities": "13.1",
"Liabilities, Current": "-23.8",
"Long Term Liabilities": "-12.2",
"Other Revenues": "44.6",
"Revenues": "44.6",
"Operating Costs and Expenses": "9.70",
"Economic Capital Ratio": "-30.4",
"Other Expenses": "23.9",
"Cost of Goods and Services Sold": "-29.9",
"General and Administrative Expense": "-9.80",
"Labor Expense": "8.79",
"Other Net Income": "-39.2",
"Depreciation, Depletion, Amortization": "1.54"
},
"2011": {
"Assets": "-4.73",
"Liabilities": "-18.2",
"Stockholders Equity": "-19.9",
"ECR before LimitedLiability": "6.97",
"Property Plant and Equipment": "-15.7",
"Assets, Current": "-15.2",
"Assets, Non-Current": "-3.66",
"Intangible Assets": "52.3",
"Other Liabilities": "10.2",
"Long Term Liabilities": "-33.2",
"Liabilities, Current": "3.16",
"Expenses": "13.6",
"Revenues": "44.0",
"Net Income": "26.8",
"Other Expenses": "26.0",
"Operating Costs and Expenses": "7.74",
"Labor Expense": "12.3",
"Cost of Goods and Services Sold": "-38.9",
"Other Revenues": "44.0",
"Other Net Income": "-26.6",
"Comprehensive Net Income": "27.1",
"Economic Capital Ratio": "0.292"
},
"2012": {
"Liabilities": "-20.4",
"Stockholders Equity": "-19.8",
"ECR before LimitedLiability": "10.3",
"Long Term Liabilities": "-40.4",
"Other Liabilities": "16.1",
"Expenses": "14.2",
"Net Income": "24.7",
"Other Expenses": "22.2",
"General and Administrative Expense": "4.28",
"Operating Costs and Expenses": "5.89",
"Cost of Goods and Services Sold": "-36.5",
"Labor Expense": "12.5",
"Other Revenues": "39.1",
"Revenues": "39.1",
"Property Plant and Equipment": "-13.3",
"Intangible Assets": "53.7",
"Assets, Current": "-17.6",
"Assets, Non-Current": "-4.08",
"Other Net Income": "-25.1",
"Comprehensive Net Income": "25.4",
"Economic Capital Ratio": "-3.88"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000920148_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "935,600",
"Assets, Non-Current": "90,700",
"Cost of Goods and Services Sold": "2,723,800",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "958,900",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,239,300",
"Labor Expense": "0",
"Liabilities, Current": "1,596,100",
"Long Term Liabilities": "1,135,600",
"Operating Costs and Expenses": "0",
"Other Assets": "71,400",
"Other Compr. Net Income": "0",
"Other Expenses": "405,100",
"Other Liabilities": "0",
"Other Net Income": "-51,300",
"Other Revenues": "4,694,700",
"Property Plant and Equipment": "500,800",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,837,800",
"Liabilities": "2,731,700",
"Expenses": "4,087,800",
"Revenues": "4,694,700",
"Stockholders Equity": "2,106,100",
"Net Income": "555,600",
"Comprehensive Net Income": "555,600",
"BaseVar": "8,201,650",
"ECR before LimitedLiability": "95%",
"Economic Capital Ratio": "168%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "1,143,800",
"Assets, Non-Current": "103,200",
"Cost of Goods and Services Sold": "2,906,100",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,034,300",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,275,400",
"Labor Expense": "0",
"Liabilities, Current": "1,722,800",
"Long Term Liabilities": "1,978,100",
"Operating Costs and Expenses": "0",
"Other Assets": "78,500",
"Other Compr. Net Income": "0",
"Other Expenses": "416,700",
"Other Liabilities": "0",
"Other Net Income": "-51,200",
"Other Revenues": "5,003,900",
"Property Plant and Equipment": "586,900",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,187,800",
"Liabilities": "3,700,900",
"Expenses": "4,357,100",
"Revenues": "5,003,900",
"Stockholders Equity": "2,486,900",
"Net Income": "595,600",
"Comprehensive Net Income": "595,600",
"BaseVar": "9,650,450",
"ECR before LimitedLiability": "85%",
"Economic Capital Ratio": "160%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "1,084,800",
"Assets, Non-Current": "94,200",
"Cost of Goods and Services Sold": "3,267,600",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,159,600",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,302,500",
"Labor Expense": "0",
"Liabilities, Current": "1,300,100",
"Long Term Liabilities": "2,312,800",
"Operating Costs and Expenses": "0",
"Other Assets": "76,800",
"Other Compr. Net Income": "0",
"Other Expenses": "587,200",
"Other Liabilities": "0",
"Other Net Income": "5,200",
"Other Revenues": "5,542,300",
"Property Plant and Equipment": "578,300",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,136,600",
"Liabilities": "3,612,900",
"Expenses": "5,014,400",
"Revenues": "5,542,300",
"Stockholders Equity": "2,523,700",
"Net Income": "533,100",
"Comprehensive Net Income": "533,100",
"BaseVar": "10,155,700",
"ECR before LimitedLiability": "86%",
"Economic Capital Ratio": "161%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,391,800",
"Assets, Non-Current": "124,900",
"Cost of Goods and Services Sold": "3,421,700",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,114,600",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,569,400",
"Labor Expense": "0",
"Liabilities, Current": "1,574,500",
"Long Term Liabilities": "2,482,400",
"Operating Costs and Expenses": "0",
"Other Assets": "78,100",
"Other Compr. Net Income": "22,200",
"Other Expenses": "565,500",
"Other Liabilities": "0",
"Other Net Income": "15,200",
"Other Revenues": "5,671,400",
"Property Plant and Equipment": "630,800",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,795,000",
"Liabilities": "4,056,900",
"Expenses": "5,101,800",
"Revenues": "5,671,400",
"Stockholders Equity": "2,738,100",
"Net Income": "584,800",
"Comprehensive Net Income": "607,000",
"BaseVar": "10,831,250",
"ECR before LimitedLiability": "84%",
"Economic Capital Ratio": "160%"
}
}
},
"top_rated": false,
"trend": -7.0,
"value": 1.5976972349395073,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000920148.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000920148.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000920148.svg"
},
{
"company_id": "0000722723",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000722723.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000722723.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000722723.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000722723_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000722723_main_keyfigs.svg",
"name": "Hanger INC",
"rank": 41,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000722723.svg",
"report_text": "The relative strengths and weaknesses of Hanger INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Hanger INC compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 42% points.The greatest weakness of Hanger INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 58% points.
The company's Economic Capital Ratio, given in the ranking table, is 157%, being 6.8% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000722723_2013_Hanger_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities": "-26.5",
"Stockholders Equity": "-21.6",
"Economic Capital Ratio": "-8.49",
"Long Term Liabilities": "-53.2",
"Liabilities, Current": "23.3",
"Expenses": "15.9",
"Revenues": "36.7",
"Net Income": "22.7",
"Research And Development Expense": "2.28",
"Other Expenses": "5.43",
"Operating Costs and Expenses": "-7.21",
"Labor Expense": "-14.6",
"General and Administrative Expense": "20.1",
"Cost of Goods and Services Sold": "7.59",
"Other Revenues": "36.7",
"Property Plant and Equipment": "-16.2",
"Assets, Current": "-5.31",
"Assets, Non-Current": "-4.51",
"Intangible Assets": "36.7",
"Other Net Income": "-26.1",
"Comprehensive Net Income": "23.0"
},
"2012": {
"Liabilities, Current": "24.6",
"Liabilities": "-21.3",
"Stockholders Equity": "-18.4",
"ECR before LimitedLiability": "7.38",
"Long Term Liabilities": "-58.1",
"Other Liabilities": "5.41",
"Expenses": "13.5",
"Net Income": "21.2",
"General and Administrative Expense": "20.2",
"Operating Costs and Expenses": "-8.31",
"Cost of Goods and Services Sold": "7.66",
"Labor Expense": "-12.9",
"Other Revenues": "36.3",
"Revenues": "36.3",
"Property Plant and Equipment": "-13.5",
"Intangible Assets": "41.9",
"Assets, Current": "-11.2",
"Assets, Non-Current": "-4.97",
"Other Net Income": "-25.2",
"Comprehensive Net Income": "21.5",
"Economic Capital Ratio": "-6.82"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000722723_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "333,471",
"Assets, Non-Current": "8,394",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "30,969",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "664,378",
"Labor Expense": "322,765",
"Liabilities, Current": "91,742",
"Long Term Liabilities": "532,786",
"Operating Costs and Expenses": "178,335",
"Other Assets": "17,485",
"Other Compr. Net Income": "0",
"Other Expenses": "331,451",
"Other Liabilities": "74,309",
"Other Net Income": "0",
"Other Revenues": "918,539",
"Property Plant and Equipment": "104,772",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,128,500",
"Liabilities": "698,837",
"Expenses": "863,520",
"Revenues": "918,539",
"Stockholders Equity": "429,663",
"Net Income": "55,019",
"Comprehensive Net Income": "55,019",
"BaseVar": "1,804,698",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "152%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "358,652",
"Assets, Non-Current": "11,126",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "34,652",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "739,055",
"Labor Expense": "335,328",
"Liabilities, Current": "107,187",
"Long Term Liabilities": "549,316",
"Operating Costs and Expenses": "188,868",
"Other Assets": "14,033",
"Other Compr. Net Income": "-734",
"Other Expenses": "363,010",
"Other Liabilities": "77,730",
"Other Net Income": "0",
"Other Revenues": "985,550",
"Property Plant and Equipment": "114,461",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,237,327",
"Liabilities": "734,233",
"Expenses": "921,858",
"Revenues": "985,550",
"Stockholders Equity": "503,094",
"Net Income": "63,692",
"Comprehensive Net Income": "62,958",
"BaseVar": "1,939,851",
"ECR before LimitedLiability": "80%",
"Economic Capital Ratio": "157%"
}
}
},
"top_rated": false,
"trend": -6.0,
"value": 1.568325769747711,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000722723.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000722723.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000722723.svg"
},
{
"company_id": "0000316253",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000316253.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000316253.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000316253.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000316253_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000316253_main_keyfigs.svg",
"name": "ENZO Biochem INC",
"rank": 42,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000316253.svg",
"report_text": "The relative strengths and weaknesses of ENZO Biochem INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of ENZO Biochem INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 71% points.The greatest weakness of ENZO Biochem INC is the variable Other Expenses, reducing the Economic Capital Ratio by 85% points.
The company's Economic Capital Ratio, given in the ranking table, is 154%, being 10% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000316253_2013_ENZO_Biochem_INC.pdf",
"shrinked_graph_json": {
"2012": {
"Property Plant and Equipment": "-25.1",
"Assets": "-46.2",
"Liabilities": "66.9",
"Stockholders Equity": "-19.3",
"Economic Capital Ratio": "-10.1",
"Intangible Assets": "-17.2",
"Assets, Non-Current": "-10.4",
"Liabilities, Current": "18.1",
"Long Term Liabilities": "45.9",
"Other Liabilities": "30.2",
"Expenses": "-74.0",
"Revenues": "71.0",
"Net Income": "-34.8",
"Other Expenses": "-84.9",
"General and Administrative Expense": "-41.2",
"Operating Costs and Expenses": "11.6",
"Cost of Goods and Services Sold": "15.2",
"Labor Expense": "25.0",
"Other Revenues": "71.0",
"Other Net Income": "-48.1",
"Comprehensive Net Income": "-34.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000316253_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "40,368",
"Assets, Non-Current": "407",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "47,928",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "19,232",
"Labor Expense": "0",
"Liabilities, Current": "18,956",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "87,689",
"Other Liabilities": "0",
"Other Net Income": "-442",
"Other Revenues": "103,083",
"Property Plant and Equipment": "9,116",
"Research And Development Expense": "6,293",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "69,123",
"Liabilities": "18,956",
"Expenses": "141,910",
"Revenues": "103,083",
"Stockholders Equity": "50,167",
"Net Income": "-39,269",
"Comprehensive Net Income": "-39,269",
"BaseVar": "166,757",
"ECR before LimitedLiability": "76%",
"Economic Capital Ratio": "154%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.5354987092886945,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000316253.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000316253.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000316253.svg"
},
{
"company_id": "0000776325",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000776325.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000776325.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000776325_main_keyfigs.svg",
"name": "RES CARE INC KY",
"rank": 43,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000776325.svg",
"report_text": "The relative strengths and weaknesses of RES CARE INC KY are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of RES CARE INC KY compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 58% points.The greatest weakness of RES CARE INC KY is the variable Other Expenses, reducing the Economic Capital Ratio by 64% points.
The company's Economic Capital Ratio, given in the ranking table, is 142%, being 21% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000776325_2013_RES_CARE_INC_KY.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-41.0",
"Stockholders Equity": "-63.6",
"Long Term Liabilities": "-23.1",
"ECR before LimitedLiability": "-14.7",
"Property Plant and Equipment": "-28.8",
"Assets, Current": "-21.2",
"Assets, Non-Current": "-5.60",
"Intangible Assets": "14.3",
"Expenses": "-9.75",
"Revenues": "56.1",
"Net Income": "33.4",
"Other Expenses": "-62.5",
"Operating Costs and Expenses": "11.7",
"Labor Expense": "18.8",
"General and Administrative Expense": "7.61",
"Cost of Goods and Services Sold": "11.7",
"Other Revenues": "56.1",
"Liabilities, Current": "25.5",
"Other Net Income": "-41.1",
"Comprehensive Net Income": "33.8",
"Economic Capital Ratio": "-21.4"
},
"2012": {
"Property Plant and Equipment": "-24.4",
"Assets": "-39.8",
"Stockholders Equity": "-60.0",
"Liabilities, Current": "29.2",
"ECR before LimitedLiability": "-7.25",
"Intangible Assets": "19.6",
"Assets, Current": "-27.4",
"Assets, Non-Current": "-6.84",
"Expenses": "-11.2",
"Revenues": "58.0",
"Net Income": "28.9",
"Other Expenses": "-63.9",
"General and Administrative Expense": "8.30",
"Operating Costs and Expenses": "8.98",
"Cost of Goods and Services Sold": "11.7",
"Labor Expense": "19.2",
"Other Revenues": "58.0",
"Long Term Liabilities": "-30.7",
"Other Net Income": "-40.2",
"Comprehensive Net Income": "29.4",
"Economic Capital Ratio": "-21.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000776325_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "297,056",
"Assets, Non-Current": "27,658",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "229,254",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "582,651",
"Labor Expense": "0",
"Liabilities, Current": "174,337",
"Long Term Liabilities": "420,054",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,266,186",
"Other Liabilities": "98,912",
"Other Net Income": "-30,903",
"Other Revenues": "1,579,335",
"Property Plant and Equipment": "84,893",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "992,258",
"Liabilities": "693,303",
"Expenses": "1,495,440",
"Revenues": "1,579,335",
"Stockholders Equity": "298,955",
"Net Income": "52,992",
"Comprehensive Net Income": "52,992",
"BaseVar": "2,395,620",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "139%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "318,216",
"Assets, Non-Current": "27,154",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "233,838",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "609,558",
"Labor Expense": "0",
"Liabilities, Current": "175,174",
"Long Term Liabilities": "414,739",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,281,872",
"Other Liabilities": "118,035",
"Other Net Income": "-42,386",
"Other Revenues": "1,599,109",
"Property Plant and Equipment": "97,030",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,051,958",
"Liabilities": "707,948",
"Expenses": "1,515,710",
"Revenues": "1,599,109",
"Stockholders Equity": "344,010",
"Net Income": "41,013",
"Comprehensive Net Income": "41,013",
"BaseVar": "2,458,556",
"ECR before LimitedLiability": "61%",
"Economic Capital Ratio": "142%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 1.4220863700905402,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000776325.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000776325.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000776325.svg"
},
{
"company_id": "0000895665",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000895665.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000895665.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000895665.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000895665_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000895665_main_keyfigs.svg",
"name": "Clearday Inc",
"rank": 44,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000895665.svg",
"report_text": "The relative strengths and weaknesses of Clearday Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Clearday Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 55% points.The greatest weakness of Clearday Inc is the variable Net Income, reducing the Economic Capital Ratio by 93% points.
The company's Economic Capital Ratio, given in the ranking table, is 140%, being 24% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000895665_2013_Clearday_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "28.2",
"Liabilities": "36.8",
"Stockholders Equity": "42.3",
"ECR before LimitedLiability": "-30.9",
"Assets, Current": "43.9",
"Intangible Assets": "-25.3",
"Long Term Liabilities": "35.7",
"Liabilities, Current": "24.9",
"Expenses": "-69.0",
"Revenues": "-14.6",
"Net Income": "-110",
"Research And Development Expense": "-52.8",
"Other Expenses": "-18.2",
"Operating Costs and Expenses": "10.7",
"Labor Expense": "17.1",
"General and Administrative Expense": "-43.0",
"Cost of Goods and Services Sold": "10.7",
"Other Revenues": "-14.6",
"Other Net Income": "-35.3",
"Comprehensive Net Income": "-110",
"Economic Capital Ratio": "-37.5"
},
"2012": {
"Property Plant and Equipment": "53.6",
"Assets": "27.1",
"Liabilities": "52.2",
"Stockholders Equity": "55.2",
"ECR before LimitedLiability": "-9.88",
"Intangible Assets": "-22.4",
"Liabilities, Current": "25.7",
"Long Term Liabilities": "29.0",
"Research And Development Expense": "-49.6",
"Expenses": "-57.3",
"Revenues": "-10.1",
"Net Income": "-93.3",
"Other Expenses": "-10.1",
"General and Administrative Expense": "-36.1",
"Operating Costs and Expenses": "7.49",
"Cost of Goods and Services Sold": "9.76",
"Labor Expense": "15.9",
"Other Revenues": "-10.1",
"Other Net Income": "-31.2",
"Comprehensive Net Income": "-93.0",
"Economic Capital Ratio": "-24.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000895665_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "8,307",
"Assets, Non-Current": "362",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,322",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,409",
"Labor Expense": "0",
"Liabilities, Current": "1,146",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "5,526",
"Other Liabilities": "628",
"Other Net Income": "22",
"Other Revenues": "3,768",
"Property Plant and Equipment": "2,871",
"Research And Development Expense": "5,325",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "12,949",
"Liabilities": "1,774",
"Expenses": "17,173",
"Revenues": "3,768",
"Stockholders Equity": "11,175",
"Net Income": "-13,383",
"Comprehensive Net Income": "-13,383",
"BaseVar": "17,843",
"ECR before LimitedLiability": "38%",
"Economic Capital Ratio": "123%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "4,122",
"Assets, Non-Current": "776",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,440",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "889",
"Labor Expense": "0",
"Liabilities, Current": "1,063",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "4,015",
"Other Liabilities": "674",
"Other Net Income": "6.0",
"Other Revenues": "3,551",
"Property Plant and Equipment": "6,242",
"Research And Development Expense": "5,030",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "12,029",
"Liabilities": "1,737",
"Expenses": "14,485",
"Revenues": "3,551",
"Stockholders Equity": "10,292",
"Net Income": "-10,928",
"Comprehensive Net Income": "-10,928",
"BaseVar": "15,904",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "140%"
}
}
},
"top_rated": false,
"trend": 6.0,
"value": 1.3957445487701339,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000895665.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000895665.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000895665.svg"
},
{
"company_id": "0001498021",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001498021.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001498021.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001498021_main_keyfigs.svg",
"name": "Examworks Group Inc",
"rank": 45,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001498021.svg",
"report_text": "The relative strengths and weaknesses of Examworks Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Examworks Group Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 51% points.The greatest weakness of Examworks Group Inc is the variable Other Liabilities, reducing the Economic Capital Ratio by 44% points.
The company's Economic Capital Ratio, given in the ranking table, is 138%, being 26% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001498021_2013_Examworks_Group_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "8.75",
"Liabilities": "-34.9",
"Stockholders Equity": "-15.8",
"ECR before LimitedLiability": "-8.34",
"Property Plant and Equipment": "-21.4",
"Assets, Current": "-6.52",
"Intangible Assets": "58.6",
"Other Liabilities": "-68.4",
"Long Term Liabilities": "16.7",
"Liabilities, Current": "9.89",
"Expenses": "22.6",
"Revenues": "22.6",
"Net Income": "15.2",
"Other Expenses": "33.8",
"Operating Costs and Expenses": "7.12",
"Labor Expense": "11.3",
"Cost of Goods and Services Sold": "-31.2",
"Other Revenues": "22.6",
"Other Net Income": "-26.7",
"Comprehensive Net Income": "15.0",
"Economic Capital Ratio": "-15.0"
},
"2012": {
"Liabilities, Current": "13.7",
"Liabilities": "-35.3",
"Stockholders Equity": "-28.1",
"ECR before LimitedLiability": "-11.9",
"Long Term Liabilities": "-6.54",
"Other Liabilities": "-43.7",
"Expenses": "19.3",
"Net Income": "14.4",
"Other Expenses": "33.0",
"Operating Costs and Expenses": "6.06",
"Cost of Goods and Services Sold": "-34.6",
"Labor Expense": "12.8",
"Other Revenues": "28.0",
"Revenues": "28.0",
"Property Plant and Equipment": "-22.0",
"Intangible Assets": "51.2",
"Assets, Current": "-19.2",
"Assets, Non-Current": "-6.48",
"Other Net Income": "-28.9",
"Comprehensive Net Income": "15.4",
"Economic Capital Ratio": "-26.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001498021_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "159,797",
"Assets, Non-Current": "438",
"Cost of Goods and Services Sold": "262,242",
"Depreciation, Depletion, Amortization": "47,439",
"General and Administrative Expense": "84,133",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "446,428",
"Labor Expense": "0",
"Liabilities, Current": "90,113",
"Long Term Liabilities": "46,040",
"Operating Costs and Expenses": "0",
"Other Assets": "11,458",
"Other Compr. Net Income": "-2,645",
"Other Expenses": "-4,082",
"Other Liabilities": "252,962",
"Other Net Income": "-16,461",
"Other Revenues": "397,860",
"Property Plant and Equipment": "8,918",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "627,039",
"Liabilities": "389,115",
"Expenses": "389,732",
"Revenues": "397,860",
"Stockholders Equity": "237,924",
"Net Income": "-8,333",
"Comprehensive Net Income": "-10,978",
"BaseVar": "911,426",
"ECR before LimitedLiability": "66%",
"Economic Capital Ratio": "146%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "159,889",
"Assets, Non-Current": "1,101",
"Cost of Goods and Services Sold": "344,051",
"Depreciation, Depletion, Amortization": "58,551",
"General and Administrative Expense": "113,510",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "523,039",
"Labor Expense": "0",
"Liabilities, Current": "110,126",
"Long Term Liabilities": "135,927",
"Operating Costs and Expenses": "0",
"Other Assets": "46,139",
"Other Compr. Net Income": "4,612",
"Other Expenses": "-7,987",
"Other Liabilities": "250,300",
"Other Net Income": "-28,051",
"Other Revenues": "521,237",
"Property Plant and Equipment": "10,333",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "740,501",
"Liabilities": "496,353",
"Expenses": "508,125",
"Revenues": "521,237",
"Stockholders Equity": "244,148",
"Net Income": "-14,939",
"Comprehensive Net Income": "-10,327",
"BaseVar": "1,149,440",
"ECR before LimitedLiability": "56%",
"Economic Capital Ratio": "138%"
}
}
},
"top_rated": false,
"trend": -6.0,
"value": 1.3757970139659939,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001498021.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001498021.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001498021.svg"
},
{
"company_id": "0000948072",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000948072.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000948072.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000948072.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000948072_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000948072_main_keyfigs.svg",
"name": "Birner Dental Management Services INC",
"rank": 46,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000948072.svg",
"report_text": "The relative strengths and weaknesses of Birner Dental Management Services INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Birner Dental Management Services INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 81% points.The greatest weakness of Birner Dental Management Services INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 110% points.
The company's Economic Capital Ratio, given in the ranking table, is 137%, being 26% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000948072_2013_Birner_Dental_Management_Services_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-67.8",
"Liabilities": "63.4",
"Stockholders Equity": "-111",
"Economic Capital Ratio": "-9.86",
"Property Plant and Equipment": "-29.4",
"Assets, Current": "-41.2",
"Assets, Non-Current": "-11.5",
"Intangible Assets": "-18.5",
"Long Term Liabilities": "39.5",
"Liabilities, Current": "39.2",
"Selling and Marketing Expense": "-7.38",
"Expenses": "-59.0",
"Revenues": "96.7",
"Net Income": "51.7",
"Other Expenses": "34.9",
"Labor Expense": "-112",
"General and Administrative Expense": "21.0",
"Cost of Goods and Services Sold": "17.9",
"Other Revenues": "96.7",
"Other Net Income": "-54.5",
"Comprehensive Net Income": "52.4"
},
"2012": {
"Property Plant and Equipment": "-20.4",
"Assets": "-71.8",
"Liabilities": "49.9",
"Stockholders Equity": "-110",
"ECR before LimitedLiability": "-12.2",
"Intangible Assets": "-19.0",
"Assets, Current": "-50.8",
"Assets, Non-Current": "-13.9",
"Liabilities, Current": "43.5",
"Long Term Liabilities": "10.9",
"Expenses": "-56.3",
"Revenues": "80.7",
"Net Income": "42.4",
"Other Expenses": "24.0",
"General and Administrative Expense": "25.3",
"Cost of Goods and Services Sold": "18.0",
"Labor Expense": "-101",
"Other Revenues": "80.7",
"Other Net Income": "-54.0",
"Comprehensive Net Income": "43.3",
"Economic Capital Ratio": "-26.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000948072_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "4,616",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "2,506",
"General and Administrative Expense": "5,706",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,096",
"Labor Expense": "35,647",
"Liabilities, Current": "5,931",
"Long Term Liabilities": "4,251",
"Operating Costs and Expenses": "5,606",
"Other Assets": "321",
"Other Compr. Net Income": "5.2",
"Other Expenses": "10,204",
"Other Liabilities": "3,814",
"Other Net Income": "830",
"Other Revenues": "63,121",
"Property Plant and Equipment": "5,790",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "2,667"
},
"output_variables": {
"Assets": "21,822",
"Liabilities": "13,996",
"Expenses": "62,335",
"Revenues": "63,121",
"Stockholders Equity": "7,826",
"Net Income": "1,615",
"Comprehensive Net Income": "1,620",
"BaseVar": "81,055",
"ECR before LimitedLiability": "72%",
"Economic Capital Ratio": "151%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "5,023",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "2,839",
"General and Administrative Expense": "4,935",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "10,193",
"Labor Expense": "35,403",
"Liabilities, Current": "5,678",
"Long Term Liabilities": "6,074",
"Operating Costs and Expenses": "5,827",
"Other Assets": "158",
"Other Compr. Net Income": "0",
"Other Expenses": "10,525",
"Other Liabilities": "4,545",
"Other Net Income": "0",
"Other Revenues": "62,354",
"Property Plant and Equipment": "7,894",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "2,018"
},
"output_variables": {
"Assets": "23,269",
"Liabilities": "16,297",
"Expenses": "61,547",
"Revenues": "62,354",
"Stockholders Equity": "6,972",
"Net Income": "807",
"Comprehensive Net Income": "807",
"BaseVar": "81,734",
"ECR before LimitedLiability": "55%",
"Economic Capital Ratio": "137%"
}
}
},
"top_rated": false,
"trend": -10.0,
"value": 1.3726094661817232,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000948072.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000948072.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000948072.svg"
},
{
"company_id": "0001035688",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001035688.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001035688.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001035688_main_keyfigs.svg",
"name": "Select Medical CORP",
"rank": 47,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001035688.svg",
"report_text": "The relative strengths and weaknesses of Select Medical CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Select Medical CORP compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 49% points.The greatest weakness of Select Medical CORP is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 68% points.
The company's Economic Capital Ratio, given in the ranking table, is 135%, being 29% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001035688_2013_Select_Medical_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-15.7",
"Liabilities": "-26.4",
"Stockholders Equity": "-40.0",
"ECR before LimitedLiability": "-14.7",
"Property Plant and Equipment": "-13.3",
"Assets, Current": "-21.0",
"Intangible Assets": "36.6",
"Long Term Liabilities": "-55.2",
"Liabilities, Current": "18.6",
"Expenses": "9.70",
"Revenues": "-44.8",
"Net Income": "25.0",
"Other Expenses": "-44.3",
"Operating Costs and Expenses": "8.86",
"Labor Expense": "14.1",
"General and Administrative Expense": "21.1",
"Cost of Goods and Services Sold": "8.82",
"Other Revenues": "-44.8",
"Other Net Income": "52.7",
"Comprehensive Net Income": "25.3",
"Economic Capital Ratio": "-21.4"
},
"2012": {
"Property Plant and Equipment": "-12.2",
"Assets": "-22.8",
"Liabilities": "-25.1",
"Stockholders Equity": "-48.6",
"ECR before LimitedLiability": "-14.6",
"Intangible Assets": "40.4",
"Assets, Current": "-30.1",
"Liabilities, Current": "22.7",
"Long Term Liabilities": "-68.1",
"Other Liabilities": "13.1",
"Other Revenues": "-45.7",
"Revenues": "-45.7",
"Net Income": "25.8",
"Comprehensive Net Income": "26.0",
"Other Expenses": "-50.4",
"General and Administrative Expense": "22.7",
"Other Net Income": "49.2",
"Operating Costs and Expenses": "7.30",
"Cost of Goods and Services Sold": "9.52",
"Labor Expense": "15.5",
"Economic Capital Ratio": "-28.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001035688_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "483,410",
"Assets, Non-Current": "72,128",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "71,517",
"General and Administrative Expense": "62,354",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,703,839",
"Labor Expense": "0",
"Liabilities, Current": "383,938",
"Long Term Liabilities": "1,450,855",
"Operating Costs and Expenses": "0",
"Other Assets": "2,742",
"Other Compr. Net Income": "0",
"Other Expenses": "2,530,101",
"Other Liabilities": "82,028",
"Other Net Income": "2,776,734",
"Other Revenues": "0",
"Property Plant and Equipment": "510,028",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,772,147",
"Liabilities": "1,916,821",
"Expenses": "2,663,972",
"Revenues": "0",
"Stockholders Equity": "855,326",
"Net Income": "112,762",
"Comprehensive Net Income": "112,762",
"BaseVar": "5,064,837",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "139%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "453,663",
"Assets, Non-Current": "91,125",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "63,311",
"General and Administrative Expense": "66,194",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,712,279",
"Labor Expense": "0",
"Liabilities, Current": "388,463",
"Long Term Liabilities": "1,527,099",
"Operating Costs and Expenses": "0",
"Other Assets": "2,742",
"Other Compr. Net Income": "-5,663",
"Other Expenses": "2,667,212",
"Other Liabilities": "89,510",
"Other Net Income": "2,950,610",
"Other Revenues": "0",
"Property Plant and Equipment": "501,552",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,761,361",
"Liabilities": "2,005,072",
"Expenses": "2,796,717",
"Revenues": "0",
"Stockholders Equity": "756,289",
"Net Income": "153,893",
"Comprehensive Net Income": "148,230",
"BaseVar": "5,259,712",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "135%"
}
}
},
"top_rated": false,
"trend": -3.0,
"value": 1.3485614478419894,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001035688.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001035688.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001035688.svg"
},
{
"company_id": "0001320414",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001320414.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001320414.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001320414.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001320414_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001320414_main_keyfigs.svg",
"name": "Select Medical Holdings Corp",
"rank": 47,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001320414.svg",
"report_text": "The relative strengths and weaknesses of Select Medical Holdings Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Select Medical Holdings Corp compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 49% points.The greatest weakness of Select Medical Holdings Corp is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 68% points.
The company's Economic Capital Ratio, given in the ranking table, is 135%, being 29% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001320414_2013_Select_Medical_Holdings_Corp.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-15.7",
"Liabilities": "-26.4",
"Stockholders Equity": "-40.0",
"ECR before LimitedLiability": "-14.7",
"Property Plant and Equipment": "-13.3",
"Assets, Current": "-21.0",
"Intangible Assets": "36.6",
"Long Term Liabilities": "-55.2",
"Liabilities, Current": "18.6",
"Expenses": "9.70",
"Revenues": "-44.8",
"Net Income": "25.0",
"Other Expenses": "-44.3",
"Operating Costs and Expenses": "8.86",
"Labor Expense": "14.1",
"General and Administrative Expense": "21.1",
"Cost of Goods and Services Sold": "8.82",
"Other Revenues": "-44.8",
"Other Net Income": "52.7",
"Comprehensive Net Income": "25.3",
"Economic Capital Ratio": "-21.4"
},
"2012": {
"Property Plant and Equipment": "-12.2",
"Assets": "-22.8",
"Liabilities": "-25.1",
"Stockholders Equity": "-48.6",
"ECR before LimitedLiability": "-14.6",
"Intangible Assets": "40.4",
"Assets, Current": "-30.1",
"Liabilities, Current": "22.7",
"Long Term Liabilities": "-68.1",
"Other Liabilities": "13.1",
"Other Revenues": "-45.7",
"Revenues": "-45.7",
"Net Income": "25.8",
"Comprehensive Net Income": "26.0",
"Other Expenses": "-50.4",
"General and Administrative Expense": "22.7",
"Other Net Income": "49.2",
"Operating Costs and Expenses": "7.30",
"Cost of Goods and Services Sold": "9.52",
"Labor Expense": "15.5",
"Economic Capital Ratio": "-28.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001320414_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "483,410",
"Assets, Non-Current": "72,128",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "71,517",
"General and Administrative Expense": "62,354",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,703,839",
"Labor Expense": "0",
"Liabilities, Current": "383,938",
"Long Term Liabilities": "1,450,855",
"Operating Costs and Expenses": "0",
"Other Assets": "2,742",
"Other Compr. Net Income": "0",
"Other Expenses": "2,530,101",
"Other Liabilities": "82,028",
"Other Net Income": "2,776,734",
"Other Revenues": "0",
"Property Plant and Equipment": "510,028",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,772,147",
"Liabilities": "1,916,821",
"Expenses": "2,663,972",
"Revenues": "0",
"Stockholders Equity": "855,326",
"Net Income": "112,762",
"Comprehensive Net Income": "112,762",
"BaseVar": "5,064,837",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "139%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "453,663",
"Assets, Non-Current": "91,125",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "63,311",
"General and Administrative Expense": "66,194",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,712,279",
"Labor Expense": "0",
"Liabilities, Current": "388,463",
"Long Term Liabilities": "1,527,099",
"Operating Costs and Expenses": "0",
"Other Assets": "2,742",
"Other Compr. Net Income": "-5,663",
"Other Expenses": "2,667,212",
"Other Liabilities": "89,510",
"Other Net Income": "2,950,610",
"Other Revenues": "0",
"Property Plant and Equipment": "501,552",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,761,361",
"Liabilities": "2,005,072",
"Expenses": "2,796,717",
"Revenues": "0",
"Stockholders Equity": "756,289",
"Net Income": "153,893",
"Comprehensive Net Income": "148,230",
"BaseVar": "5,259,712",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "135%"
}
}
},
"top_rated": false,
"trend": -3.0,
"value": 1.3485614478419894,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001320414.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001320414.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001320414.svg"
},
{
"company_id": "0000927066",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000927066.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000927066.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000927066.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000927066_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000927066_main_keyfigs.svg",
"name": "Davita INC",
"rank": 49,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000927066.svg",
"report_text": "The relative strengths and weaknesses of Davita INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Davita INC compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 49% points.The greatest weakness of Davita INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 79% points.
The company's Economic Capital Ratio, given in the ranking table, is 134%, being 29% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000927066_2013_Davita_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Assets": "17.8",
"Stockholders Equity": "-20.5",
"ECR before LimitedLiability": "-50.7",
"Assets, Current": "9.43",
"Property Plant and Equipment": "6.46",
"Liabilities, Current": "6.74",
"Liabilities": "-56.3",
"Long Term Liabilities": "-57.8",
"Other Liabilities": "-5.71",
"Other Expenses": "12.6",
"Expenses": "20.6",
"Revenues": "-56.5",
"Net Income": "-2.14",
"General and Administrative Expense": "2.71",
"Cost of Goods and Services Sold": "49.5",
"Labor Expense": "4.46",
"Operating Costs and Expenses": "-38.9",
"Other Revenues": "-56.5",
"Comprehensive Net Income": "-2.14",
"Other Net Income": "45.1",
"Economic Capital Ratio": "-50.3"
},
"2010": {
"Assets, Current": "2.37",
"Assets": "-13.2",
"Liabilities": "-36.4",
"Stockholders Equity": "-43.0",
"ECR before LimitedLiability": "-53.1",
"Property Plant and Equipment": "-14.1",
"Assets, Non-Current": "-4.65",
"Intangible Assets": "6.02",
"Other Liabilities": "4.18",
"Liabilities, Current": "6.13",
"Long Term Liabilities": "-48.4",
"Other Revenues": "-33.4",
"Revenues": "-33.4",
"Net Income": "-4.20",
"Other Expenses": "24.1",
"Comprehensive Net Income": "-3.16",
"Cost of Goods and Services Sold": "12.8",
"Labor Expense": "9.39",
"Operating Costs and Expenses": "-38.6",
"Other Net Income": "33.7",
"Economic Capital Ratio": "-51.3"
},
"2011": {
"Liabilities": "-38.6",
"Stockholders Equity": "-30.3",
"ECR before LimitedLiability": "-12.4",
"Long Term Liabilities": "-58.4",
"Liabilities, Current": "15.0",
"Expenses": "20.4",
"Net Income": "24.5",
"Other Expenses": "26.7",
"Operating Costs and Expenses": "-38.7",
"Labor Expense": "12.2",
"General and Administrative Expense": "12.3",
"Cost of Goods and Services Sold": "7.62",
"Other Revenues": "-39.2",
"Revenues": "-39.2",
"Property Plant and Equipment": "-11.5",
"Assets, Current": "-9.38",
"Assets, Non-Current": "-5.16",
"Intangible Assets": "36.5",
"Other Net Income": "51.7",
"Comprehensive Net Income": "24.7",
"Economic Capital Ratio": "-19.1"
},
"2012": {
"Property Plant and Equipment": "-10.2",
"Assets": "14.9",
"Liabilities": "-54.8",
"Stockholders Equity": "-25.1",
"ECR before LimitedLiability": "-15.3",
"Intangible Assets": "48.7",
"Assets, Current": "-17.9",
"Liabilities, Current": "12.2",
"Long Term Liabilities": "-78.6",
"Expenses": "30.0",
"Revenues": "-33.5",
"Net Income": "18.2",
"Other Expenses": "22.2",
"General and Administrative Expense": "12.1",
"Operating Costs and Expenses": "-26.6",
"Cost of Goods and Services Sold": "6.77",
"Labor Expense": "11.0",
"Other Revenues": "-33.5",
"Other Net Income": "27.1",
"Comprehensive Net Income": "17.9",
"Economic Capital Ratio": "-29.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000927066_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "2,302,521",
"Assets, Non-Current": "32,615",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "228,986",
"General and Administrative Expense": "531,531",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,087,928",
"Labor Expense": "0",
"Liabilities, Current": "1,046,941",
"Long Term Liabilities": "3,619,909",
"Operating Costs and Expenses": "4,248,668",
"Other Assets": "30,247",
"Other Compr. Net Income": "0",
"Other Expenses": "623,564",
"Other Liabilities": "365,502",
"Other Net Income": "6,108,800",
"Other Revenues": "3,708",
"Property Plant and Equipment": "1,104,925",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,558,236",
"Liabilities": "5,032,352",
"Expenses": "5,632,749",
"Revenues": "3,708",
"Stockholders Equity": "2,525,884",
"Net Income": "479,759",
"Comprehensive Net Income": "479,759",
"BaseVar": "12,167,922",
"ECR before LimitedLiability": "66%",
"Economic Capital Ratio": "146%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "2,622,854",
"Assets, Non-Current": "32,054",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "234,378",
"General and Administrative Expense": "579,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,253,942",
"Labor Expense": "0",
"Liabilities, Current": "924,345",
"Long Term Liabilities": "4,323,140",
"Operating Costs and Expenses": "4,474,735",
"Other Assets": "34,766",
"Other Compr. Net Income": "0",
"Other Expenses": "678,479",
"Other Liabilities": "446,753",
"Other Net Income": "6,447,391",
"Other Revenues": "3,420",
"Property Plant and Equipment": "1,170,808",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,114,424",
"Liabilities": "5,694,238",
"Expenses": "5,966,592",
"Revenues": "3,420",
"Stockholders Equity": "2,420,186",
"Net Income": "484,219",
"Comprehensive Net Income": "484,219",
"BaseVar": "13,113,032",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "139%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "2,281,608",
"Assets, Non-Current": "34,231",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "266,628",
"General and Administrative Expense": "691,243",
"Goodwill Impairment Loss": "24,000",
"Intangible Assets": "5,106,467",
"Labor Expense": "0",
"Liabilities, Current": "1,153,116",
"Long Term Liabilities": "4,549,630",
"Operating Costs and Expenses": "4,680,772",
"Other Assets": "37,215",
"Other Compr. Net Income": "0",
"Other Expenses": "745,623",
"Other Liabilities": "443,085",
"Other Net Income": "6,978,679",
"Other Revenues": "2,982",
"Property Plant and Equipment": "1,432,651",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,892,172",
"Liabilities": "6,145,831",
"Expenses": "6,408,266",
"Revenues": "2,982",
"Stockholders Equity": "2,746,341",
"Net Income": "573,395",
"Comprehensive Net Income": "573,395",
"BaseVar": "14,213,965",
"ECR before LimitedLiability": "61%",
"Economic Capital Ratio": "142%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "2,878,794",
"Assets, Non-Current": "80,194",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "341,969",
"General and Administrative Expense": "894,575",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,092,747",
"Labor Expense": "0",
"Liabilities, Current": "2,018,174",
"Long Term Liabilities": "8,770,277",
"Operating Costs and Expenses": "5,578,853",
"Other Assets": "94,491",
"Other Compr. Net Income": "-101,033",
"Other Expenses": "733,161",
"Other Liabilities": "721,405",
"Other Net Income": "8,186,058",
"Other Revenues": "3,737",
"Property Plant and Equipment": "1,872,370",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "16,018,596",
"Liabilities": "11,509,856",
"Expenses": "7,548,558",
"Revenues": "3,737",
"Stockholders Equity": "4,508,740",
"Net Income": "641,237",
"Comprehensive Net Income": "540,204",
"BaseVar": "21,683,919",
"ECR before LimitedLiability": "51%",
"Economic Capital Ratio": "134%"
}
}
},
"top_rated": false,
"trend": -8.0,
"value": 1.3418922823178603,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000927066.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000927066.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000927066.svg"
},
{
"company_id": "0001360474",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001360474.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001360474.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001360474_main_keyfigs.svg",
"name": "CRC Health LLC",
"rank": 50,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001360474.svg",
"report_text": "The relative strengths and weaknesses of CRC Health LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of CRC Health LLC compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 49% points.The greatest weakness of CRC Health LLC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 82% points.
The company's Economic Capital Ratio, given in the ranking table, is 128%, being 36% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001360474_2013_CRC_Health_LLC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "29.8",
"Liabilities": "-67.6",
"Stockholders Equity": "-23.1",
"ECR before LimitedLiability": "-26.9",
"Property Plant and Equipment": "-10.6",
"Assets, Current": "-21.5",
"Intangible Assets": "48.3",
"Other Liabilities": "-11.6",
"Long Term Liabilities": "-77.4",
"Liabilities, Current": "18.5",
"Expenses": "36.9",
"Revenues": "-32.1",
"Net Income": "14.5",
"Other Expenses": "25.6",
"Operating Costs and Expenses": "-6.43",
"Labor Expense": "-9.74",
"General and Administrative Expense": "16.2",
"Other Revenues": "-32.1",
"Other Net Income": "14.9",
"Comprehensive Net Income": "14.9",
"Economic Capital Ratio": "-33.6"
},
"2012": {
"Property Plant and Equipment": "-8.99",
"Assets": "20.4",
"Liabilities": "-61.5",
"Stockholders Equity": "-26.2",
"ECR before LimitedLiability": "-21.7",
"Intangible Assets": "48.6",
"Assets, Current": "-26.8",
"Liabilities, Current": "21.3",
"Long Term Liabilities": "-81.8",
"Expenses": "31.9",
"Revenues": "-32.9",
"Net Income": "14.5",
"Other Expenses": "18.7",
"General and Administrative Expense": "17.4",
"Operating Costs and Expenses": "-7.55",
"Cost of Goods and Services Sold": "6.63",
"Labor Expense": "-9.52",
"Other Revenues": "-32.9",
"Other Net Income": "20.5",
"Comprehensive Net Income": "14.7",
"Economic Capital Ratio": "-35.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001360474_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "65,859",
"Assets, Non-Current": "21,119",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "19,730",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "825,139",
"Labor Expense": "208,472",
"Liabilities, Current": "59,206",
"Long Term Liabilities": "594,629",
"Operating Costs and Expenses": "134,486",
"Other Assets": "0",
"Other Compr. Net Income": "2,106",
"Other Expenses": "26,863",
"Other Liabilities": "120,168",
"Other Net Income": "392,091",
"Other Revenues": "0",
"Property Plant and Equipment": "126,840",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,038,957",
"Liabilities": "774,003",
"Expenses": "389,551",
"Revenues": "0",
"Stockholders Equity": "264,954",
"Net Income": "2,540",
"Comprehensive Net Income": "4,646",
"BaseVar": "1,298,354",
"ECR before LimitedLiability": "43%",
"Economic Capital Ratio": "127%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "73,615",
"Assets, Non-Current": "20,396",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "20,254",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "811,799",
"Labor Expense": "215,530",
"Liabilities, Current": "61,565",
"Long Term Liabilities": "584,535",
"Operating Costs and Expenses": "135,422",
"Other Assets": "0",
"Other Compr. Net Income": "-571",
"Other Expenses": "74,711",
"Other Liabilities": "122,304",
"Other Net Income": "452,694",
"Other Revenues": "0",
"Property Plant and Equipment": "130,381",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,036,191",
"Liabilities": "768,404",
"Expenses": "445,917",
"Revenues": "0",
"Stockholders Equity": "267,787",
"Net Income": "6,777",
"Comprehensive Net Income": "6,206",
"BaseVar": "1,351,888",
"ECR before LimitedLiability": "44%",
"Economic Capital Ratio": "128%"
}
}
},
"top_rated": false,
"trend": -2.0,
"value": 1.277601067566313,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001360474.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001360474.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001360474.svg"
},
{
"company_id": "0001332349",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001332349.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001332349.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001332349.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001332349_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001332349_main_keyfigs.svg",
"name": "Brookdale Senior Living Inc",
"rank": 51,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001332349.svg",
"report_text": "The relative strengths and weaknesses of Brookdale Senior Living Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Brookdale Senior Living Inc compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 46% points.The greatest weakness of Brookdale Senior Living Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 58% points.
The company's Economic Capital Ratio, given in the ranking table, is 119%, being 45% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001332349_2013_Brookdale_Senior_Living_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Liabilities": "-60.8",
"Stockholders Equity": "-40.8",
"ECR before LimitedLiability": "-70.3",
"Long Term Liabilities": "-58.8",
"Other Expenses": "-29.0",
"Expenses": "13.3",
"Revenues": "16.7",
"Net Income": "-9.61",
"Cost of Goods and Services Sold": "11.3",
"General and Administrative Expense": "8.07",
"Labor Expense": "8.30",
"Operating Costs and Expenses": "9.17",
"Depreciation, Depletion, Amortization": "7.93",
"Other Revenues": "16.7",
"Assets, Current": "-19.9",
"Property Plant and Equipment": "47.3",
"Other Assets": "4.64",
"Intangible Assets": "-35.7",
"Comprehensive Net Income": "-8.71",
"Other Net Income": "-35.9",
"Economic Capital Ratio": "-68.5"
},
"2011": {
"Assets": "11.2",
"Liabilities": "-59.9",
"Stockholders Equity": "-34.3",
"ECR before LimitedLiability": "-32.4",
"Property Plant and Equipment": "46.7",
"Assets, Current": "-26.1",
"Intangible Assets": "-26.3",
"Long Term Liabilities": "-67.0",
"Liabilities, Current": "9.76",
"Expenses": "28.8",
"Revenues": "14.4",
"Net Income": "15.1",
"Other Expenses": "-14.5",
"Operating Costs and Expenses": "7.21",
"Labor Expense": "11.5",
"General and Administrative Expense": "15.5",
"Cost of Goods and Services Sold": "7.19",
"Other Revenues": "14.4",
"Other Net Income": "-25.0",
"Comprehensive Net Income": "15.4",
"Economic Capital Ratio": "-39.1"
},
"2012": {
"Liabilities": "-57.4",
"Stockholders Equity": "-40.1",
"ECR before LimitedLiability": "-30.6",
"Long Term Liabilities": "-57.8",
"Expenses": "24.5",
"Net Income": "14.6",
"Other Expenses": "-20.9",
"General and Administrative Expense": "16.2",
"Operating Costs and Expenses": "5.93",
"Cost of Goods and Services Sold": "7.71",
"Labor Expense": "12.5",
"Other Revenues": "18.2",
"Revenues": "18.2",
"Property Plant and Equipment": "46.4",
"Intangible Assets": "-25.9",
"Assets, Current": "-32.8",
"Other Assets": "5.60",
"Assets, Non-Current": "-4.28",
"Other Net Income": "-25.1",
"Comprehensive Net Income": "15.0",
"Economic Capital Ratio": "-44.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001332349_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "328,109",
"Assets, Non-Current": "98,973",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "-292,341",
"General and Administrative Expense": "-131,709",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "109,693",
"Labor Expense": "0",
"Liabilities, Current": "606,358",
"Long Term Liabilities": "2,527,885",
"Operating Costs and Expenses": "0",
"Other Assets": "256,853",
"Other Compr. Net Income": "0",
"Other Expenses": "2,681,492",
"Other Liabilities": "336,230",
"Other Net Income": "-4,723",
"Other Revenues": "2,213,264",
"Property Plant and Equipment": "3,736,842",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,530,470",
"Liabilities": "3,470,473",
"Expenses": "2,257,442",
"Revenues": "2,213,264",
"Stockholders Equity": "1,059,997",
"Net Income": "-48,901",
"Comprehensive Net Income": "-48,901",
"BaseVar": "6,238,186",
"ECR before LimitedLiability": "37%",
"Economic Capital Ratio": "122%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "280,875",
"Assets, Non-Current": "109,934",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "268,506",
"General and Administrative Expense": "148,327",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "109,553",
"Labor Expense": "0",
"Liabilities, Current": "620,950",
"Long Term Liabilities": "2,458,497",
"Operating Costs and Expenses": "0",
"Other Assets": "271,635",
"Other Compr. Net Income": "0",
"Other Expenses": "2,091,545",
"Other Liabilities": "346,406",
"Other Net Income": "-17,715",
"Other Revenues": "2,457,918",
"Property Plant and Equipment": "3,694,064",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,466,061",
"Liabilities": "3,425,853",
"Expenses": "2,508,378",
"Revenues": "2,457,918",
"Stockholders Equity": "1,040,208",
"Net Income": "-68,175",
"Comprehensive Net Income": "-68,175",
"BaseVar": "6,437,962",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "122%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "309,038",
"Assets, Non-Current": "113,315",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "252,281",
"General and Administrative Expense": "178,829",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "109,553",
"Labor Expense": "0",
"Liabilities, Current": "1,121,503",
"Long Term Liabilities": "2,212,109",
"Operating Costs and Expenses": "0",
"Other Assets": "254,095",
"Other Compr. Net Income": "1,015",
"Other Expenses": "2,405,152",
"Other Liabilities": "329,649",
"Other Net Income": "532",
"Other Revenues": "2,770,085",
"Property Plant and Equipment": "3,879,977",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,665,978",
"Liabilities": "3,663,261",
"Expenses": "2,836,262",
"Revenues": "2,770,085",
"Stockholders Equity": "1,002,717",
"Net Income": "-65,645",
"Comprehensive Net Income": "-64,630",
"BaseVar": "6,968,566",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "119%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 1.1880708227545727,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001332349.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001332349.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001332349.svg"
},
{
"company_id": "0001101723",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001101723.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001101723.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001101723_main_keyfigs.svg",
"name": "United Surgical Partners International INC",
"rank": 52,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001101723.svg",
"report_text": "The relative strengths and weaknesses of United Surgical Partners International INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of United Surgical Partners International INC compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 36% points.The greatest weakness of United Surgical Partners International INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 96% points.
The company's Economic Capital Ratio, given in the ranking table, is 119%, being 45% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001101723_2013_United_Surgical_Partners_International_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "46.3",
"Liabilities": "-60.2",
"ECR before LimitedLiability": "-8.16",
"Property Plant and Equipment": "-8.82",
"Assets, Current": "-16.0",
"Assets, Non-Current": "19.7",
"Intangible Assets": "58.8",
"Other Liabilities": "-5.37",
"Long Term Liabilities": "-60.7",
"Liabilities, Current": "5.71",
"Expenses": "38.6",
"Net Income": "12.8",
"Other Expenses": "16.6",
"Goodwill Impairment Loss": "-3.10",
"General and Administrative Expense": "11.8",
"Cost of Goods and Services Sold": "5.18",
"Other Revenues": "-27.5",
"Revenues": "-27.5",
"Other Net Income": "6.24",
"Comprehensive Net Income": "13.1",
"Economic Capital Ratio": "-14.8"
},
"2012": {
"Property Plant and Equipment": "-13.8",
"Assets": "31.4",
"Liabilities": "-86.3",
"Stockholders Equity": "-27.4",
"ECR before LimitedLiability": "-30.9",
"Intangible Assets": "36.1",
"Assets, Current": "-23.4",
"Assets, Non-Current": "24.7",
"Liabilities, Current": "7.63",
"Long Term Liabilities": "-96.3",
"Research And Development Expense": "2.16",
"Expenses": "31.6",
"Revenues": "-28.1",
"Net Income": "16.1",
"Other Expenses": "16.7",
"General and Administrative Expense": "12.8",
"Cost of Goods and Services Sold": "5.60",
"Labor Expense": "3.26",
"Other Revenues": "-28.1",
"Comprehensive Net Income": "16.0",
"Economic Capital Ratio": "-45.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001101723_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "155,328",
"Assets, Non-Current": "466,364",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "29,462",
"General and Administrative Expense": "43,710",
"Goodwill Impairment Loss": "107,028",
"Intangible Assets": "1,536,485",
"Labor Expense": "165,083",
"Liabilities, Current": "277,237",
"Long Term Liabilities": "1,073,776",
"Operating Costs and Expenses": "98,246",
"Other Assets": "0",
"Other Compr. Net Income": "3,318",
"Other Expenses": "164,407",
"Other Liabilities": "167,946",
"Other Net Income": "627,021",
"Other Revenues": "0",
"Property Plant and Equipment": "235,321",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,393,498",
"Liabilities": "1,518,959",
"Expenses": "607,936",
"Revenues": "0",
"Stockholders Equity": "874,539",
"Net Income": "19,085",
"Comprehensive Net Income": "22,403",
"BaseVar": "2,575,366",
"ECR before LimitedLiability": "66%",
"Economic Capital Ratio": "146%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "171,974",
"Assets, Non-Current": "507,141",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "23,955",
"General and Administrative Expense": "41,434",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,555,108",
"Labor Expense": "138,020",
"Liabilities, Current": "274,406",
"Long Term Liabilities": "1,492,204",
"Operating Costs and Expenses": "87,173",
"Other Assets": "0",
"Other Compr. Net Income": "-9,596",
"Other Expenses": "122,314",
"Other Liabilities": "168,753",
"Other Net Income": "516,380",
"Other Revenues": "0",
"Property Plant and Equipment": "126,526",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,360,749",
"Liabilities": "1,935,363",
"Expenses": "412,896",
"Revenues": "0",
"Stockholders Equity": "425,386",
"Net Income": "103,484",
"Comprehensive Net Income": "93,888",
"BaseVar": "2,617,492",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "119%"
}
}
},
"top_rated": false,
"trend": -14.0,
"value": 1.1856528836975082,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001101723.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001101723.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001101723.svg"
},
{
"company_id": "0000919956",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000919956.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000919956.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000919956.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000919956_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000919956_main_keyfigs.svg",
"name": "Diversicare Healthcare Services Inc",
"rank": 53,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000919956.svg",
"report_text": "The relative strengths and weaknesses of Diversicare Healthcare Services Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Diversicare Healthcare Services Inc compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 76% points.The greatest weakness of Diversicare Healthcare Services Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 136% points.
The company's Economic Capital Ratio, given in the ranking table, is 116%, being 48% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000919956_2013_Diversicare_Healthcare_Services_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-76.5",
"Liabilities": "37.0",
"Stockholders Equity": "-114",
"ECR before LimitedLiability": "-29.6",
"Property Plant and Equipment": "-22.2",
"Assets, Current": "-36.0",
"Intangible Assets": "-53.8",
"Other Liabilities": "20.1",
"Liabilities, Current": "36.5",
"Expenses": "-52.1",
"Revenues": "-83.1",
"Net Income": "37.0",
"Other Expenses": "-129",
"Operating Costs and Expenses": "18.0",
"Labor Expense": "29.1",
"General and Administrative Expense": "24.4",
"Cost of Goods and Services Sold": "18.0",
"Other Revenues": "-83.1",
"Other Net Income": "83.1",
"Comprehensive Net Income": "37.0",
"Economic Capital Ratio": "-36.3"
},
"2012": {
"Property Plant and Equipment": "-21.9",
"Assets": "-82.5",
"Liabilities": "29.0",
"Stockholders Equity": "-121",
"ECR before LimitedLiability": "-33.3",
"Intangible Assets": "-54.2",
"Assets, Current": "-48.1",
"Liabilities, Current": "28.9",
"Long Term Liabilities": "-31.5",
"Other Liabilities": "28.7",
"Expenses": "-58.2",
"Revenues": "-82.8",
"Net Income": "28.8",
"Other Expenses": "-136",
"General and Administrative Expense": "27.1",
"Cost of Goods and Services Sold": "19.0",
"Labor Expense": "28.7",
"Other Revenues": "-82.8",
"Other Net Income": "76.2",
"Comprehensive Net Income": "28.9",
"Economic Capital Ratio": "-47.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000919956_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "45,320",
"Assets, Non-Current": "24,346",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "6,592",
"General and Administrative Expense": "25,589",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "29,885",
"Long Term Liabilities": "58,972",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-945",
"Other Expenses": "278,683",
"Other Liabilities": "0",
"Other Net Income": "312,231",
"Other Revenues": "0",
"Property Plant and Equipment": "47,078",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "116,744",
"Liabilities": "88,857",
"Expenses": "310,864",
"Revenues": "0",
"Stockholders Equity": "27,887",
"Net Income": "1,367",
"Comprehensive Net Income": "422",
"BaseVar": "414,820",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "124%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "46,856",
"Assets, Non-Current": "26,185",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "7,043",
"General and Administrative Expense": "24,419",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "31,193",
"Long Term Liabilities": "60,101",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-101",
"Other Expenses": "276,738",
"Other Liabilities": "0",
"Other Net Income": "305,280",
"Other Revenues": "0",
"Property Plant and Equipment": "41,922",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "114,963",
"Liabilities": "91,294",
"Expenses": "308,200",
"Revenues": "0",
"Stockholders Equity": "23,669",
"Net Income": "-2,920",
"Comprehensive Net Income": "-3,021",
"BaseVar": "409,919",
"ECR before LimitedLiability": "30%",
"Economic Capital Ratio": "116%"
}
}
},
"top_rated": false,
"trend": -4.0,
"value": 1.1613855089795178,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000919956.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000919956.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000919956.svg"
},
{
"company_id": "0001351051",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001351051.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001351051.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001351051.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001351051_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001351051_main_keyfigs.svg",
"name": "Genesis Healthcare Inc",
"rank": 54,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001351051.svg",
"report_text": "The relative strengths and weaknesses of Genesis Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Genesis Healthcare Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 29% points.The greatest weakness of Genesis Healthcare Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 87% points.
The company's Economic Capital Ratio, given in the ranking table, is 113%, being 51% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001351051_2013_Genesis_Healthcare_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-44.8",
"Liabilities": "-18.5",
"Stockholders Equity": "-78.2",
"Property Plant and Equipment": "2.10",
"Assets, Current": "-27.4",
"Intangible Assets": "-27.0",
"Other Liabilities": "0.845",
"Long Term Liabilities": "-67.3",
"Liabilities, Current": "2.30",
"Expenses": "-0.351",
"ECR before LimitedLiability": "-66.9",
"Other Expenses": "-41.2",
"Goodwill Impairment Loss": "-23.8",
"Operating Costs and Expenses": "0.899",
"Labor Expense": "1.66",
"General and Administrative Expense": "2.78",
"Cost of Goods and Services Sold": "0.894",
"Other Revenues": "9.59",
"Revenues": "9.59",
"Economic Capital Ratio": "-73.6",
"Other Net Income": "-35.1"
},
"2012": {
"Property Plant and Equipment": "25.1",
"Assets": "-40.8",
"Liabilities": "-30.7",
"Stockholders Equity": "-74.4",
"ECR before LimitedLiability": "-36.9",
"Intangible Assets": "-25.7",
"Assets, Current": "-37.2",
"Other Assets": "-18.3",
"Assets, Non-Current": "22.4",
"Liabilities, Current": "25.1",
"Long Term Liabilities": "-87.0",
"Other Liabilities": "19.8",
"Other Revenues": "28.8",
"Revenues": "28.8",
"Net Income": "25.1",
"Comprehensive Net Income": "25.1",
"Other Expenses": "-61.5",
"General and Administrative Expense": "25.1",
"Other Net Income": "-40.4",
"Labor Expense": "18.4",
"Economic Capital Ratio": "-51.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001351051_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "143,331",
"Assets, Non-Current": "32,119",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "25,730",
"Goodwill Impairment Loss": "270,478",
"Intangible Assets": "106,712",
"Labor Expense": "0",
"Liabilities, Current": "98,378",
"Long Term Liabilities": "519,409",
"Operating Costs and Expenses": "0",
"Other Assets": "37,336",
"Other Compr. Net Income": "0",
"Other Expenses": "739,935",
"Other Liabilities": "0",
"Other Net Income": "-36,824",
"Other Revenues": "869,701",
"Property Plant and Equipment": "375,502",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "695,000",
"Liabilities": "617,787",
"Expenses": "1,036,143",
"Revenues": "869,701",
"Stockholders Equity": "77,213",
"Net Income": "-203,266",
"Comprehensive Net Income": "-203,266",
"BaseVar": "1,627,728",
"ECR before LimitedLiability": "-14%",
"Economic Capital Ratio": "87%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "138,825",
"Assets, Non-Current": "163,153",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "24,249",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "107,644",
"Labor Expense": "0",
"Liabilities, Current": "104,303",
"Long Term Liabilities": "478,502",
"Operating Costs and Expenses": "0",
"Other Assets": "-97,731",
"Other Compr. Net Income": "363",
"Other Expenses": "787,319",
"Other Liabilities": "0",
"Other Net Income": "-39,458",
"Other Revenues": "872,623",
"Property Plant and Equipment": "370,745",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "682,636",
"Liabilities": "582,805",
"Expenses": "811,568",
"Revenues": "872,623",
"Stockholders Equity": "99,831",
"Net Income": "21,597",
"Comprehensive Net Income": "21,960",
"BaseVar": "1,494,726",
"ECR before LimitedLiability": "26%",
"Economic Capital Ratio": "113%"
}
}
},
"top_rated": false,
"trend": 7.0,
"value": 1.1254384015148677,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001351051.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001351051.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001351051.svg"
},
{
"company_id": "0001383960",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001383960.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001383960.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001383960_main_keyfigs.svg",
"name": "University General Health System INC",
"rank": 55,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001383960.svg",
"report_text": "The relative strengths and weaknesses of University General Health System INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of University General Health System INC compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 51% points.The greatest weakness of University General Health System INC is the variable Liabilities, reducing the Economic Capital Ratio by 72% points.
The company's Economic Capital Ratio, given in the ranking table, is 96%, being 67% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001383960_2013_University_General_Health_System_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-4.31",
"Liabilities": "-82.0",
"Stockholders Equity": "-68.7",
"Property Plant and Equipment": "8.98",
"Assets, Current": "-26.0",
"Assets, Non-Current": "-2.55",
"Intangible Assets": "-18.6",
"Other Liabilities": "-32.0",
"Long Term Liabilities": "0.653",
"Liabilities, Current": "-63.3",
"Expenses": "1.89",
"Revenues": "0.678",
"Net Income": "0.658",
"Other Expenses": "-4.77",
"Depreciation, Depletion, Amortization": "-1.04",
"Labor Expense": "0.427",
"Other Revenues": "0.678",
"ECR before LimitedLiability": "-66.6",
"Other Net Income": "-26.3",
"Comprehensive Net Income": "0.675",
"Economic Capital Ratio": "-73.2"
},
"2012": {
"Liabilities, Current": "-25.7",
"Liabilities": "-71.8",
"Property Plant and Equipment": "12.3",
"Stockholders Equity": "-62.3",
"Long Term Liabilities": "-59.7",
"Other Liabilities": "9.10",
"Expenses": "9.74",
"Net Income": "9.12",
"Other Expenses": "9.11",
"Cost of Goods and Services Sold": "8.51",
"Labor Expense": "-9.12",
"Other Revenues": "9.27",
"Revenues": "9.27",
"ECR before LimitedLiability": "-53.0",
"Comprehensive Net Income": "9.13",
"Intangible Assets": "-9.18",
"Assets, Current": "-30.6",
"Other Assets": "-68.2",
"Assets, Non-Current": "51.1",
"Other Net Income": "-30.4",
"Economic Capital Ratio": "-67.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001383960_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "15,293",
"Assets, Non-Current": "2,235",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "7,337",
"General and Administrative Expense": "18,079",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "18,299",
"Labor Expense": "0",
"Liabilities, Current": "73,794",
"Long Term Liabilities": "8,459",
"Operating Costs and Expenses": "0",
"Other Assets": "1,827",
"Other Compr. Net Income": "0",
"Other Expenses": "49,980",
"Other Liabilities": "32,822",
"Other Net Income": "0",
"Other Revenues": "73,007",
"Property Plant and Equipment": "77,013",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "114,668",
"Liabilities": "115,075",
"Expenses": "75,395",
"Revenues": "73,007",
"Stockholders Equity": "-407",
"Net Income": "-2,388",
"Comprehensive Net Income": "-2,388",
"BaseVar": "189,073",
"ECR before LimitedLiability": "-2.6%",
"Economic Capital Ratio": "87%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "29,303",
"Assets, Non-Current": "145,538",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "9,216",
"General and Administrative Expense": "32,766",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "39,272",
"Labor Expense": "39,627",
"Liabilities, Current": "71,100",
"Long Term Liabilities": "90,456",
"Operating Costs and Expenses": "0",
"Other Assets": "-136,238",
"Other Compr. Net Income": "0",
"Other Expenses": "30,080",
"Other Liabilities": "0",
"Other Net Income": "-5,318",
"Other Revenues": "113,223",
"Property Plant and Equipment": "96,966",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "174,841",
"Liabilities": "161,557",
"Expenses": "111,689",
"Revenues": "113,223",
"Stockholders Equity": "13,284",
"Net Income": "-3,784",
"Comprehensive Net Income": "-3,784",
"BaseVar": "283,314",
"ECR before LimitedLiability": "9.2%",
"Economic Capital Ratio": "96%"
}
}
},
"top_rated": false,
"trend": 3.0,
"value": 0.9649742290813964,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001383960.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001383960.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001383960.svg"
},
{
"company_id": "0000790526",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000790526.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000790526.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000790526.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000790526_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000790526_main_keyfigs.svg",
"name": "Radnet Inc",
"rank": 56,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000790526.svg",
"report_text": "The relative strengths and weaknesses of Radnet Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Radnet Inc compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 13% points.The greatest weakness of Radnet Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 98% points.
The company's Economic Capital Ratio, given in the ranking table, is 96%, being 68% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000790526_2013_Radnet_Inc.pdf",
"shrinked_graph_json": {
"2012": {
"Assets": "-25.6",
"Liabilities": "-69.2",
"Stockholders Equity": "-77.6",
"Assets, Current": "-31.2",
"Other Assets": "8.76",
"Assets, Non-Current": "-9.52",
"Liabilities, Current": "8.70",
"Long Term Liabilities": "-97.5",
"Expenses": "8.98",
"Revenues": "-45.8",
"Net Income": "9.32",
"Other Expenses": "10.2",
"General and Administrative Expense": "9.06",
"Operating Costs and Expenses": "7.28",
"Cost of Goods and Services Sold": "-56.7",
"Labor Expense": "8.69",
"Other Revenues": "-45.8",
"ECR before LimitedLiability": "-53.4",
"Other Net Income": "12.8",
"Comprehensive Net Income": "9.37",
"Economic Capital Ratio": "-67.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000790526_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "155,900",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "542,993",
"Depreciation, Depletion, Amortization": "57,740",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "245,545",
"Labor Expense": "0",
"Liabilities, Current": "118,613",
"Long Term Liabilities": "545,904",
"Operating Costs and Expenses": "0",
"Other Assets": "97,114",
"Other Compr. Net Income": "1,215",
"Other Expenses": "-11,391",
"Other Liabilities": "52,603",
"Other Net Income": "653,629",
"Other Revenues": "0",
"Property Plant and Equipment": "216,560",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "715,119",
"Liabilities": "717,120",
"Expenses": "589,342",
"Revenues": "0",
"Stockholders Equity": "-2,001",
"Net Income": "64,287",
"Comprehensive Net Income": "65,502",
"BaseVar": "1,338,212",
"ECR before LimitedLiability": "8.7%",
"Economic Capital Ratio": "96%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.9605205570971814,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000790526.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000790526.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000790526.svg"
},
{
"company_id": "0001001604",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001001604.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001001604.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001001604_main_keyfigs.svg",
"name": "Emeritus CORP WA",
"rank": 57,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001001604.svg",
"report_text": "The relative strengths and weaknesses of Emeritus CORP WA are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Emeritus CORP WA compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 34% points.The greatest weakness of Emeritus CORP WA is the variable Liabilities, reducing the Economic Capital Ratio by 93% points.
The company's Economic Capital Ratio, given in the ranking table, is 93%, being 71% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001001604_2013_Emeritus_CORP_WA.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-19.8",
"Assets": "9.69",
"Liabilities": "-79.4",
"Stockholders Equity": "-51.0",
"ECR before LimitedLiability": "-87.1",
"Property Plant and Equipment": "36.5",
"Other Assets": "4.37",
"Intangible Assets": "-37.6",
"Other Liabilities": "-33.9",
"Liabilities, Current": "5.36",
"Long Term Liabilities": "-47.1",
"Expenses": "18.0",
"Revenues": "7.32",
"Net Income": "-10.6",
"Cost of Goods and Services Sold": "11.1",
"Labor Expense": "8.14",
"Operating Costs and Expenses": "8.98",
"Other Revenues": "7.32",
"Comprehensive Net Income": "-9.69",
"Other Net Income": "-39.1",
"Economic Capital Ratio": "-85.3"
},
"2011": {
"Assets": "12.4",
"Liabilities": "-82.5",
"Stockholders Equity": "-49.8",
"ECR before LimitedLiability": "-54.2",
"Property Plant and Equipment": "32.9",
"Assets, Current": "-28.6",
"Assets, Non-Current": "-4.99",
"Intangible Assets": "-27.2",
"Other Liabilities": "-32.9",
"Long Term Liabilities": "-62.2",
"Liabilities, Current": "12.4",
"Expenses": "13.9",
"Revenues": "4.79",
"Net Income": "12.4",
"Operating Costs and Expenses": "7.18",
"Labor Expense": "11.4",
"General and Administrative Expense": "12.4",
"Cost of Goods and Services Sold": "7.15",
"Other Net Income": "-28.9",
"Comprehensive Net Income": "12.4",
"Economic Capital Ratio": "-60.9"
},
"2012": {
"Property Plant and Equipment": "33.7",
"Assets": "5.74",
"Liabilities": "-93.2",
"Stockholders Equity": "-53.7",
"ECR before LimitedLiability": "-56.8",
"Intangible Assets": "-24.6",
"Assets, Current": "-33.9",
"Other Assets": "3.41",
"Assets, Non-Current": "-6.43",
"Liabilities, Current": "5.51",
"Long Term Liabilities": "-32.8",
"Other Liabilities": "-76.2",
"Expenses": "7.96",
"Other Net Income": "-26.5",
"Net Income": "5.34",
"General and Administrative Expense": "5.45",
"Operating Costs and Expenses": "5.25",
"Cost of Goods and Services Sold": "5.26",
"Labor Expense": "5.31",
"Comprehensive Net Income": "5.35",
"Economic Capital Ratio": "-71.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001001604_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "216,649",
"Assets, Non-Current": "23,969",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "86,697",
"General and Administrative Expense": "74,480",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "75,820",
"Labor Expense": "0",
"Liabilities, Current": "234,377",
"Long Term Liabilities": "1,305,757",
"Operating Costs and Expenses": "0",
"Other Assets": "133,798",
"Other Compr. Net Income": "0",
"Other Expenses": "786,855",
"Other Liabilities": "722,152",
"Other Net Income": "-116,875",
"Other Revenues": "1,007,065",
"Property Plant and Equipment": "2,163,556",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,613,792",
"Liabilities": "2,262,286",
"Expenses": "948,032",
"Revenues": "1,007,065",
"Stockholders Equity": "351,506",
"Net Income": "-57,842",
"Comprehensive Net Income": "-57,842",
"BaseVar": "3,474,025",
"ECR before LimitedLiability": "19%",
"Economic Capital Ratio": "105%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "174,162",
"Assets, Non-Current": "29,288",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "122,372",
"General and Administrative Expense": "88,767",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "118,725",
"Labor Expense": "0",
"Liabilities, Current": "274,241",
"Long Term Liabilities": "1,528,710",
"Operating Costs and Expenses": "0",
"Other Assets": "132,728",
"Other Compr. Net Income": "0",
"Other Expenses": "982,963",
"Other Liabilities": "724,641",
"Other Net Income": "-132,931",
"Other Revenues": "1,254,770",
"Property Plant and Equipment": "2,355,425",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,810,328",
"Liabilities": "2,527,592",
"Expenses": "1,194,102",
"Revenues": "1,254,770",
"Stockholders Equity": "282,736",
"Net Income": "-72,263",
"Comprehensive Net Income": "-72,263",
"BaseVar": "3,959,862",
"ECR before LimitedLiability": "13%",
"Economic Capital Ratio": "100%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "277,971",
"Assets, Non-Current": "26,429",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "140,629",
"General and Administrative Expense": "95,625",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "186,756",
"Labor Expense": "0",
"Liabilities, Current": "351,670",
"Long Term Liabilities": "1,558,936",
"Operating Costs and Expenses": "0",
"Other Assets": "157,710",
"Other Compr. Net Income": "231",
"Other Expenses": "1,232,931",
"Other Liabilities": "2,525,315",
"Other Net Income": "-183,966",
"Other Revenues": "1,568,076",
"Property Plant and Equipment": "4,011,884",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,660,750",
"Liabilities": "4,435,921",
"Expenses": "1,469,185",
"Revenues": "1,568,076",
"Stockholders Equity": "224,829",
"Net Income": "-85,075",
"Comprehensive Net Income": "-84,844",
"BaseVar": "6,159,064",
"ECR before LimitedLiability": "5.3%",
"Economic Capital Ratio": "93%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 0.9270035328324702,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001001604.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001001604.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001001604.svg"
},
{
"company_id": "0000885074",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000885074.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000885074.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000885074.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000885074_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000885074_main_keyfigs.svg",
"name": "Aeon Global Health Corp",
"rank": 58,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000885074.svg",
"report_text": "The relative strengths and weaknesses of Aeon Global Health Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Aeon Global Health Corp compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 12% points.The greatest weakness of Aeon Global Health Corp is the variable Net Income, reducing the Economic Capital Ratio by 58% points.
The company's Economic Capital Ratio, given in the ranking table, is 92%, being 72% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000885074_2013_Aeon_Global_Health_Corp.pdf",
"shrinked_graph_json": {
"2012": {
"Property Plant and Equipment": "-22.5",
"Assets": "5.34",
"Liabilities": "-24.3",
"ECR before LimitedLiability": "-57.5",
"Intangible Assets": "-35.7",
"Assets, Current": "12.0",
"Other Assets": "6.34",
"Liabilities, Current": "-16.3",
"Other Liabilities": "-32.6",
"Research And Development Expense": "-5.79",
"Expenses": "-11.6",
"Net Income": "-57.9",
"Depreciation, Depletion, Amortization": "-7.73",
"Other Expenses": "6.10",
"General and Administrative Expense": "-37.9",
"Cost of Goods and Services Sold": "-16.5",
"Other Revenues": "-15.6",
"Revenues": "-15.6",
"Other Net Income": "-34.9",
"Comprehensive Net Income": "-57.6",
"Economic Capital Ratio": "-71.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000885074_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "8,449",
"Assets, Non-Current": "1,128",
"Cost of Goods and Services Sold": "2,589",
"Depreciation, Depletion, Amortization": "1,019",
"General and Administrative Expense": "6,359",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,647",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "2,367",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "3,147",
"Other Net Income": "-645",
"Other Revenues": "3,188",
"Property Plant and Equipment": "917",
"Research And Development Expense": "928",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "12,861",
"Liabilities": "6,794",
"Expenses": "10,895",
"Revenues": "3,188",
"Stockholders Equity": "6,067",
"Net Income": "-8,352",
"Comprehensive Net Income": "-8,352",
"BaseVar": "17,192",
"ECR before LimitedLiability": "4.5%",
"Economic Capital Ratio": "92%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.9194168829566522,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000885074.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000885074.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000885074.svg"
},
{
"company_id": "0001051488",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001051488.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001051488.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001051488_main_keyfigs.svg",
"name": "Integrated Healthcare Holdings Inc",
"rank": 59,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001051488.svg",
"report_text": "The relative strengths and weaknesses of Integrated Healthcare Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Integrated Healthcare Holdings Inc compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 44% points.The greatest weakness of Integrated Healthcare Holdings Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 134% points.
The company's Economic Capital Ratio, given in the ranking table, is 87%, being 76% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001051488_2013_Integrated_Healthcare_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-91.2",
"Other Liabilities": "-25.9",
"Stockholders Equity": "-141",
"Property Plant and Equipment": "-29.4",
"Assets, Current": "-17.7",
"Assets, Non-Current": "-12.1",
"Intangible Assets": "-62.1",
"Expenses": "-34.0",
"Revenues": "-80.2",
"Net Income": "5.59",
"Other Expenses": "8.92",
"Operating Costs and Expenses": "-68.7",
"Labor Expense": "-83.5",
"General and Administrative Expense": "4.21",
"Other Revenues": "-80.2",
"ECR before LimitedLiability": "-66.6",
"Long Term Liabilities": "4.98",
"Liabilities, Current": "-34.2",
"Other Net Income": "48.1",
"Comprehensive Net Income": "5.69",
"Economic Capital Ratio": "-73.3"
},
"2012": {
"Property Plant and Equipment": "-15.8",
"Assets": "-88.4",
"Stockholders Equity": "-134",
"Liabilities, Current": "-22.4",
"Intangible Assets": "-56.2",
"Assets, Current": "-30.9",
"Assets, Non-Current": "-12.2",
"Expenses": "-35.4",
"Revenues": "-74.9",
"Net Income": "3.81",
"Other Expenses": "8.93",
"General and Administrative Expense": "4.44",
"Operating Costs and Expenses": "-59.0",
"Labor Expense": "-91.5",
"Other Revenues": "-74.9",
"ECR before LimitedLiability": "-62.1",
"Long Term Liabilities": "3.48",
"Other Liabilities": "-16.0",
"Other Net Income": "44.3",
"Comprehensive Net Income": "3.93",
"Economic Capital Ratio": "-76.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001051488_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "97,206",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "4,165",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "211,636",
"Liabilities, Current": "118,459",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "162,600",
"Other Assets": "445",
"Other Compr. Net Income": "0",
"Other Expenses": "14,000",
"Other Liabilities": "52,004",
"Other Net Income": "412,966",
"Other Revenues": "0",
"Property Plant and Equipment": "54,251",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "151,902",
"Liabilities": "170,463",
"Expenses": "392,401",
"Revenues": "0",
"Stockholders Equity": "-18,561",
"Net Income": "20,565",
"Comprehensive Net Income": "20,565",
"BaseVar": "563,866",
"ECR before LimitedLiability": "-3.9%",
"Economic Capital Ratio": "87%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "89,356",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "4,208",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "218,801",
"Liabilities, Current": "103,949",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "129,581",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "52,585",
"Other Net Income": "360,395",
"Other Revenues": "0",
"Property Plant and Equipment": "55,529",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "144,885",
"Liabilities": "156,534",
"Expenses": "352,590",
"Revenues": "0",
"Stockholders Equity": "-11,649",
"Net Income": "7,805",
"Comprehensive Net Income": "7,805",
"BaseVar": "507,202",
"ECR before LimitedLiability": "-6.0%",
"Economic Capital Ratio": "87%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 0.873832600810396,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001051488.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001051488.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001051488.svg"
},
{
"company_id": "0000817135",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000817135.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000817135.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000817135_main_keyfigs.svg",
"name": "Alliance Healthcare Services Inc",
"rank": 60,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000817135.svg",
"report_text": "The relative strengths and weaknesses of Alliance Healthcare Services Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Alliance Healthcare Services Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 3.9% points.The greatest weakness of Alliance Healthcare Services Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 77% points.
The company's Economic Capital Ratio, given in the ranking table, is 86%, being 78% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000817135_2013_Alliance_Healthcare_Services_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-3.11",
"Expenses": "2.33",
"Stockholders Equity": "-63.0",
"ECR before LimitedLiability": "-69.8",
"Property Plant and Equipment": "2.88",
"Assets, Current": "-3.03",
"Assets, Non-Current": "-0.778",
"Intangible Assets": "-1.52",
"Other Liabilities": "-3.22",
"Liabilities": "-48.1",
"Long Term Liabilities": "-19.4",
"Liabilities, Current": "2.06",
"Other Expenses": "-3.28",
"Operating Costs and Expenses": "1.48",
"Labor Expense": "2.45",
"General and Administrative Expense": "2.10",
"Cost of Goods and Services Sold": "1.48",
"Other Revenues": "3.19",
"Revenues": "3.19",
"Economic Capital Ratio": "-76.5",
"Other Net Income": "-3.10"
},
"2012": {
"Property Plant and Equipment": "1.08",
"Assets": "-9.03",
"Stockholders Equity": "-77.5",
"Assets, Current": "-10.6",
"Liabilities, Current": "2.00",
"Liabilities": "-65.9",
"Long Term Liabilities": "-40.3",
"Other Liabilities": "-14.2",
"Expenses": "3.11",
"Revenues": "3.86",
"Net Income": "2.40",
"Other Expenses": "-4.06",
"General and Administrative Expense": "1.30",
"Operating Costs and Expenses": "0.777",
"Cost of Goods and Services Sold": "1.04",
"Labor Expense": "1.81",
"Other Revenues": "3.86",
"ECR before LimitedLiability": "-63.4",
"Other Net Income": "-5.06",
"Comprehensive Net Income": "2.46",
"Economic Capital Ratio": "-77.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000817135_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "135,740",
"Assets, Non-Current": "19,270",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "77,140",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "199,517",
"Labor Expense": "0",
"Liabilities, Current": "105,564",
"Long Term Liabilities": "431,330",
"Operating Costs and Expenses": "0",
"Other Assets": "17,268",
"Other Compr. Net Income": "0",
"Other Expenses": "575,131",
"Other Liabilities": "231,111",
"Other Net Income": "3,516",
"Other Revenues": "493,651",
"Property Plant and Equipment": "291,299",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "663,094",
"Liabilities": "768,005",
"Expenses": "652,271",
"Revenues": "493,651",
"Stockholders Equity": "-104,911",
"Net Income": "-155,104",
"Comprehensive Net Income": "-155,104",
"BaseVar": "1,290,268",
"ECR before LimitedLiability": "-43%",
"Economic Capital Ratio": "84%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "128,637",
"Assets, Non-Current": "23,022",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "76,022",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "183,424",
"Labor Expense": "0",
"Liabilities, Current": "83,535",
"Long Term Liabilities": "361,370",
"Operating Costs and Expenses": "0",
"Other Assets": "16,497",
"Other Compr. Net Income": "0",
"Other Expenses": "402,066",
"Other Liabilities": "231,529",
"Other Net Income": "4,667",
"Other Revenues": "472,258",
"Property Plant and Equipment": "208,561",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "560,141",
"Liabilities": "676,434",
"Expenses": "478,088",
"Revenues": "472,258",
"Stockholders Equity": "-116,293",
"Net Income": "-1,163",
"Comprehensive Net Income": "-1,163",
"BaseVar": "1,095,794",
"ECR before LimitedLiability": "-27%",
"Economic Capital Ratio": "86%"
}
}
},
"top_rated": false,
"trend": 2.0,
"value": 0.8608765182329632,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000817135.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000817135.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000817135.svg"
},
{
"company_id": "0000862692",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000862692.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000862692.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000862692.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000862692_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000862692_main_keyfigs.svg",
"name": "CRYO CELL International INC",
"rank": 61,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000862692.svg",
"report_text": "The relative strengths and weaknesses of CRYO CELL International INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of CRYO CELL International INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 18% points.The greatest weakness of CRYO CELL International INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 78% points.
The company's Economic Capital Ratio, given in the ranking table, is 85%, being 78% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000862692_2013_CRYO_CELL_International_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-10.8",
"Other Liabilities": "11.1",
"Stockholders Equity": "-19.2",
"Economic Capital Ratio": "-10.2",
"Property Plant and Equipment": "-20.3",
"Assets, Current": "52.8",
"Assets, Non-Current": "17.3",
"Intangible Assets": "-28.4",
"Expenses": "7.05",
"Revenues": "46.8",
"Net Income": "9.19",
"Other Expenses": "10.7",
"Operating Costs and Expenses": "8.82",
"Labor Expense": "14.1",
"General and Administrative Expense": "-38.1",
"Cost of Goods and Services Sold": "8.79",
"Other Revenues": "46.8",
"Long Term Liabilities": "35.5",
"Liabilities, Current": "-60.4",
"Other Net Income": "-37.3",
"Comprehensive Net Income": "9.46"
},
"2012": {
"Property Plant and Equipment": "-14.6",
"Assets": "-53.2",
"Liabilities": "-0.951",
"Stockholders Equity": "-77.7",
"Intangible Assets": "-32.5",
"Assets, Current": "1.27",
"Liabilities, Current": "-49.7",
"ECR before LimitedLiability": "-64.1",
"Long Term Liabilities": "5.04",
"Other Liabilities": "3.09",
"Expenses": "-1.98",
"Revenues": "17.7",
"Net Income": "-1.92",
"General and Administrative Expense": "-51.1",
"Operating Costs and Expenses": "1.56",
"Cost of Goods and Services Sold": "2.11",
"Labor Expense": "3.72",
"Other Revenues": "17.7",
"Other Net Income": "-39.9",
"Comprehensive Net Income": "-1.90",
"Economic Capital Ratio": "-78.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000862692_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "14,053",
"Assets, Non-Current": "3,873",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "361",
"General and Administrative Expense": "12,413",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "10,563",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "5,409",
"Other Liabilities": "0",
"Other Net Income": "-1,647",
"Other Revenues": "17,918",
"Property Plant and Equipment": "1,540",
"Research And Development Expense": "184",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "19,467",
"Liabilities": "10,563",
"Expenses": "18,367",
"Revenues": "17,918",
"Stockholders Equity": "8,903",
"Net Income": "-2,096",
"Comprehensive Net Income": "-2,096",
"BaseVar": "33,981",
"ECR before LimitedLiability": "72%",
"Economic Capital Ratio": "151%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "9,315",
"Assets, Non-Current": "1,735",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "204",
"General and Administrative Expense": "14,426",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "10,664",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "6,829",
"Other Liabilities": "0",
"Other Net Income": "-2,709",
"Other Revenues": "17,970",
"Property Plant and Equipment": "1,281",
"Research And Development Expense": "110",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "12,331",
"Liabilities": "10,664",
"Expenses": "21,569",
"Revenues": "17,970",
"Stockholders Equity": "1,667",
"Net Income": "-6,308",
"Comprehensive Net Income": "-6,308",
"BaseVar": "32,621",
"ECR before LimitedLiability": "-34%",
"Economic Capital Ratio": "85%"
}
}
},
"top_rated": false,
"trend": -24.0,
"value": 0.8538887387132982,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000862692.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000862692.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000862692.svg"
},
{
"company_id": "0000882289",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000882289.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000882289.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000882289_main_keyfigs.svg",
"name": "Apria Healthcare Group INC",
"rank": 62,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000882289.svg",
"report_text": "The relative strengths and weaknesses of Apria Healthcare Group INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Apria Healthcare Group INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 39% points.The greatest weakness of Apria Healthcare Group INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 108% points.
The company's Economic Capital Ratio, given in the ranking table, is 82%, being 82% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000882289_2013_Apria_Healthcare_Group_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "3.79",
"Assets": "-42.6",
"Liabilities": "-4.21",
"Stockholders Equity": "-79.9",
"ECR before LimitedLiability": "-72.1",
"Property Plant and Equipment": "-9.68",
"Assets, Current": "-5.35",
"Assets, Non-Current": "-2.42",
"Long Term Liabilities": "-5.51",
"Liabilities, Current": "4.19",
"Expenses": "-5.01",
"Revenues": "-26.2",
"Net Income": "-2.86",
"Operating Costs and Expenses": "2.88",
"Labor Expense": "4.76",
"General and Administrative Expense": "-5.29",
"Cost of Goods and Services Sold": "-5.47",
"Other Revenues": "-26.2",
"Other Net Income": "29.0",
"Comprehensive Net Income": "-2.80",
"Economic Capital Ratio": "-78.8"
},
"2012": {
"Property Plant and Equipment": "-7.99",
"Assets": "-60.5",
"Liabilities": "-4.42",
"Stockholders Equity": "-108",
"Intangible Assets": "-4.75",
"Assets, Current": "-11.3",
"Other Assets": "5.79",
"Assets, Non-Current": "-2.60",
"Liabilities, Current": "3.93",
"ECR before LimitedLiability": "-67.4",
"Long Term Liabilities": "-33.8",
"Other Liabilities": "2.86",
"Expenses": "-4.78",
"Other Expenses": "5.83",
"General and Administrative Expense": "-5.40",
"Cost of Goods and Services Sold": "-12.1",
"Labor Expense": "5.38",
"Other Revenues": "-30.2",
"Revenues": "-30.2",
"Economic Capital Ratio": "-81.6",
"Other Net Income": "39.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000882289_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "451,767",
"Assets, Non-Current": "8,997",
"Cost of Goods and Services Sold": "980,333",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,225,400",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "744,091",
"Labor Expense": "0",
"Liabilities, Current": "310,853",
"Long Term Liabilities": "1,068,550",
"Operating Costs and Expenses": "0",
"Other Assets": "211,405",
"Other Compr. Net Income": "0",
"Other Expenses": "843,660",
"Other Liabilities": "200,225",
"Other Net Income": "2,302,069",
"Other Revenues": "0",
"Property Plant and Equipment": "83,768",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,500,028",
"Liabilities": "1,579,628",
"Expenses": "3,049,393",
"Revenues": "0",
"Stockholders Equity": "-79,600",
"Net Income": "-747,324",
"Comprehensive Net Income": "-747,324",
"BaseVar": "4,215,559",
"ECR before LimitedLiability": "-56%",
"Economic Capital Ratio": "82%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "460,264",
"Assets, Non-Current": "26,448",
"Cost of Goods and Services Sold": "1,032,135",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,244,411",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "392,506",
"Labor Expense": "0",
"Liabilities, Current": "356,507",
"Long Term Liabilities": "1,078,718",
"Operating Costs and Expenses": "0",
"Other Assets": "216,667",
"Other Compr. Net Income": "0",
"Other Expenses": "421,549",
"Other Liabilities": "68,907",
"Other Net Income": "2,437,679",
"Other Revenues": "0",
"Property Plant and Equipment": "76,823",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,172,708",
"Liabilities": "1,504,132",
"Expenses": "2,698,095",
"Revenues": "0",
"Stockholders Equity": "-331,424",
"Net Income": "-260,416",
"Comprehensive Net Income": "-260,416",
"BaseVar": "3,906,307",
"ECR before LimitedLiability": "-55%",
"Economic Capital Ratio": "82%"
}
}
},
"top_rated": false,
"trend": 1.0,
"value": 0.820453923340314,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000882289.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000882289.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000882289.svg"
},
{
"company_id": "0001449934",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001449934.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001449934.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001449934_main_keyfigs.svg",
"name": "Cannlabs Inc",
"rank": 63,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001449934.svg",
"report_text": "The relative strengths and weaknesses of Cannlabs Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Cannlabs Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 72% points.The greatest weakness of Cannlabs Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 177% points.
The company's Economic Capital Ratio, given in the ranking table, is 77%, being 87% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001449934_2013_Cannlabs_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-17.1",
"Stockholders Equity": "-17.9",
"Long Term Liabilities": "5.58",
"ECR before LimitedLiability": "-101",
"Property Plant and Equipment": "39.0",
"Assets, Current": "-12.6",
"Assets, Non-Current": "-5.66",
"Intangible Assets": "-25.1",
"Expenses": "-29.8",
"Revenues": "-14.4",
"Net Income": "-65.7",
"Other Expenses": "16.2",
"Depreciation, Depletion, Amortization": "-14.1",
"Operating Costs and Expenses": "3.95",
"Labor Expense": "6.20",
"General and Administrative Expense": "-39.9",
"Other Revenues": "-14.4",
"Liabilities, Current": "-14.0",
"Other Net Income": "-13.6",
"Comprehensive Net Income": "-65.4",
"Economic Capital Ratio": "-108"
},
"2012": {
"Assets": "-123",
"Liabilities": "20.1",
"Stockholders Equity": "-177",
"ECR before LimitedLiability": "-72.9",
"Intangible Assets": "-58.5",
"Assets, Current": "-84.9",
"Assets, Non-Current": "-8.08",
"Long Term Liabilities": "14.0",
"Other Liabilities": "9.46",
"Expenses": "-117",
"Revenues": "72.2",
"Net Income": "-5.51",
"Other Expenses": "-88.7",
"General and Administrative Expense": "-99.4",
"Operating Costs and Expenses": "6.86",
"Cost of Goods and Services Sold": "9.10",
"Labor Expense": "15.4",
"Other Revenues": "72.2",
"Other Net Income": "-40.3",
"Comprehensive Net Income": "-5.25",
"Economic Capital Ratio": "-87.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001449934_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "23",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "34",
"General and Administrative Expense": "138",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "58",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1.5",
"Other Liabilities": "0",
"Other Net Income": "1.3",
"Other Revenues": "16",
"Property Plant and Equipment": "64",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "87",
"Liabilities": "58",
"Expenses": "173",
"Revenues": "16",
"Stockholders Equity": "30",
"Net Income": "-155",
"Comprehensive Net Income": "-155",
"BaseVar": "168",
"ECR before LimitedLiability": "-155%",
"Economic Capital Ratio": "53%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "83",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "30",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "91",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "146",
"Property Plant and Equipment": "32",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "32",
"Liabilities": "30",
"Expenses": "174",
"Revenues": "146",
"Stockholders Equity": "2.1",
"Net Income": "-28",
"Comprehensive Net Income": "-28",
"BaseVar": "191",
"ECR before LimitedLiability": "-80%",
"Economic Capital Ratio": "77%"
}
}
},
"top_rated": false,
"trend": 3.0,
"value": 0.7652892481945921,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001449934.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001449934.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001449934.svg"
},
{
"company_id": "0001550020",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001550020.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001550020.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001550020_main_keyfigs.svg",
"name": "Ewellness Healthcare Corp",
"rank": 64,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001550020.svg",
"report_text": "The relative strengths and weaknesses of Ewellness Healthcare Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ewellness Healthcare Corp compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 49% points.The greatest weakness of Ewellness Healthcare Corp is the variable Liabilities, Current, reducing the Economic Capital Ratio by 36% points.
The company's Economic Capital Ratio, given in the ranking table, is 69%, being 94% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001550020_2013_Ewellness_Healthcare_Corp.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "-36.1",
"Liabilities": "-16.3",
"Stockholders Equity": "-17.1",
"ECR before LimitedLiability": "-80.1",
"Long Term Liabilities": "3.75",
"Other Liabilities": "2.46",
"Expenses": "-4.00",
"Net Income": "-17.1",
"Other Expenses": "-13.9",
"General and Administrative Expense": "2.63",
"Cost of Goods and Services Sold": "2.37",
"Labor Expense": "3.86",
"Other Revenues": "-10.9",
"Revenues": "-10.9",
"Property Plant and Equipment": "-10.9",
"Intangible Assets": "-12.0",
"Assets, Current": "49.4",
"Assets, Non-Current": "-3.33",
"Other Net Income": "-7.52",
"Comprehensive Net Income": "-17.0",
"Economic Capital Ratio": "-94.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001550020_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "26",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "3.0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "27",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "23",
"Other Liabilities": "0",
"Other Net Income": "-0.012",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "26",
"Liabilities": "27",
"Expenses": "26",
"Revenues": "0",
"Stockholders Equity": "-1.4",
"Net Income": "-26",
"Comprehensive Net Income": "-26",
"BaseVar": "40",
"ECR before LimitedLiability": "-105%",
"Economic Capital Ratio": "69%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.6940467311733199,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001550020.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001550020.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001550020.svg"
},
{
"company_id": "0001294157",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001294157.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001294157.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001294157_main_keyfigs.svg",
"name": "DR Tattoff INC",
"rank": 65,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001294157.svg",
"report_text": "The relative strengths and weaknesses of DR Tattoff INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of DR Tattoff INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 15% points.The greatest weakness of DR Tattoff INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 64% points.
The company's Economic Capital Ratio, given in the ranking table, is 53%, being 110% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001294157_2013_DR_Tattoff_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-52.0",
"Stockholders Equity": "-54.5",
"ECR before LimitedLiability": "-108",
"Assets, Current": "-29.8",
"Assets, Non-Current": "-5.70",
"Intangible Assets": "-36.3",
"Selling and Marketing Expense": "-11.0",
"Expenses": "-38.5",
"Revenues": "22.7",
"Net Income": "-36.9",
"Other Expenses": "-9.77",
"Operating Costs and Expenses": "5.97",
"Labor Expense": "9.27",
"General and Administrative Expense": "-39.0",
"Cost of Goods and Services Sold": "5.95",
"Other Revenues": "22.7",
"Long Term Liabilities": "5.31",
"Liabilities, Current": "-6.53",
"Other Net Income": "-22.3",
"Comprehensive Net Income": "-36.8",
"Economic Capital Ratio": "-115"
},
"2012": {
"Property Plant and Equipment": "5.13",
"Assets": "-34.2",
"Liabilities": "-8.44",
"Stockholders Equity": "-64.2",
"ECR before LimitedLiability": "-96.3",
"Intangible Assets": "-26.9",
"Assets, Current": "-26.5",
"Liabilities, Current": "-12.4",
"Long Term Liabilities": "4.46",
"Expenses": "-23.8",
"Revenues": "15.2",
"Net Income": "-24.8",
"Other Expenses": "-14.9",
"General and Administrative Expense": "-20.1",
"Selling and Marketing Expense": "-6.83",
"Cost of Goods and Services Sold": "4.90",
"Labor Expense": "7.85",
"Other Revenues": "15.2",
"Other Net Income": "-16.3",
"Comprehensive Net Income": "-24.6",
"Economic Capital Ratio": "-110"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001294157_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "440",
"Assets, Non-Current": "70",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "235",
"General and Administrative Expense": "2,750",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,179",
"Long Term Liabilities": "155",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,610",
"Other Liabilities": "206",
"Other Net Income": "-3.2",
"Other Revenues": "2,666",
"Property Plant and Equipment": "929",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "541"
},
"output_variables": {
"Assets": "1,439",
"Liabilities": "1,540",
"Expenses": "5,137",
"Revenues": "2,666",
"Stockholders Equity": "-101",
"Net Income": "-2,474",
"Comprehensive Net Income": "-2,474",
"BaseVar": "5,392",
"ECR before LimitedLiability": "-176%",
"Economic Capital Ratio": "46%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "647",
"Assets, Non-Current": "231",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "282",
"General and Administrative Expense": "2,567",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,194",
"Long Term Liabilities": "122",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2,589",
"Other Liabilities": "678",
"Other Net Income": "20",
"Other Revenues": "3,200",
"Property Plant and Equipment": "1,311",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "622"
},
"output_variables": {
"Assets": "2,189",
"Liabilities": "2,995",
"Expenses": "6,060",
"Revenues": "3,200",
"Stockholders Equity": "-806",
"Net Income": "-2,840",
"Comprehensive Net Income": "-2,840",
"BaseVar": "7,232",
"ECR before LimitedLiability": "-155%",
"Economic Capital Ratio": "53%"
}
}
},
"top_rated": false,
"trend": 4.0,
"value": 0.5315269337331786,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001294157.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001294157.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001294157.svg"
},
{
"company_id": "0001383183",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001383183.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001383183.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001383183_main_keyfigs.svg",
"name": "Combimatrix Corp",
"rank": 66,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001383183.svg",
"report_text": "The relative strengths and weaknesses of Combimatrix Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Combimatrix Corp compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 15% points.The greatest weakness of Combimatrix Corp is the variable Stockholders Equity, reducing the Economic Capital Ratio by 45% points.
The company's Economic Capital Ratio, given in the ranking table, is 41%, being 123% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001383183_2013_Combimatrix_Corp.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "8.29",
"Liabilities": "66.3",
"Stockholders Equity": "68.2",
"Economic Capital Ratio": "-5.25",
"Property Plant and Equipment": "-22.1",
"Assets, Current": "98.6",
"Intangible Assets": "-29.2",
"Other Liabilities": "8.30",
"Long Term Liabilities": "40.5",
"Liabilities, Current": "20.7",
"Selling and Marketing Expense": "-33.5",
"Expenses": "-55.1",
"Revenues": "8.26",
"Net Income": "-76.0",
"Research And Development Expense": "-15.6",
"Operating Costs and Expenses": "9.98",
"Labor Expense": "15.9",
"General and Administrative Expense": "-48.4",
"Cost of Goods and Services Sold": "9.95",
"Other Revenues": "8.26",
"Other Net Income": "-30.0",
"Comprehensive Net Income": "-75.7"
},
"2012": {
"Property Plant and Equipment": "-22.7",
"Assets": "-43.5",
"Liabilities": "-3.84",
"Stockholders Equity": "-45.0",
"ECR before LimitedLiability": "-108",
"Intangible Assets": "-31.6",
"Assets, Non-Current": "-5.67",
"Liabilities, Current": "-14.4",
"Research And Development Expense": "-6.53",
"Expenses": "-21.3",
"Revenues": "5.61",
"Net Income": "-42.3",
"Other Expenses": "15.0",
"General and Administrative Expense": "-20.2",
"Selling and Marketing Expense": "-14.5",
"Cost of Goods and Services Sold": "-11.5",
"Labor Expense": "7.33",
"Other Revenues": "5.61",
"Other Net Income": "-31.7",
"Comprehensive Net Income": "-42.1",
"Economic Capital Ratio": "-123"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001383183_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "8,582",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,567",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "132",
"Labor Expense": "0",
"Liabilities, Current": "1,119",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "127",
"Other Compr. Net Income": "0",
"Other Expenses": "2,808",
"Other Liabilities": "179",
"Other Net Income": "299",
"Other Revenues": "4,558",
"Property Plant and Equipment": "607",
"Research And Development Expense": "1,366",
"Selling and Marketing Expense": "2,715"
},
"output_variables": {
"Assets": "9,448",
"Liabilities": "1,298",
"Expenses": "12,456",
"Revenues": "4,558",
"Stockholders Equity": "8,150",
"Net Income": "-7,599",
"Comprehensive Net Income": "-7,599",
"BaseVar": "14,030",
"ECR before LimitedLiability": "79%",
"Economic Capital Ratio": "155%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "4,237",
"Assets, Non-Current": "211",
"Cost of Goods and Services Sold": "2,702",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,378",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "66",
"Labor Expense": "0",
"Liabilities, Current": "5,679",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "266",
"Other Liabilities": "226",
"Other Net Income": "-2,535",
"Other Revenues": "5,350",
"Property Plant and Equipment": "666",
"Research And Development Expense": "1,400",
"Selling and Marketing Expense": "2,596"
},
"output_variables": {
"Assets": "5,180",
"Liabilities": "5,905",
"Expenses": "12,342",
"Revenues": "5,350",
"Stockholders Equity": "-725",
"Net Income": "-9,527",
"Comprehensive Net Income": "-9,527",
"BaseVar": "15,656",
"ECR before LimitedLiability": "-191%",
"Economic Capital Ratio": "41%"
}
}
},
"top_rated": false,
"trend": -32.0,
"value": 0.4097518034626791,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001383183.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001383183.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001383183.svg"
},
{
"company_id": "0000022872",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000022872.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000022872.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000022872.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000022872_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000022872_main_keyfigs.svg",
"name": "Advanzeon Solutions Inc",
"rank": 67,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000022872.svg",
"report_text": "The relative strengths and weaknesses of Advanzeon Solutions Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Advanzeon Solutions Inc compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 29% points.The greatest weakness of Advanzeon Solutions Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 222% points.
The company's Economic Capital Ratio, given in the ranking table, is 29%, being 134% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000022872_2013_Advanzeon_Solutions_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "-4.81",
"Assets": "-97.9",
"Stockholders Equity": "-157",
"Long Term Liabilities": "6.47",
"ECR before LimitedLiability": "-103",
"Property Plant and Equipment": "-33.7",
"Assets, Current": "-35.2",
"Assets, Non-Current": "-9.31",
"Intangible Assets": "-20.6",
"Expenses": "-32.1",
"Revenues": "43.1",
"Net Income": "-3.65",
"Other Expenses": "-85.9",
"Operating Costs and Expenses": "7.30",
"Labor Expense": "11.4",
"Cost of Goods and Services Sold": "7.27",
"Other Revenues": "43.1",
"Liabilities, Current": "-17.6",
"Other Net Income": "-25.1",
"Comprehensive Net Income": "-3.42",
"Economic Capital Ratio": "-110"
},
"2012": {
"Property Plant and Equipment": "-46.9",
"Assets": "-129",
"Stockholders Equity": "-222",
"Liabilities, Current": "-12.2",
"ECR before LimitedLiability": "-120",
"Intangible Assets": "-50.7",
"Assets, Current": "-53.3",
"Assets, Non-Current": "-13.5",
"Expenses": "-45.5",
"Revenues": "-45.5",
"Net Income": "3.83",
"Other Expenses": "-57.9",
"General and Administrative Expense": "7.48",
"Goodwill Impairment Loss": "-19.5",
"Operating Costs and Expenses": "5.38",
"Cost of Goods and Services Sold": "6.85",
"Labor Expense": "10.5",
"Other Revenues": "-45.5",
"Other Net Income": "29.2",
"Comprehensive Net Income": "4.12",
"Economic Capital Ratio": "-134"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000022872_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "2,365",
"Assets, Non-Current": "381",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "839",
"General and Administrative Expense": "11,291",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "12,178",
"Labor Expense": "0",
"Liabilities, Current": "27,895",
"Long Term Liabilities": "3,903",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "73,187",
"Other Liabilities": "0",
"Other Net Income": "19",
"Other Revenues": "71,210",
"Property Plant and Equipment": "392",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "15,316",
"Liabilities": "31,798",
"Expenses": "85,317",
"Revenues": "71,210",
"Stockholders Equity": "-16,482",
"Net Income": "-14,088",
"Comprehensive Net Income": "-14,088",
"BaseVar": "101,830",
"ECR before LimitedLiability": "-161%",
"Economic Capital Ratio": "51%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "5,647",
"Assets, Non-Current": "305",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "249",
"General and Administrative Expense": "6,770",
"Goodwill Impairment Loss": "12,150",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "27,335",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "56,730",
"Other Liabilities": "1,732",
"Other Net Income": "68,909",
"Other Revenues": "0",
"Property Plant and Equipment": "172",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,124",
"Liabilities": "29,067",
"Expenses": "75,899",
"Revenues": "0",
"Stockholders Equity": "-22,943",
"Net Income": "-6,990",
"Comprehensive Net Income": "-6,990",
"BaseVar": "90,000",
"ECR before LimitedLiability": "-229%",
"Economic Capital Ratio": "29%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 0.29419101445912466,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000022872.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000022872.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000022872.svg"
},
{
"company_id": "0000941020",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0000941020.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0000941020.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000941020_main_keyfigs.svg",
"name": "Genelink INC",
"rank": 68,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0000941020.svg",
"report_text": "The relative strengths and weaknesses of Genelink INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Genelink INC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 8.7% points.The greatest weakness of Genelink INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 78% points.
The company's Economic Capital Ratio, given in the ranking table, is 24%, being 139% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0000941020_2013_Genelink_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "13.2",
"Assets": "-39.2",
"Liabilities": "-9.15",
"Stockholders Equity": "-71.1",
"ECR before LimitedLiability": "-106",
"Property Plant and Equipment": "-27.2",
"Assets, Current": "-7.59",
"Assets, Non-Current": "-6.63",
"Intangible Assets": "-31.1",
"Liabilities, Current": "-5.92",
"Expenses": "-22.3",
"Revenues": "16.5",
"Net Income": "-24.9",
"Other Expenses": "18.6",
"Labor Expense": "7.53",
"General and Administrative Expense": "-37.9",
"Cost of Goods and Services Sold": "-11.9",
"Other Revenues": "16.5",
"Other Net Income": "-20.1",
"Comprehensive Net Income": "-24.7",
"Economic Capital Ratio": "-113"
},
"2012": {
"Property Plant and Equipment": "-20.7",
"Assets": "-57.1",
"Liabilities": "-6.51",
"Stockholders Equity": "-78.0",
"ECR before LimitedLiability": "-125",
"Intangible Assets": "-30.5",
"Assets, Current": "-26.2",
"Other Assets": "8.01",
"Assets, Non-Current": "-6.25",
"Expenses": "-18.3",
"Revenues": "1.94",
"Net Income": "-25.5",
"Other Expenses": "8.72",
"General and Administrative Expense": "-28.1",
"Operating Costs and Expenses": "2.38",
"Cost of Goods and Services Sold": "-13.5",
"Labor Expense": "4.79",
"Other Revenues": "1.94",
"Other Net Income": "-8.04",
"Comprehensive Net Income": "-25.3",
"Economic Capital Ratio": "-139"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0000941020_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "1,859",
"Assets, Non-Current": "29",
"Cost of Goods and Services Sold": "1,735",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,247",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,296",
"Long Term Liabilities": "965",
"Operating Costs and Expenses": "0",
"Other Assets": "723",
"Other Compr. Net Income": "0",
"Other Expenses": "135",
"Other Liabilities": "1,000",
"Other Net Income": "-264",
"Other Revenues": "4,685",
"Property Plant and Equipment": "168",
"Research And Development Expense": "134",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,780",
"Liabilities": "4,261",
"Expenses": "8,251",
"Revenues": "4,685",
"Stockholders Equity": "-1,481",
"Net Income": "-3,830",
"Comprehensive Net Income": "-3,830",
"BaseVar": "10,120",
"ECR before LimitedLiability": "-170%",
"Economic Capital Ratio": "48%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "772",
"Assets, Non-Current": "20",
"Cost of Goods and Services Sold": "1,671",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "3,442",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,839",
"Long Term Liabilities": "1,090",
"Operating Costs and Expenses": "0",
"Other Assets": "405",
"Other Compr. Net Income": "0",
"Other Expenses": "241",
"Other Liabilities": "1,188",
"Other Net Income": "417",
"Other Revenues": "2,136",
"Property Plant and Equipment": "258",
"Research And Development Expense": "251",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,455",
"Liabilities": "4,116",
"Expenses": "5,605",
"Revenues": "2,136",
"Stockholders Equity": "-2,661",
"Net Income": "-3,052",
"Comprehensive Net Income": "-3,052",
"BaseVar": "6,865",
"ECR before LimitedLiability": "-248%",
"Economic Capital Ratio": "24%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 0.2428964817622545,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0000941020.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0000941020.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0000941020.svg"
},
{
"company_id": "0001136174",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001136174.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001136174.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001136174.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001136174_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001136174_main_keyfigs.svg",
"name": "Ontrak Inc",
"rank": 69,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001136174.svg",
"report_text": "The relative strengths and weaknesses of Ontrak Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ontrak Inc compared to the market average is the variable Labor Expense, increasing the Economic Capital Ratio by 2.7% points.The greatest weakness of Ontrak Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 67% points.
The company's Economic Capital Ratio, given in the ranking table, is 20%, being 144% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001136174_2013_Ontrak_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "-1.74",
"Assets": "-33.3",
"Liabilities": "-8.09",
"Stockholders Equity": "-59.0",
"ECR before LimitedLiability": "-130",
"Property Plant and Equipment": "-20.0",
"Assets, Current": "-10.3",
"Other Liabilities": "-5.71",
"Liabilities, Current": "-2.18",
"Expenses": "-11.7",
"Revenues": "-12.5",
"Net Income": "-37.4",
"Other Expenses": "16.0",
"Operating Costs and Expenses": "2.08",
"Labor Expense": "3.22",
"General and Administrative Expense": "-52.4",
"Cost of Goods and Services Sold": "2.07",
"Other Revenues": "-12.5",
"Other Net Income": "-8.86",
"Comprehensive Net Income": "-37.3",
"Economic Capital Ratio": "-137"
},
"2012": {
"Property Plant and Equipment": "-15.7",
"Assets": "-38.0",
"Liabilities": "-6.92",
"Stockholders Equity": "-66.9",
"ECR before LimitedLiability": "-130",
"Intangible Assets": "-12.5",
"Assets, Current": "-6.56",
"Other Assets": "-0.751",
"Assets, Non-Current": "-2.72",
"Other Liabilities": "-7.48",
"Expenses": "-3.79",
"Revenues": "-9.60",
"Net Income": "-23.1",
"General and Administrative Expense": "-13.0",
"Operating Costs and Expenses": "1.31",
"Cost of Goods and Services Sold": "1.69",
"Labor Expense": "2.67",
"Other Revenues": "-9.60",
"Other Net Income": "-6.71",
"Comprehensive Net Income": "-23.0",
"Economic Capital Ratio": "-144"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001136174_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "1,359",
"Assets, Non-Current": "212",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "349",
"General and Administrative Expense": "11,145",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,920",
"Labor Expense": "0",
"Liabilities, Current": "3,530",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-3,145",
"Other Liabilities": "4,546",
"Other Net Income": "-41",
"Other Revenues": "271",
"Property Plant and Equipment": "89",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,580",
"Liabilities": "8,076",
"Expenses": "8,349",
"Revenues": "271",
"Stockholders Equity": "-4,496",
"Net Income": "-8,119",
"Comprehensive Net Income": "-8,119",
"BaseVar": "10,158",
"ECR before LimitedLiability": "-251%",
"Economic Capital Ratio": "24%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "3,622",
"Assets, Non-Current": "205",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "289",
"General and Administrative Expense": "8,341",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,048",
"Labor Expense": "0",
"Liabilities, Current": "3,998",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "3,554",
"Other Liabilities": "14,694",
"Other Net Income": "0",
"Other Revenues": "541",
"Property Plant and Equipment": "59",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,934",
"Liabilities": "18,692",
"Expenses": "12,184",
"Revenues": "541",
"Stockholders Equity": "-13,758",
"Net Income": "-11,643",
"Comprehensive Net Income": "-11,643",
"BaseVar": "18,176",
"ECR before LimitedLiability": "-267%",
"Economic Capital Ratio": "20%"
}
}
},
"top_rated": false,
"trend": 3.0,
"value": 0.1973866755616634,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001136174.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001136174.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001136174.svg"
},
{
"company_id": "0001272597",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001272597.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001272597.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001272597_main_keyfigs.svg",
"name": "Foundation Healthcare Inc",
"rank": 70,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001272597.svg",
"report_text": "The relative strengths and weaknesses of Foundation Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Foundation Healthcare Inc compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 5.9% points.The greatest weakness of Foundation Healthcare Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 75% points.
The company's Economic Capital Ratio, given in the ranking table, is 13%, being 151% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001272597_2013_Foundation_Healthcare_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "-3.44",
"Assets": "-7.24",
"Liabilities": "-59.0",
"Stockholders Equity": "-54.6",
"Property Plant and Equipment": "-24.4",
"Assets, Non-Current": "-6.77",
"Intangible Assets": "5.51",
"Other Liabilities": "3.44",
"Long Term Liabilities": "-74.3",
"Expenses": "3.68",
"Revenues": "3.73",
"Net Income": "-3.38",
"Other Expenses": "5.30",
"Operating Costs and Expenses": "3.44",
"Labor Expense": "3.59",
"General and Administrative Expense": "-28.5",
"Cost of Goods and Services Sold": "-17.1",
"Other Revenues": "3.73",
"ECR before LimitedLiability": "-63.2",
"Other Net Income": "-34.1",
"Economic Capital Ratio": "-69.9"
},
"2012": {
"Property Plant and Equipment": "-14.9",
"Assets": "-68.1",
"Stockholders Equity": "-74.7",
"Liabilities, Current": "2.73",
"ECR before LimitedLiability": "-137",
"Intangible Assets": "-30.5",
"Assets, Current": "-29.9",
"Assets, Non-Current": "-4.56",
"Expenses": "-19.9",
"Revenues": "4.17",
"Net Income": "-29.0",
"Other Expenses": "5.92",
"General and Administrative Expense": "-10.7",
"Goodwill Impairment Loss": "-21.0",
"Operating Costs and Expenses": "1.70",
"Cost of Goods and Services Sold": "-5.48",
"Labor Expense": "3.35",
"Other Revenues": "4.17",
"Other Net Income": "-12.3",
"Comprehensive Net Income": "-28.8",
"Economic Capital Ratio": "-151"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001272597_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "9,771",
"Assets, Non-Current": "280",
"Cost of Goods and Services Sold": "6,880",
"Depreciation, Depletion, Amortization": "1,111",
"General and Administrative Expense": "13,744",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "14,944",
"Labor Expense": "0",
"Liabilities, Current": "5,839",
"Long Term Liabilities": "17,321",
"Operating Costs and Expenses": "0",
"Other Assets": "54",
"Other Compr. Net Income": "0",
"Other Expenses": "910",
"Other Liabilities": "0",
"Other Net Income": "-992",
"Other Revenues": "17,510",
"Property Plant and Equipment": "2,936",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "27,985",
"Liabilities": "23,160",
"Expenses": "22,645",
"Revenues": "17,510",
"Stockholders Equity": "4,825",
"Net Income": "-6,126",
"Comprehensive Net Income": "-6,126",
"BaseVar": "46,146",
"ECR before LimitedLiability": "3.4%",
"Economic Capital Ratio": "91%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "3,904",
"Assets, Non-Current": "352",
"Cost of Goods and Services Sold": "6,923",
"Depreciation, Depletion, Amortization": "1,234",
"General and Administrative Expense": "14,055",
"Goodwill Impairment Loss": "14,787",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "24,128",
"Long Term Liabilities": "105",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,445",
"Other Liabilities": "0",
"Other Net Income": "-1,309",
"Other Revenues": "16,961",
"Property Plant and Equipment": "2,820",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,076",
"Liabilities": "24,233",
"Expenses": "38,444",
"Revenues": "16,961",
"Stockholders Equity": "-17,157",
"Net Income": "-22,793",
"Comprehensive Net Income": "-22,793",
"BaseVar": "44,012",
"ECR before LimitedLiability": "-305%",
"Economic Capital Ratio": "13%"
}
}
},
"top_rated": false,
"trend": -13.0,
"value": 0.12693853774442188,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001272597.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001272597.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001272597.svg"
},
{
"company_id": "0001505497",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001505497.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001505497.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001505497.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001505497_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001505497_main_keyfigs.svg",
"name": "Biorestorative Therapies Inc",
"rank": 71,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001505497.svg",
"report_text": "The relative strengths and weaknesses of Biorestorative Therapies Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Biorestorative Therapies Inc compared to the market average is the variable Other Liabilities, increasing the Economic Capital Ratio by 5.5% points.The greatest weakness of Biorestorative Therapies Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 72% points.
The company's Economic Capital Ratio, given in the ranking table, is 5.5%, being 158% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001505497_2013_Biorestorative_Therapies_Inc.pdf",
"shrinked_graph_json": {
"2012": {
"Property Plant and Equipment": "-10.7",
"Assets": "-44.3",
"Liabilities": "4.38",
"Stockholders Equity": "-72.0",
"ECR before LimitedLiability": "-144",
"Intangible Assets": "-0.831",
"Assets, Current": "-21.7",
"Assets, Non-Current": "-2.23",
"Liabilities, Current": "-0.801",
"Other Liabilities": "5.48",
"Expenses": "-4.37",
"Revenues": "-5.86",
"Net Income": "-28.3",
"Other Expenses": "-1.01",
"General and Administrative Expense": "-0.651",
"Cost of Goods and Services Sold": "0.752",
"Labor Expense": "-3.78",
"Other Revenues": "-5.86",
"Other Net Income": "-6.96",
"Comprehensive Net Income": "-28.2",
"Economic Capital Ratio": "-158"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001505497_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "31",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,225",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,177",
"Labor Expense": "1,980",
"Liabilities, Current": "0",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,835",
"Other Liabilities": "6,410",
"Other Net Income": "-964",
"Other Revenues": "16",
"Property Plant and Equipment": "59",
"Research And Development Expense": "416",
"Selling and Marketing Expense": "132"
},
"output_variables": {
"Assets": "1,268",
"Liabilities": "6,410",
"Expenses": "5,588",
"Revenues": "16",
"Stockholders Equity": "-5,142",
"Net Income": "-6,537",
"Comprehensive Net Income": "-6,537",
"BaseVar": "7,123",
"ECR before LimitedLiability": "-364%",
"Economic Capital Ratio": "5.5%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.05508252276711188,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001505497.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001505497.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001505497.svg"
},
{
"company_id": "0001468679",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution_0001468679.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2012/graphs/IME_0001468679.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001468679.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001468679_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001468679_main_keyfigs.svg",
"name": "American Cryostem Corp",
"rank": 72,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_0001468679.svg",
"report_text": "The relative strengths and weaknesses of American Cryostem Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of American Cryostem Corp compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 0.087% points.The greatest weakness of American Cryostem Corp is the variable Net Income, reducing the Economic Capital Ratio by 120% points.
The company's Economic Capital Ratio, given in the ranking table, is 0.087%, being 164% points below the market average of 164%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2012/report/0001468679_2013_American_Cryostem_Corp.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "19.0",
"Assets": "-16.6",
"Liabilities": "5.28",
"Stockholders Equity": "8.97",
"ECR before LimitedLiability": "-114",
"Property Plant and Equipment": "31.3",
"Assets, Current": "-19.5",
"Assets, Non-Current": "-7.34",
"Intangible Assets": "-34.3",
"Expenses": "-55.4",
"Revenues": "-26.6",
"Net Income": "-157",
"Research And Development Expense": "-15.4",
"Other Expenses": "27.3",
"Operating Costs and Expenses": "4.49",
"Labor Expense": "6.97",
"General and Administrative Expense": "-155",
"Other Revenues": "-26.6",
"Other Net Income": "-17.2",
"Comprehensive Net Income": "-157",
"Economic Capital Ratio": "-121"
},
"2012": {
"Property Plant and Equipment": "0.0800",
"Assets": "-38.8",
"Liabilities": "-0.294",
"Stockholders Equity": "-1.57",
"ECR before LimitedLiability": "-149",
"Intangible Assets": "-8.74",
"Assets, Current": "-21.0",
"Other Assets": "0.0866",
"Assets, Non-Current": "-0.321",
"Long Term Liabilities": "-0.177",
"Other Liabilities": "-0.101",
"Research And Development Expense": "-0.389",
"Expenses": "-51.6",
"Revenues": "-0.961",
"Net Income": "-120",
"Other Expenses": "0.0863",
"General and Administrative Expense": "-112",
"Other Revenues": "-0.961",
"Other Net Income": "-0.414",
"Comprehensive Net Income": "-119",
"Economic Capital Ratio": "-164"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2012/plot_over_time/0001468679_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "125",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "1.4",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,294",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "145",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "102",
"Other Compr. Net Income": "0",
"Other Expenses": "-172",
"Other Liabilities": "0",
"Other Net Income": "5.1",
"Other Revenues": "5.0",
"Property Plant and Equipment": "334",
"Research And Development Expense": "177",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "561",
"Liabilities": "145",
"Expenses": "1,301",
"Revenues": "5.0",
"Stockholders Equity": "416",
"Net Income": "-1,290",
"Comprehensive Net Income": "-1,290",
"BaseVar": "1,009",
"ECR before LimitedLiability": "-195%",
"Economic Capital Ratio": "40%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "4.0",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0.66",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,374",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "261",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "137",
"Other Compr. Net Income": "0",
"Other Expenses": "-294",
"Other Liabilities": "0",
"Other Net Income": "0.0020",
"Other Revenues": "21",
"Property Plant and Equipment": "319",
"Research And Development Expense": "304",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "460",
"Liabilities": "261",
"Expenses": "2,386",
"Revenues": "21",
"Stockholders Equity": "199",
"Net Income": "-2,364",
"Comprehensive Net Income": "-2,364",
"BaseVar": "1,564",
"ECR before LimitedLiability": "-576%",
"Economic Capital Ratio": "0.087%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 0.0008720532686660534,
"company_index": "https://www.realrate-archive.com/us_health_services/2012/industry_indexes/0001468679.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2012/analytics/equity/0001468679.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2012/analytics/profit_loss/0001468679.svg"
}
],
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2012/feature_distribution/feature_distribution.svg",
"final_var_label": "Economic Capital Ratio",
"industry_box": [
[
"Revenues",
"37.5 B"
],
[
"Assets",
"122 B"
],
[
"Expenses",
"72.4 B"
],
[
"Stockholders Equity",
"69.1 B"
]
],
"industry_id": "us_health_services",
"industry_label": "Health Services",
"num_companies": 72,
"num_top_companies": 18,
"ecr_records": {
"2009": {
"0001022079": {
"rank": 1,
"ecr": "268"
},
"0000896262": {
"rank": 2,
"ecr": "205"
},
"0001014739": {
"rank": 3,
"ecr": "194"
},
"0000920148": {
"rank": 4,
"ecr": "168"
},
"0000927066": {
"rank": 5,
"ecr": "146"
}
},
"2010": {
"0000895930": {
"rank": 1,
"ecr": "295"
},
"0000352915": {
"rank": 2,
"ecr": "266"
},
"0000731012": {
"rank": 3,
"ecr": "265"
},
"0001022079": {
"rank": 4,
"ecr": "261"
},
"0000893949": {
"rank": 5,
"ecr": "221"
},
"0000896262": {
"rank": 6,
"ecr": "212"
},
"0000019411": {
"rank": 7,
"ecr": "211"
},
"0000019584": {
"rank": 8,
"ecr": "188"
},
"0000882235": {
"rank": 9,
"ecr": "175"
},
"0001301611": {
"rank": 10,
"ecr": "165"
},
"0000920148": {
"rank": 11,
"ecr": "160"
},
"0000785161": {
"rank": 12,
"ecr": "147"
},
"0000927066": {
"rank": 13,
"ecr": "139"
},
"0001332349": {
"rank": 14,
"ecr": "122"
},
"0001108109": {
"rank": 15,
"ecr": "117"
},
"0001001604": {
"rank": 16,
"ecr": "105"
}
},
"2011": {
"0000895930": {
"rank": 1,
"ecr": "292"
},
"0001091312": {
"rank": 2,
"ecr": "275"
},
"0001043000": {
"rank": 3,
"ecr": "270"
},
"0000352915": {
"rank": 4,
"ecr": "269"
},
"0000731012": {
"rank": 5,
"ecr": "262"
},
"0001522138": {
"rank": 6,
"ecr": "259"
},
"0001367832": {
"rank": 7,
"ecr": "258"
},
"0000744825": {
"rank": 8,
"ecr": "256"
},
"0001294632": {
"rank": 9,
"ecr": "252"
},
"0001125376": {
"rank": 10,
"ecr": "252"
},
"0001022079": {
"rank": 11,
"ecr": "249"
},
"0001131324": {
"rank": 12,
"ecr": "245"
},
"0000860730": {
"rank": 13,
"ecr": "244"
},
"0001138476": {
"rank": 14,
"ecr": "241"
},
"0000885978": {
"rank": 15,
"ecr": "239"
},
"0000893949": {
"rank": 16,
"ecr": "234"
},
"0001124140": {
"rank": 17,
"ecr": "232"
},
"0001060009": {
"rank": 18,
"ecr": "231"
},
"0001047335": {
"rank": 19,
"ecr": "229"
},
"0001410471": {
"rank": 20,
"ecr": "218"
},
"0000704415": {
"rank": 21,
"ecr": "217"
},
"0000792641": {
"rank": 22,
"ecr": "215"
},
"0000931059": {
"rank": 23,
"ecr": "212"
},
"0000929994": {
"rank": 24,
"ecr": "206"
},
"0000019411": {
"rank": 25,
"ecr": "203"
},
"0000019584": {
"rank": 26,
"ecr": "182"
},
"0001003130": {
"rank": 27,
"ecr": "181"
},
"0001316645": {
"rank": 28,
"ecr": "179"
},
"0001468328": {
"rank": 29,
"ecr": "178"
},
"0001159281": {
"rank": 30,
"ecr": "176"
},
"0001301611": {
"rank": 31,
"ecr": "164"
},
"0000882235": {
"rank": 32,
"ecr": "162"
},
"0000920148": {
"rank": 33,
"ecr": "161"
},
"0001383183": {
"rank": 34,
"ecr": "155"
},
"0000722723": {
"rank": 35,
"ecr": "152"
},
"0000948072": {
"rank": 36,
"ecr": "151"
},
"0000862692": {
"rank": 37,
"ecr": "151"
},
"0001101723": {
"rank": 38,
"ecr": "146"
},
"0001498021": {
"rank": 39,
"ecr": "146"
},
"0000896262": {
"rank": 40,
"ecr": "143"
},
"0000927066": {
"rank": 41,
"ecr": "142"
},
"0000320017": {
"rank": 42,
"ecr": "140"
},
"0000776325": {
"rank": 43,
"ecr": "139"
},
"0001035688": {
"rank": 44,
"ecr": "139"
},
"0001320414": {
"rank": 44,
"ecr": "139"
},
"0001014739": {
"rank": 46,
"ecr": "138"
},
"0000785161": {
"rank": 47,
"ecr": "136"
},
"0001360474": {
"rank": 48,
"ecr": "127"
},
"0000919956": {
"rank": 49,
"ecr": "124"
},
"0000895665": {
"rank": 50,
"ecr": "123"
},
"0001332349": {
"rank": 51,
"ecr": "122"
},
"0001300524": {
"rank": 52,
"ecr": "120"
},
"0001108109": {
"rank": 53,
"ecr": "118"
},
"0001520697": {
"rank": 54,
"ecr": "115"
},
"0000096793": {
"rank": 55,
"ecr": "113"
},
"0001001604": {
"rank": 56,
"ecr": "100"
},
"0001272597": {
"rank": 57,
"ecr": "91"
},
"0001383960": {
"rank": 58,
"ecr": "87"
},
"0001051488": {
"rank": 59,
"ecr": "87"
},
"0001503518": {
"rank": 60,
"ecr": "87"
},
"0001351051": {
"rank": 61,
"ecr": "87"
},
"0000817135": {
"rank": 62,
"ecr": "84"
},
"0000882289": {
"rank": 63,
"ecr": "82"
},
"0001289496": {
"rank": 64,
"ecr": "73"
},
"0001416876": {
"rank": 65,
"ecr": "68"
},
"0001449934": {
"rank": 66,
"ecr": "53"
},
"0000022872": {
"rank": 67,
"ecr": "51"
},
"0000941020": {
"rank": 68,
"ecr": "48"
},
"0001294157": {
"rank": 69,
"ecr": "46"
},
"0001507881": {
"rank": 70,
"ecr": "40"
},
"0001468679": {
"rank": 71,
"ecr": "40"
},
"0001136174": {
"rank": 72,
"ecr": "24"
}
},
"2012": {
"0001300524": {
"rank": 1,
"ecr": "307"
},
"0000895930": {
"rank": 2,
"ecr": "291"
},
"0000352915": {
"rank": 3,
"ecr": "269"
},
"0001022079": {
"rank": 4,
"ecr": "268"
},
"0001043000": {
"rank": 5,
"ecr": "265"
},
"0001091312": {
"rank": 6,
"ecr": "261"
},
"0000806517": {
"rank": 7,
"ecr": "256"
},
"0001294632": {
"rank": 8,
"ecr": "255"
},
"0000744825": {
"rank": 9,
"ecr": "255"
},
"0001138476": {
"rank": 10,
"ecr": "255"
},
"0000931059": {
"rank": 11,
"ecr": "254"
},
"0001522138": {
"rank": 12,
"ecr": "253"
},
"0001131324": {
"rank": 13,
"ecr": "250"
},
"0000731012": {
"rank": 14,
"ecr": "247"
},
"0000885978": {
"rank": 15,
"ecr": "246"
},
"0000704415": {
"rank": 16,
"ecr": "243"
},
"0000860730": {
"rank": 17,
"ecr": "234"
},
"0001060009": {
"rank": 18,
"ecr": "233"
},
"0001047335": {
"rank": 19,
"ecr": "230"
},
"0000792641": {
"rank": 20,
"ecr": "229"
},
"0000893949": {
"rank": 21,
"ecr": "227"
},
"0000019411": {
"rank": 22,
"ecr": "213"
},
"0001410471": {
"rank": 23,
"ecr": "208"
},
"0001367832": {
"rank": 24,
"ecr": "208"
},
"0001539778": {
"rank": 25,
"ecr": "207"
},
"0001124140": {
"rank": 26,
"ecr": "206"
},
"0001507881": {
"rank": 27,
"ecr": "205"
},
"0001468328": {
"rank": 28,
"ecr": "199"
},
"0001552845": {
"rank": 29,
"ecr": "196"
},
"0001316645": {
"rank": 30,
"ecr": "194"
},
"0000019584": {
"rank": 31,
"ecr": "183"
},
"0000896262": {
"rank": 32,
"ecr": "181"
},
"0001159281": {
"rank": 33,
"ecr": "180"
},
"0000890908": {
"rank": 34,
"ecr": "175"
},
"0000929994": {
"rank": 35,
"ecr": "171"
},
"0001003130": {
"rank": 36,
"ecr": "169"
},
"0001089815": {
"rank": 37,
"ecr": "162"
},
"0001301611": {
"rank": 38,
"ecr": "162"
},
"0001520697": {
"rank": 39,
"ecr": "160"
},
"0000920148": {
"rank": 40,
"ecr": "160"
},
"0000722723": {
"rank": 41,
"ecr": "157"
},
"0000316253": {
"rank": 42,
"ecr": "154"
},
"0000776325": {
"rank": 43,
"ecr": "142"
},
"0000895665": {
"rank": 44,
"ecr": "140"
},
"0001498021": {
"rank": 45,
"ecr": "138"
},
"0000948072": {
"rank": 46,
"ecr": "137"
},
"0001035688": {
"rank": 47,
"ecr": "135"
},
"0001320414": {
"rank": 47,
"ecr": "135"
},
"0000927066": {
"rank": 49,
"ecr": "134"
},
"0001360474": {
"rank": 50,
"ecr": "128"
},
"0001332349": {
"rank": 51,
"ecr": "119"
},
"0001101723": {
"rank": 52,
"ecr": "119"
},
"0000919956": {
"rank": 53,
"ecr": "116"
},
"0001351051": {
"rank": 54,
"ecr": "113"
},
"0001383960": {
"rank": 55,
"ecr": "96"
},
"0000790526": {
"rank": 56,
"ecr": "96"
},
"0001001604": {
"rank": 57,
"ecr": "93"
},
"0000885074": {
"rank": 58,
"ecr": "92"
},
"0001051488": {
"rank": 59,
"ecr": "87"
},
"0000817135": {
"rank": 60,
"ecr": "86"
},
"0000862692": {
"rank": 61,
"ecr": "85"
},
"0000882289": {
"rank": 62,
"ecr": "82"
},
"0001449934": {
"rank": 63,
"ecr": "77"
},
"0001550020": {
"rank": 64,
"ecr": "69"
},
"0001294157": {
"rank": 65,
"ecr": "53"
},
"0001383183": {
"rank": 66,
"ecr": "41"
},
"0000022872": {
"rank": 67,
"ecr": "29"
},
"0000941020": {
"rank": 68,
"ecr": "24"
},
"0001136174": {
"rank": 69,
"ecr": "20"
},
"0001272597": {
"rank": 70,
"ecr": "13"
},
"0001505497": {
"rank": 71,
"ecr": "5.5"
},
"0001468679": {
"rank": 72,
"ecr": "0.087"
}
}
},
"rating_box": [
[
"Top rated",
"18 of 72"
],
[
"Best, worst rating",
"307 %, 0.0872 %"
],
[
"New companies",
"10"
]
],
"regression_plot": "https://www.realrate-archive.com/us_health_services/2012/backtesting_correlation/regression_2012.svg",
"scentences": [
"American International Holdings CORP climbed 51 positions from 52 to 1 due to its excellent Stockholders Equity.",
"Combimatrix Corp lost 32 positions from 34 to 66 due to its bad Stockholders Equity.",
"Psychemedics CORP entered the 2013 ranking at rank 7, making it the best newcomer."
],
"url_segment": "2013-us-health-services",
"year": 2013,
"feature_importance": "https://www.realrate-archive.com/us_health_services/2012/feature_importance/feature_importance.svg",
"obs_ecr": {
"0000920148": {
"2011": {
"obs_EconomicCapitalRatio": 1.663923414286983
},
"2012": {
"obs_EconomicCapitalRatio": 1.4407170672094647
},
"2013": {
"obs_EconomicCapitalRatio": 1.323792718489346
},
"2014": {
"obs_EconomicCapitalRatio": 1.470242712096841
},
"2015": {
"obs_EconomicCapitalRatio": 1.0214010482206495
},
"2016": {
"obs_EconomicCapitalRatio": 1.0954224043543792
},
"2017": {
"obs_EconomicCapitalRatio": 1.1879221981344004
},
"2018": {
"obs_EconomicCapitalRatio": 0.9477895219666614
},
"2019": {
"obs_EconomicCapitalRatio": 1.0949627880974482
},
"2021": {
"obs_EconomicCapitalRatio": 1.8399468745460335
},
"2022": {
"obs_EconomicCapitalRatio": 1.3068086669177197
},
"2023": {
"obs_EconomicCapitalRatio": 1.4492522183616858
},
"2024": {
"obs_EconomicCapitalRatio": 1.3176610991160915
},
"2025": {
"obs_EconomicCapitalRatio": 1.487123295160136
}
},
"0001022079": {
"2011": {
"obs_EconomicCapitalRatio": 1.267911138352765
},
"2012": {
"obs_EconomicCapitalRatio": 1.3862017229025643
},
"2013": {
"obs_EconomicCapitalRatio": 1.2031665213960887
},
"2014": {
"obs_EconomicCapitalRatio": 1.3396669994127473
},
"2015": {
"obs_EconomicCapitalRatio": 1.4903768348790714
},
"2016": {
"obs_EconomicCapitalRatio": 1.9095314518428617
},
"2017": {
"obs_EconomicCapitalRatio": 1.9713217210734026
},
"2018": {
"obs_EconomicCapitalRatio": 1.542844211769263
},
"2019": {
"obs_EconomicCapitalRatio": 1.7072037694942166
},
"2020": {
"obs_EconomicCapitalRatio": 1.8434784506594455
},
"2021": {
"obs_EconomicCapitalRatio": 2.4801222638557205
},
"2022": {
"obs_EconomicCapitalRatio": 2.303864240107965
},
"2023": {
"obs_EconomicCapitalRatio": 1.846925205369018
},
"2024": {
"obs_EconomicCapitalRatio": 1.810747224018149
},
"2025": {
"obs_EconomicCapitalRatio": 2.0966621477837926
}
},
"0001014739": {
"2011": {
"obs_EconomicCapitalRatio": 0.5455058467503717
},
"2018": {
"obs_EconomicCapitalRatio": 0.754424645512964
},
"2019": {
"obs_EconomicCapitalRatio": 1.1945159127889264
},
"2020": {
"obs_EconomicCapitalRatio": 1.3372488526870943
},
"2021": {
"obs_EconomicCapitalRatio": 2.287045484201052
},
"2022": {
"obs_EconomicCapitalRatio": 2.2629706450273175
},
"2023": {
"obs_EconomicCapitalRatio": 2.369798550093667
},
"2024": {
"obs_EconomicCapitalRatio": 1.431722453146353
},
"2025": {
"obs_EconomicCapitalRatio": 1.840512605157507
}
},
"0000927066": {
"2011": {
"obs_EconomicCapitalRatio": 0.9398495018958859
},
"2012": {
"obs_EconomicCapitalRatio": 0.7666044539176664
},
"2013": {
"obs_EconomicCapitalRatio": 0.9312599987060045
},
"2014": {
"obs_EconomicCapitalRatio": 1.0994201795059793
},
"2015": {
"obs_EconomicCapitalRatio": 0.9688014559679293
},
"2016": {
"obs_EconomicCapitalRatio": 0.8477409793726618
},
"2017": {
"obs_EconomicCapitalRatio": 0.824189439126132
},
"2018": {
"obs_EconomicCapitalRatio": 0.5103927085716712
},
"2019": {
"obs_EconomicCapitalRatio": 0.6180542558126978
},
"2020": {
"obs_EconomicCapitalRatio": 0.8322454933184945
},
"2021": {
"obs_EconomicCapitalRatio": 0.7116567354875124
},
"2022": {
"obs_EconomicCapitalRatio": 0.41763359468294975
},
"2023": {
"obs_EconomicCapitalRatio": 0.6154642053257157
},
"2024": {
"obs_EconomicCapitalRatio": 0.7615486641660242
},
"2025": {
"obs_EconomicCapitalRatio": 0.4785719594527293
}
},
"0000731012": {
"2011": {
"obs_EconomicCapitalRatio": 5.269267575857689
},
"2012": {
"obs_EconomicCapitalRatio": 5.962718744523781
},
"2013": {
"obs_EconomicCapitalRatio": 5.857390336910617
},
"2014": {
"obs_EconomicCapitalRatio": 6.010654031230302
},
"2015": {
"obs_EconomicCapitalRatio": 7.220294551700417
},
"2016": {
"obs_EconomicCapitalRatio": 7.592293402247349
},
"2017": {
"obs_EconomicCapitalRatio": 7.648779377528277
},
"2018": {
"obs_EconomicCapitalRatio": 5.948743829553438
},
"2019": {
"obs_EconomicCapitalRatio": 3.6760348928352986
},
"2020": {
"obs_EconomicCapitalRatio": 3.9099437641971453
},
"2021": {
"obs_EconomicCapitalRatio": 2.5108136581327076
},
"2022": {
"obs_EconomicCapitalRatio": 2.0121273406342404
},
"2023": {
"obs_EconomicCapitalRatio": 1.503981335283937
},
"2024": {
"obs_EconomicCapitalRatio": 1.6965676535663106
},
"2025": {
"obs_EconomicCapitalRatio": 2.8638609322827606
}
},
"0001332349": {
"2011": {
"obs_EconomicCapitalRatio": 0.5097293760371813
},
"2012": {
"obs_EconomicCapitalRatio": 0.7321295047182582
},
"2013": {
"obs_EconomicCapitalRatio": 0.7994065409175654
},
"2014": {
"obs_EconomicCapitalRatio": 0.7310943113449674
},
"2015": {
"obs_EconomicCapitalRatio": 0.3861457207385632
},
"2016": {
"obs_EconomicCapitalRatio": 0.29096091336542823
},
"2017": {
"obs_EconomicCapitalRatio": 0.26366034864469273
},
"2018": {
"obs_EconomicCapitalRatio": 0.21789711902103157
},
"2019": {
"obs_EconomicCapitalRatio": 0.1903375612099341
},
"2020": {
"obs_EconomicCapitalRatio": 0.12286042900676535
},
"2021": {
"obs_EconomicCapitalRatio": 0.15643986114831185
},
"2022": {
"obs_EconomicCapitalRatio": 0.09034196093382922
},
"2023": {
"obs_EconomicCapitalRatio": 0.20082534077007566
},
"2024": {
"obs_EconomicCapitalRatio": 0.16215618529739215
},
"2025": {
"obs_EconomicCapitalRatio": 0.42924858957859935
}
},
"0000785161": {
"2011": {
"obs_EconomicCapitalRatio": 0.6799239972910698
},
"2020": {
"obs_EconomicCapitalRatio": 1.4182305505026696
},
"2021": {
"obs_EconomicCapitalRatio": 1.0814619308963784
},
"2022": {
"obs_EconomicCapitalRatio": 1.2168672567310501
},
"2023": {
"obs_EconomicCapitalRatio": 1.3276977177956595
},
"2024": {
"obs_EconomicCapitalRatio": 1.8380528311696858
},
"2025": {
"obs_EconomicCapitalRatio": 1.9742320708117875
}
},
"0000893949": {
"2011": {
"obs_EconomicCapitalRatio": 2.4472442147004276
},
"2012": {
"obs_EconomicCapitalRatio": 2.324430027116807
},
"2013": {
"obs_EconomicCapitalRatio": 1.4153980642767163
},
"2014": {
"obs_EconomicCapitalRatio": 2.705255141805469
},
"2015": {
"obs_EconomicCapitalRatio": 2.0403070361793634
},
"2016": {
"obs_EconomicCapitalRatio": 1.5757900099368114
},
"2017": {
"obs_EconomicCapitalRatio": 1.1407480403624084
},
"2018": {
"obs_EconomicCapitalRatio": 0.6705050146055793
},
"2020": {
"obs_EconomicCapitalRatio": 0.6921913773195393
},
"2021": {
"obs_EconomicCapitalRatio": 1.0300015663795175
},
"2022": {
"obs_EconomicCapitalRatio": 0.6489855323488252
}
},
"0000352915": {
"2011": {
"obs_EconomicCapitalRatio": 0.0553602404895168
},
"2012": {
"obs_EconomicCapitalRatio": 0.0667388364815138
},
"2013": {
"obs_EconomicCapitalRatio": 0.10746186223320742
},
"2014": {
"obs_EconomicCapitalRatio": 0.1377020365266119
},
"2015": {
"obs_EconomicCapitalRatio": 0.14053215356654963
},
"2016": {
"obs_EconomicCapitalRatio": 0.11621934942230021
},
"2017": {
"obs_EconomicCapitalRatio": 0.114780744950106
},
"2018": {
"obs_EconomicCapitalRatio": 0.11647085422878821
},
"2019": {
"obs_EconomicCapitalRatio": 0.13844490306808155
},
"2020": {
"obs_EconomicCapitalRatio": 0.10967403520573908
},
"2021": {
"obs_EconomicCapitalRatio": 0.10964465033831926
},
"2022": {
"obs_EconomicCapitalRatio": 0.11838136871728291
}
},
"0001108109": {
"2011": {
"obs_EconomicCapitalRatio": 0.11115589636411495
},
"2018": {
"obs_EconomicCapitalRatio": 0.020711060055743875
},
"2019": {
"obs_EconomicCapitalRatio": 0.02087391002128378
},
"2020": {
"obs_EconomicCapitalRatio": 0.055024335706864366
},
"2021": {
"obs_EconomicCapitalRatio": 0.11238728706954826
},
"2022": {
"obs_EconomicCapitalRatio": 0.03480717712086575
}
},
"0000019584": {
"2011": {
"obs_EconomicCapitalRatio": 1.6007792741509022
},
"2012": {
"obs_EconomicCapitalRatio": 1.9490756925806219
},
"2013": {
"obs_EconomicCapitalRatio": 1.914488847567999
},
"2014": {
"obs_EconomicCapitalRatio": 2.7276355806390216
},
"2015": {
"obs_EconomicCapitalRatio": 4.108866362531992
},
"2016": {
"obs_EconomicCapitalRatio": 4.056449959720801
},
"2017": {
"obs_EconomicCapitalRatio": 5.771321991229426
},
"2018": {
"obs_EconomicCapitalRatio": 6.4038316847246515
},
"2019": {
"obs_EconomicCapitalRatio": 7.58709219872699
},
"2020": {
"obs_EconomicCapitalRatio": 8.473284302050429
},
"2021": {
"obs_EconomicCapitalRatio": 7.75419875738273
},
"2022": {
"obs_EconomicCapitalRatio": 7.217090228251971
},
"2023": {
"obs_EconomicCapitalRatio": 7.848784782008866
},
"2024": {
"obs_EconomicCapitalRatio": 7.020418240239263
},
"2025": {
"obs_EconomicCapitalRatio": 5.834267895037539
}
},
"0000885978": {
"2011": {
"obs_EconomicCapitalRatio": 1.8249280503248755
},
"2012": {
"obs_EconomicCapitalRatio": 2.5724402670747026
},
"2013": {
"obs_EconomicCapitalRatio": 2.440280256916831
},
"2014": {
"obs_EconomicCapitalRatio": 2.7841283878931624
},
"2015": {
"obs_EconomicCapitalRatio": 3.1734064882953517
},
"2016": {
"obs_EconomicCapitalRatio": 3.0246117738545863
},
"2017": {
"obs_EconomicCapitalRatio": 3.0139939481056994
},
"2018": {
"obs_EconomicCapitalRatio": 4.338573763941583
},
"2019": {
"obs_EconomicCapitalRatio": 3.5619391851687783
},
"2020": {
"obs_EconomicCapitalRatio": 3.608060136945878
},
"2021": {
"obs_EconomicCapitalRatio": 2.2035870209619968
},
"2022": {
"obs_EconomicCapitalRatio": 1.6051840413020122
},
"2023": {
"obs_EconomicCapitalRatio": 1.9917917705186083
}
},
"0001043000": {
"2011": {
"obs_EconomicCapitalRatio": 0.8293232149926116
},
"2012": {
"obs_EconomicCapitalRatio": 1.4742528917925262
},
"2013": {
"obs_EconomicCapitalRatio": 1.7089349147012525
},
"2014": {
"obs_EconomicCapitalRatio": 1.4658517655187218
},
"2015": {
"obs_EconomicCapitalRatio": 1.1163300237064913
},
"2016": {
"obs_EconomicCapitalRatio": 0.8011463796423269
},
"2017": {
"obs_EconomicCapitalRatio": 0.6657619630661099
},
"2018": {
"obs_EconomicCapitalRatio": 0.3499332196919161
},
"2019": {
"obs_EconomicCapitalRatio": 0.1435327336460731
},
"2020": {
"obs_EconomicCapitalRatio": 0.7691184527453718
},
"2021": {
"obs_EconomicCapitalRatio": 0.2472761050128782
},
"2022": {
"obs_EconomicCapitalRatio": 0.11342826064079066
},
"2023": {
"obs_EconomicCapitalRatio": 0.12215537075834612
},
"2024": {
"obs_EconomicCapitalRatio": 0.5680879390824175
},
"2025": {
"obs_EconomicCapitalRatio": 0.7440503530902668
}
},
"0001047335": {
"2011": {
"obs_EconomicCapitalRatio": 0.7030648064303432
},
"2012": {
"obs_EconomicCapitalRatio": 0.7986366131163368
},
"2013": {
"obs_EconomicCapitalRatio": 0.8810375321554819
},
"2014": {
"obs_EconomicCapitalRatio": 1.0391703058215966
},
"2015": {
"obs_EconomicCapitalRatio": 1.1792883497574127
},
"2016": {
"obs_EconomicCapitalRatio": 1.4494970214093919
},
"2018": {
"obs_EconomicCapitalRatio": 1.3317026977764668
},
"2019": {
"obs_EconomicCapitalRatio": 1.2199733107599542
},
"2020": {
"obs_EconomicCapitalRatio": 0.9159128240235758
},
"2021": {
"obs_EconomicCapitalRatio": 0.974181561146432
},
"2022": {
"obs_EconomicCapitalRatio": 1.0185115295379144
},
"2023": {
"obs_EconomicCapitalRatio": 1.6164670839378312
},
"2024": {
"obs_EconomicCapitalRatio": 1.6149386864581519
},
"2025": {
"obs_EconomicCapitalRatio": 2.1616166738307125
}
},
"0001125376": {
"2011": {
"obs_EconomicCapitalRatio": 1399.2430658223911
},
"2013": {
"obs_EconomicCapitalRatio": 1.5989526445598863
},
"2014": {
"obs_EconomicCapitalRatio": 2.650540849834678
},
"2015": {
"obs_EconomicCapitalRatio": 1.0482953396008179
},
"2016": {
"obs_EconomicCapitalRatio": 1.43190595552074
},
"2017": {
"obs_EconomicCapitalRatio": 1.298859391390505
},
"2018": {
"obs_EconomicCapitalRatio": 2.258510853301959
},
"2020": {
"obs_EconomicCapitalRatio": 1.8301794320010123
},
"2021": {
"obs_EconomicCapitalRatio": 1.9403448034625244
},
"2022": {
"obs_EconomicCapitalRatio": 1.8563425494032437
},
"2023": {
"obs_EconomicCapitalRatio": 1.8496058389879095
},
"2024": {
"obs_EconomicCapitalRatio": 2.05284060578683
},
"2025": {
"obs_EconomicCapitalRatio": 2.3535867345733354
}
},
"0001320414": {
"2011": {
"obs_EconomicCapitalRatio": 0.4096752742860925
},
"2012": {
"obs_EconomicCapitalRatio": 0.4783822969318578
},
"2019": {
"obs_EconomicCapitalRatio": 0.44294593397271526
},
"2020": {
"obs_EconomicCapitalRatio": 0.4886895190465231
},
"2021": {
"obs_EconomicCapitalRatio": 0.5402804679327372
},
"2022": {
"obs_EconomicCapitalRatio": 0.4248829592184213
},
"2023": {
"obs_EconomicCapitalRatio": 0.42798358473497655
},
"2024": {
"obs_EconomicCapitalRatio": 0.5226074625086464
},
"2025": {
"obs_EconomicCapitalRatio": 0.37980794355505854
}
},
"0000860730": {
"2011": {
"obs_EconomicCapitalRatio": 0.4286902706847537
},
"2012": {
"obs_EconomicCapitalRatio": 0.7436572689093711
},
"2013": {
"obs_EconomicCapitalRatio": 1.1206263058489003
},
"2014": {
"obs_EconomicCapitalRatio": 1.6352993886568388
},
"2015": {
"obs_EconomicCapitalRatio": 1.3417604658415376
},
"2016": {
"obs_EconomicCapitalRatio": 1.2987056545778823
},
"2017": {
"obs_EconomicCapitalRatio": 1.3588133779185207
},
"2018": {
"obs_EconomicCapitalRatio": 1.690582150801402
},
"2019": {
"obs_EconomicCapitalRatio": 1.8037161509724668
},
"2020": {
"obs_EconomicCapitalRatio": 1.8890537469679993
},
"2021": {
"obs_EconomicCapitalRatio": 2.5241883533491696
},
"2022": {
"obs_EconomicCapitalRatio": 2.1212350019474413
}
},
"0000744825": {
"2011": {
"obs_EconomicCapitalRatio": 0.3013270885313684
},
"2012": {
"obs_EconomicCapitalRatio": 0.2786524695351668
},
"2014": {
"obs_EconomicCapitalRatio": 0.32061093649804834
},
"2015": {
"obs_EconomicCapitalRatio": 0.27328011615268516
},
"2016": {
"obs_EconomicCapitalRatio": 0.507485494797134
},
"2019": {
"obs_EconomicCapitalRatio": 0.47749793539701463
},
"2020": {
"obs_EconomicCapitalRatio": 0.4205109400804776
},
"2021": {
"obs_EconomicCapitalRatio": 0.5408241989221371
},
"2022": {
"obs_EconomicCapitalRatio": 0.551218384744222
},
"2023": {
"obs_EconomicCapitalRatio": 0.43442074411285875
},
"2024": {
"obs_EconomicCapitalRatio": 0.4546792591572024
},
"2025": {
"obs_EconomicCapitalRatio": 0.33160145828748444
}
},
"0001124140": {
"2011": {
"obs_EconomicCapitalRatio": 8.166711011815341
},
"2012": {
"obs_EconomicCapitalRatio": 10.92431895435195
},
"2013": {
"obs_EconomicCapitalRatio": 11.153573080374903
},
"2014": {
"obs_EconomicCapitalRatio": 13.87272928515707
},
"2015": {
"obs_EconomicCapitalRatio": 4.498727547879557
},
"2016": {
"obs_EconomicCapitalRatio": 7.186191888088503
},
"2017": {
"obs_EconomicCapitalRatio": 18.744201313894912
},
"2018": {
"obs_EconomicCapitalRatio": 6.328551540717717
},
"2019": {
"obs_EconomicCapitalRatio": 5.219972902769483
},
"2020": {
"obs_EconomicCapitalRatio": 5.8461764979525555
},
"2021": {
"obs_EconomicCapitalRatio": 2.693158098121996
},
"2022": {
"obs_EconomicCapitalRatio": 1.8966263786723718
},
"2023": {
"obs_EconomicCapitalRatio": 2.675453724118233
},
"2024": {
"obs_EconomicCapitalRatio": 2.2518786178746426
},
"2025": {
"obs_EconomicCapitalRatio": 4.130870838625185
}
},
"0001416876": {
"2011": {
"obs_EconomicCapitalRatio": 6.005379679717644
}
},
"0001468328": {
"2011": {
"obs_EconomicCapitalRatio": 0.3339618789772089
},
"2012": {
"obs_EconomicCapitalRatio": 0.7361666670249098
},
"2013": {
"obs_EconomicCapitalRatio": 2.4221362236697006
},
"2014": {
"obs_EconomicCapitalRatio": 2.247833539524948
},
"2015": {
"obs_EconomicCapitalRatio": 2.1765194287839145
},
"2016": {
"obs_EconomicCapitalRatio": 2.669870396751533
},
"2017": {
"obs_EconomicCapitalRatio": 2.225023618015959
},
"2018": {
"obs_EconomicCapitalRatio": 3.999238099074307
},
"2019": {
"obs_EconomicCapitalRatio": 3.6416558946940984
},
"2020": {
"obs_EconomicCapitalRatio": 2.8759264575125654
},
"2021": {
"obs_EconomicCapitalRatio": 2.2511133868811335
},
"2022": {
"obs_EconomicCapitalRatio": 2.6282063462550895
},
"2025": {
"obs_EconomicCapitalRatio": 2.289809915160802
}
},
"0000320017": {
"2011": {
"obs_EconomicCapitalRatio": 0.7845651461442082
},
"2017": {
"obs_EconomicCapitalRatio": 0.8441397867838771
},
"2018": {
"obs_EconomicCapitalRatio": 1.450029837906473
},
"2019": {
"obs_EconomicCapitalRatio": 1.3779837923295708
},
"2020": {
"obs_EconomicCapitalRatio": 1.4413081267952197
},
"2021": {
"obs_EconomicCapitalRatio": 1.0188229702380915
},
"2022": {
"obs_EconomicCapitalRatio": 0.4977353007777521
},
"2023": {
"obs_EconomicCapitalRatio": 0.7478434592910281
},
"2024": {
"obs_EconomicCapitalRatio": 1.2214669648900207
},
"2025": {
"obs_EconomicCapitalRatio": 1.697675419723171
}
},
"0000862692": {
"2012": {
"obs_EconomicCapitalRatio": 1.6030934401757337
},
"2013": {
"obs_EconomicCapitalRatio": 1.4904801656352977
},
"2014": {
"obs_EconomicCapitalRatio": 2.29460235161725
},
"2015": {
"obs_EconomicCapitalRatio": 1.5555905563042072
},
"2016": {
"obs_EconomicCapitalRatio": 0.8703509764233575
},
"2017": {
"obs_EconomicCapitalRatio": 1.745275561455659
},
"2018": {
"obs_EconomicCapitalRatio": 1.0071098975322699
},
"2019": {
"obs_EconomicCapitalRatio": 0.9780748861936736
},
"2020": {
"obs_EconomicCapitalRatio": 0.9549593957112342
},
"2021": {
"obs_EconomicCapitalRatio": 1.392951720347594
},
"2022": {
"obs_EconomicCapitalRatio": 0.49974368258860846
}
},
"0001138476": {
"2011": {
"obs_EconomicCapitalRatio": 1.0159968197446956
},
"2012": {
"obs_EconomicCapitalRatio": 2.6993579909368757
},
"2013": {
"obs_EconomicCapitalRatio": 13.336168649980072
},
"2014": {
"obs_EconomicCapitalRatio": 9.494406793998118
},
"2015": {
"obs_EconomicCapitalRatio": 1.9380748685240585
},
"2016": {
"obs_EconomicCapitalRatio": 2.7272575024723023
},
"2017": {
"obs_EconomicCapitalRatio": 3.028696524958903
},
"2018": {
"obs_EconomicCapitalRatio": 2.885688962134937
},
"2020": {
"obs_EconomicCapitalRatio": 1.8494446405798506
},
"2021": {
"obs_EconomicCapitalRatio": 1.8473038660504764
},
"2022": {
"obs_EconomicCapitalRatio": 1.3523816738275818
},
"2023": {
"obs_EconomicCapitalRatio": 1.4350490259676654
}
},
"0001520697": {
"2011": {
"obs_EconomicCapitalRatio": 0.6081713564397228
},
"2012": {
"obs_EconomicCapitalRatio": 1.2349126249303797
},
"2013": {
"obs_EconomicCapitalRatio": 2.431136189781226
},
"2014": {
"obs_EconomicCapitalRatio": 2.1113051231339535
},
"2015": {
"obs_EconomicCapitalRatio": 1.3038377293511394
},
"2017": {
"obs_EconomicCapitalRatio": 0.5522060999716568
},
"2018": {
"obs_EconomicCapitalRatio": 0.4571543250579229
},
"2019": {
"obs_EconomicCapitalRatio": 0.5212458993293995
},
"2020": {
"obs_EconomicCapitalRatio": 0.7890311768704694
},
"2021": {
"obs_EconomicCapitalRatio": 1.5307713118327542
},
"2022": {
"obs_EconomicCapitalRatio": 2.1315460187424224
}
},
"0000790526": {
"2012": {
"obs_EconomicCapitalRatio": 0.13358036301597942
},
"2013": {
"obs_EconomicCapitalRatio": 0.09085026990368239
},
"2014": {
"obs_EconomicCapitalRatio": 0.5431310806294178
},
"2015": {
"obs_EconomicCapitalRatio": 0.3505983920433856
},
"2016": {
"obs_EconomicCapitalRatio": 0.3682069337967622
},
"2017": {
"obs_EconomicCapitalRatio": 0.5710188707297758
},
"2024": {
"obs_EconomicCapitalRatio": 1.973558336079889
},
"2025": {
"obs_EconomicCapitalRatio": 1.822716365763516
}
},
"0000806517": {
"2012": {
"obs_EconomicCapitalRatio": 4.60715791025414
},
"2014": {
"obs_EconomicCapitalRatio": 3.3264549819016556
},
"2015": {
"obs_EconomicCapitalRatio": 2.6996817675995533
},
"2016": {
"obs_EconomicCapitalRatio": 5.952072258353605
},
"2017": {
"obs_EconomicCapitalRatio": 5.394572797693456
},
"2018": {
"obs_EconomicCapitalRatio": 4.474632330961844
},
"2019": {
"obs_EconomicCapitalRatio": 2.3961219464673005
},
"2020": {
"obs_EconomicCapitalRatio": 1.3262727318756238
},
"2021": {
"obs_EconomicCapitalRatio": 2.3750491230099042
},
"2022": {
"obs_EconomicCapitalRatio": 2.026772375492911
},
"2023": {
"obs_EconomicCapitalRatio": 1.8485765440798285
},
"2024": {
"obs_EconomicCapitalRatio": 1.9825798798980514
}
},
"0001505497": {
"2012": {
"obs_EconomicCapitalRatio": 0.0
},
"2013": {
"obs_EconomicCapitalRatio": 0.0
},
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2016": {
"obs_EconomicCapitalRatio": 0.0
},
"2017": {
"obs_EconomicCapitalRatio": 0.0
},
"2018": {
"obs_EconomicCapitalRatio": 0.0
},
"2021": {
"obs_EconomicCapitalRatio": 1.3561386622109721
},
"2022": {
"obs_EconomicCapitalRatio": 1.2272159903361468
},
"2024": {
"obs_EconomicCapitalRatio": 1.3211056224972826
},
"2025": {
"obs_EconomicCapitalRatio": 2.6392582155377524
}
},
"0001089815": {
"2012": {
"obs_EconomicCapitalRatio": 0.27461324171750273
},
"2013": {
"obs_EconomicCapitalRatio": 0.5652182034205951
},
"2014": {
"obs_EconomicCapitalRatio": 0.5784619345201361
},
"2015": {
"obs_EconomicCapitalRatio": 0.1633049803157926
},
"2016": {
"obs_EconomicCapitalRatio": 0.2753162215937384
},
"2017": {
"obs_EconomicCapitalRatio": 0.4022421591008146
},
"2018": {
"obs_EconomicCapitalRatio": 0.3316176238371148
},
"2019": {
"obs_EconomicCapitalRatio": 0.4783975439001473
},
"2020": {
"obs_EconomicCapitalRatio": 0.919678507057958
},
"2021": {
"obs_EconomicCapitalRatio": 0.9237462870829648
},
"2022": {
"obs_EconomicCapitalRatio": 1.539192368372456
},
"2023": {
"obs_EconomicCapitalRatio": 3.7939396247631856
},
"2024": {
"obs_EconomicCapitalRatio": 6.231155648407009
},
"2025": {
"obs_EconomicCapitalRatio": 7.171877525786021
}
},
"0000802257": {
"2013": {
"obs_EconomicCapitalRatio": 0.0
},
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2020": {
"obs_EconomicCapitalRatio": 1.9744005113966216
},
"2021": {
"obs_EconomicCapitalRatio": 3.6904748791510964
},
"2022": {
"obs_EconomicCapitalRatio": 18.356104790380286
}
},
"0000948320": {
"2013": {
"obs_EconomicCapitalRatio": 19.122408312536397
},
"2014": {
"obs_EconomicCapitalRatio": 12.544382169245214
},
"2015": {
"obs_EconomicCapitalRatio": 10.709507411111359
},
"2018": {
"obs_EconomicCapitalRatio": 3.298409579098017
},
"2019": {
"obs_EconomicCapitalRatio": 1.7309580285301396
},
"2020": {
"obs_EconomicCapitalRatio": 10.40786666630324
},
"2021": {
"obs_EconomicCapitalRatio": 3.3516170514357024
},
"2022": {
"obs_EconomicCapitalRatio": 2.1668311020786786
},
"2023": {
"obs_EconomicCapitalRatio": 5.666378657404718
},
"2024": {
"obs_EconomicCapitalRatio": 2.9540486786201483
},
"2025": {
"obs_EconomicCapitalRatio": 2.8022594173750055
}
},
"0001384101": {
"2013": {
"obs_EconomicCapitalRatio": 5.726396731332951
},
"2014": {
"obs_EconomicCapitalRatio": 4.2258505750915285
},
"2015": {
"obs_EconomicCapitalRatio": 4.002792419943674
},
"2016": {
"obs_EconomicCapitalRatio": 2.907069930522243
},
"2017": {
"obs_EconomicCapitalRatio": 3.6955164524484863
},
"2018": {
"obs_EconomicCapitalRatio": 5.903084432595021
},
"2019": {
"obs_EconomicCapitalRatio": 9.17221087672525
},
"2020": {
"obs_EconomicCapitalRatio": 12.009349418296129
},
"2021": {
"obs_EconomicCapitalRatio": 4.569266085280168
},
"2022": {
"obs_EconomicCapitalRatio": 2.957324756862987
},
"2023": {
"obs_EconomicCapitalRatio": 3.476700938886737
},
"2024": {
"obs_EconomicCapitalRatio": 4.4085578126382945
},
"2025": {
"obs_EconomicCapitalRatio": 4.485792425264168
}
},
"0001443863": {
"2013": {
"obs_EconomicCapitalRatio": 3.48321910388931
},
"2014": {
"obs_EconomicCapitalRatio": 3.4046294626511577
},
"2015": {
"obs_EconomicCapitalRatio": 1.5631269234101999
},
"2016": {
"obs_EconomicCapitalRatio": 1.1237533540614515
},
"2018": {
"obs_EconomicCapitalRatio": 4.838143851132696
},
"2020": {
"obs_EconomicCapitalRatio": 1.516717809911702
},
"2021": {
"obs_EconomicCapitalRatio": 6.736268258202685
},
"2022": {
"obs_EconomicCapitalRatio": 1.547614374795819
},
"2025": {
"obs_EconomicCapitalRatio": 0.9131965951472314
}
},
"0001597892": {
"2016": {
"obs_EconomicCapitalRatio": 0.4573910404286819
},
"2017": {
"obs_EconomicCapitalRatio": 0.7307048923124139
},
"2018": {
"obs_EconomicCapitalRatio": 1.0765984359761611
},
"2019": {
"obs_EconomicCapitalRatio": 2.9112556811490666
},
"2020": {
"obs_EconomicCapitalRatio": 0.0805492763350369
},
"2023": {
"obs_EconomicCapitalRatio": 2.308586009655766
}
},
"0001217234": {
"2014": {
"obs_EconomicCapitalRatio": 2.106099248600515
},
"2015": {
"obs_EconomicCapitalRatio": 1.8606992876041615
},
"2016": {
"obs_EconomicCapitalRatio": 0.8991741565472338
},
"2017": {
"obs_EconomicCapitalRatio": 2.3625185935969757
},
"2018": {
"obs_EconomicCapitalRatio": 10.988768401944188
},
"2019": {
"obs_EconomicCapitalRatio": 9.295696048608347
},
"2020": {
"obs_EconomicCapitalRatio": 15.894232884028792
},
"2021": {
"obs_EconomicCapitalRatio": 7.107376945609629
},
"2022": {
"obs_EconomicCapitalRatio": 1.868289639503857
},
"2023": {
"obs_EconomicCapitalRatio": 1.9021864798831671
},
"2024": {
"obs_EconomicCapitalRatio": 3.75555356135359
},
"2025": {
"obs_EconomicCapitalRatio": 3.8258403033619546
}
},
"0000811222": {
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2016": {
"obs_EconomicCapitalRatio": 0.0
},
"2017": {
"obs_EconomicCapitalRatio": 0.0
},
"2018": {
"obs_EconomicCapitalRatio": 0.0
},
"2022": {
"obs_EconomicCapitalRatio": 0.0
},
"2023": {
"obs_EconomicCapitalRatio": 0.0
},
"2024": {
"obs_EconomicCapitalRatio": 2.313895027277619
},
"2025": {
"obs_EconomicCapitalRatio": 1.2879555622882315
}
},
"0001477449": {
"2015": {
"obs_EconomicCapitalRatio": 5.544764703239246
},
"2016": {
"obs_EconomicCapitalRatio": 4.7132034470335
},
"2017": {
"obs_EconomicCapitalRatio": 4.690116935020641
},
"2018": {
"obs_EconomicCapitalRatio": 4.243448916525309
},
"2019": {
"obs_EconomicCapitalRatio": 7.066330202032505
},
"2020": {
"obs_EconomicCapitalRatio": 3.2033660875692913
},
"2021": {
"obs_EconomicCapitalRatio": 1.6724116401293925
},
"2022": {
"obs_EconomicCapitalRatio": 1.6400447522007024
},
"2023": {
"obs_EconomicCapitalRatio": 1.4808360827926537
},
"2024": {
"obs_EconomicCapitalRatio": 0.5824872091940608
},
"2025": {
"obs_EconomicCapitalRatio": 0.5880410245147577
}
},
"0001638833": {
"2015": {
"obs_EconomicCapitalRatio": 0.8690576081521365
},
"2016": {
"obs_EconomicCapitalRatio": 0.5809479181547815
},
"2018": {
"obs_EconomicCapitalRatio": 0.19992190836322066
},
"2019": {
"obs_EconomicCapitalRatio": 0.28413337094038393
},
"2020": {
"obs_EconomicCapitalRatio": 0.47610580888076925
},
"2021": {
"obs_EconomicCapitalRatio": 1.3205930250979123
},
"2022": {
"obs_EconomicCapitalRatio": 0.6666538559780858
},
"2023": {
"obs_EconomicCapitalRatio": 1.1049807370417983
},
"2024": {
"obs_EconomicCapitalRatio": 0.6276252284290024
},
"2025": {
"obs_EconomicCapitalRatio": 0.46493861746268283
}
},
"0001590750": {
"2015": {
"obs_EconomicCapitalRatio": 0.932903006677119
},
"2016": {
"obs_EconomicCapitalRatio": 13.0711249565521
},
"2017": {
"obs_EconomicCapitalRatio": 6.356633171990735
},
"2018": {
"obs_EconomicCapitalRatio": 2.0254040755220735
},
"2019": {
"obs_EconomicCapitalRatio": 0.6907471032007421
},
"2020": {
"obs_EconomicCapitalRatio": 14.802536994480796
},
"2021": {
"obs_EconomicCapitalRatio": 4.033972483760562
},
"2023": {
"obs_EconomicCapitalRatio": 4.295100066488977
},
"2024": {
"obs_EconomicCapitalRatio": 3.7757140806874343
},
"2025": {
"obs_EconomicCapitalRatio": 5.655591493377748
}
},
"0001604821": {
"2015": {
"obs_EconomicCapitalRatio": 3.240855334715597
},
"2016": {
"obs_EconomicCapitalRatio": 3.9343020841567653
},
"2017": {
"obs_EconomicCapitalRatio": 2.797164141426769
},
"2018": {
"obs_EconomicCapitalRatio": 3.2298690908277656
},
"2019": {
"obs_EconomicCapitalRatio": 5.987358295647832
},
"2020": {
"obs_EconomicCapitalRatio": 12.840764363166384
},
"2021": {
"obs_EconomicCapitalRatio": 9.697207220674155
},
"2022": {
"obs_EconomicCapitalRatio": 3.8690619189941047
},
"2023": {
"obs_EconomicCapitalRatio": 6.871334386701791
},
"2024": {
"obs_EconomicCapitalRatio": 19.864753055012294
}
},
"0000792935": {
"2016": {
"obs_EconomicCapitalRatio": 0.47107162549473863
},
"2019": {
"obs_EconomicCapitalRatio": 0.06465501080251583
},
"2020": {
"obs_EconomicCapitalRatio": 0.5290719268064846
},
"2021": {
"obs_EconomicCapitalRatio": 0.2676343291130003
},
"2022": {
"obs_EconomicCapitalRatio": 0.13585432723348395
},
"2024": {
"obs_EconomicCapitalRatio": 0.2432404069211452
}
},
"0001674930": {
"2016": {
"obs_EconomicCapitalRatio": 5.977117435291776
},
"2017": {
"obs_EconomicCapitalRatio": 2.4695749151172817
},
"2018": {
"obs_EconomicCapitalRatio": 2.079409314730264
},
"2019": {
"obs_EconomicCapitalRatio": 5.306880144073147
},
"2020": {
"obs_EconomicCapitalRatio": 2.8216283049254067
},
"2021": {
"obs_EconomicCapitalRatio": 4.339147344390559
},
"2022": {
"obs_EconomicCapitalRatio": 1.1938018387890712
}
},
"0001680139": {
"2017": {
"obs_EconomicCapitalRatio": 3.9395693520833825
},
"2018": {
"obs_EconomicCapitalRatio": 6.2256973384254515
},
"2019": {
"obs_EconomicCapitalRatio": 3.533160492046391
},
"2021": {
"obs_EconomicCapitalRatio": 15.437613384223065
},
"2022": {
"obs_EconomicCapitalRatio": 3.5079397431580226
},
"2023": {
"obs_EconomicCapitalRatio": 4.4482071080504575
}
},
"0001603454": {
"2018": {
"obs_EconomicCapitalRatio": 17.66433991837258
},
"2019": {
"obs_EconomicCapitalRatio": 9.527163233702987
},
"2021": {
"obs_EconomicCapitalRatio": 3.7696196477965644
},
"2022": {
"obs_EconomicCapitalRatio": 1.8690407255909658
},
"2023": {
"obs_EconomicCapitalRatio": 2.9173109469879184
},
"2024": {
"obs_EconomicCapitalRatio": 2.485696746340044
},
"2025": {
"obs_EconomicCapitalRatio": 11.243231230995297
}
},
"0001713210": {
"2023": {
"obs_EconomicCapitalRatio": 14.39400262713444
},
"2024": {
"obs_EconomicCapitalRatio": 2.0773963940030575
},
"2025": {
"obs_EconomicCapitalRatio": 0.44125322995284166
}
},
"0000070318": {
"2018": {
"obs_EconomicCapitalRatio": 0.08552924410432898
},
"2019": {
"obs_EconomicCapitalRatio": 0.17754638364786196
},
"2020": {
"obs_EconomicCapitalRatio": 0.16463973728908057
},
"2021": {
"obs_EconomicCapitalRatio": 0.33521955077878823
},
"2022": {
"obs_EconomicCapitalRatio": 0.20317691382837733
},
"2023": {
"obs_EconomicCapitalRatio": 0.30062697803053423
},
"2024": {
"obs_EconomicCapitalRatio": 0.4934054549593957
},
"2025": {
"obs_EconomicCapitalRatio": 0.6933671309524378
}
},
"0001576280": {
"2018": {
"obs_EconomicCapitalRatio": 9.409998338204176
},
"2019": {
"obs_EconomicCapitalRatio": 14.015133034824808
},
"2020": {
"obs_EconomicCapitalRatio": 8.033623509502428
},
"2021": {
"obs_EconomicCapitalRatio": 5.378829839582666
},
"2022": {
"obs_EconomicCapitalRatio": 1.8770406090353164
},
"2023": {
"obs_EconomicCapitalRatio": 1.9270482881595639
},
"2024": {
"obs_EconomicCapitalRatio": 2.4823202710500136
},
"2025": {
"obs_EconomicCapitalRatio": 6.1920599604917745
}
},
"0001766400": {
"2019": {
"obs_EconomicCapitalRatio": 2.2358107646248047
},
"2020": {
"obs_EconomicCapitalRatio": 3.7377872544961175
},
"2021": {
"obs_EconomicCapitalRatio": 1.317407127445334
},
"2022": {
"obs_EconomicCapitalRatio": 0.7196383548705427
},
"2023": {
"obs_EconomicCapitalRatio": 0.8927955560969081
},
"2024": {
"obs_EconomicCapitalRatio": 1.7720749372810554
},
"2025": {
"obs_EconomicCapitalRatio": 1.2970657367956044
}
},
"0001274737": {
"2019": {
"obs_EconomicCapitalRatio": 5.3105465475101905
},
"2020": {
"obs_EconomicCapitalRatio": 2.660107841280965
},
"2021": {
"obs_EconomicCapitalRatio": 2.2167256957939694
},
"2022": {
"obs_EconomicCapitalRatio": 0.6076712499435017
},
"2023": {
"obs_EconomicCapitalRatio": 0.654214032721451
},
"2024": {
"obs_EconomicCapitalRatio": 2.2025057987368397
},
"2025": {
"obs_EconomicCapitalRatio": 2.875555288576213
}
},
"0001447362": {
"2019": {
"obs_EconomicCapitalRatio": 6.498753866445175
},
"2020": {
"obs_EconomicCapitalRatio": 6.026288703848502
},
"2021": {
"obs_EconomicCapitalRatio": 4.175460360278498
},
"2022": {
"obs_EconomicCapitalRatio": 2.4739768633055252
},
"2023": {
"obs_EconomicCapitalRatio": 2.256072832055694
},
"2024": {
"obs_EconomicCapitalRatio": 2.501859695117348
},
"2025": {
"obs_EconomicCapitalRatio": 3.3619067449345166
}
},
"0001527753": {
"2019": {
"obs_EconomicCapitalRatio": 2.953743430117927
},
"2020": {
"obs_EconomicCapitalRatio": 10.527770127762217
},
"2021": {
"obs_EconomicCapitalRatio": 2.645722439374889
},
"2022": {
"obs_EconomicCapitalRatio": 0.47315593157114144
}
},
"0001725255": {
"2019": {
"obs_EconomicCapitalRatio": 0.5857155046057619
},
"2020": {
"obs_EconomicCapitalRatio": 1.4955681062795707
},
"2021": {
"obs_EconomicCapitalRatio": 0.7234441813573314
},
"2022": {
"obs_EconomicCapitalRatio": 0.6234341278934857
},
"2023": {
"obs_EconomicCapitalRatio": 0.26119597375409453
},
"2024": {
"obs_EconomicCapitalRatio": 0.35440894588014293
},
"2025": {
"obs_EconomicCapitalRatio": 0.3887325800588612
}
},
"0001551306": {
"2019": {
"obs_EconomicCapitalRatio": 23.128888643767834
},
"2020": {
"obs_EconomicCapitalRatio": 21.25263485685163
},
"2021": {
"obs_EconomicCapitalRatio": 19.928211362808444
},
"2022": {
"obs_EconomicCapitalRatio": 8.182587418805609
},
"2023": {
"obs_EconomicCapitalRatio": 7.48169024244033
},
"2024": {
"obs_EconomicCapitalRatio": 3.143226224073416
},
"2025": {
"obs_EconomicCapitalRatio": 4.595221185166977
}
},
"0001729149": {
"2019": {
"obs_EconomicCapitalRatio": 3.9141912518645925
},
"2020": {
"obs_EconomicCapitalRatio": 4.377758147257698
},
"2021": {
"obs_EconomicCapitalRatio": 3.1175442632229804
},
"2022": {
"obs_EconomicCapitalRatio": 4.165808200790573
},
"2023": {
"obs_EconomicCapitalRatio": 3.0905943820113806
},
"2024": {
"obs_EconomicCapitalRatio": 2.8280699797927302
},
"2025": {
"obs_EconomicCapitalRatio": 2.208374174708051
}
},
"0001729944": {
"2019": {
"obs_EconomicCapitalRatio": 0.80033022263604
},
"2020": {
"obs_EconomicCapitalRatio": 0.8939501524991209
},
"2021": {
"obs_EconomicCapitalRatio": 1.670257709676602
},
"2022": {
"obs_EconomicCapitalRatio": 0.7555010825436428
},
"2023": {
"obs_EconomicCapitalRatio": 1.486124730980496
},
"2024": {
"obs_EconomicCapitalRatio": 0.5100288861637816
}
},
"0001799191": {
"2020": {
"obs_EconomicCapitalRatio": 1.9354663360497144
},
"2021": {
"obs_EconomicCapitalRatio": 1.4314265160413502
},
"2022": {
"obs_EconomicCapitalRatio": 0.5369289711729511
},
"2024": {
"obs_EconomicCapitalRatio": 0.09570735084291766
},
"2025": {
"obs_EconomicCapitalRatio": 2.001660729797598
}
},
"0001439725": {
"2020": {
"obs_EconomicCapitalRatio": 4.899553478061839
},
"2021": {
"obs_EconomicCapitalRatio": 1.7991006973357486
},
"2022": {
"obs_EconomicCapitalRatio": 0.9045190531820879
}
},
"0001737523": {
"2021": {
"obs_EconomicCapitalRatio": 671.1968392005622
},
"2022": {
"obs_EconomicCapitalRatio": 385.49382888758356
},
"2023": {
"obs_EconomicCapitalRatio": 1.5191647865482536
},
"2024": {
"obs_EconomicCapitalRatio": 0.7490768181400523
},
"2025": {
"obs_EconomicCapitalRatio": 2.0065585272756072
}
},
"0001759655": {
"2021": {
"obs_EconomicCapitalRatio": 5.9854315421959114
},
"2022": {
"obs_EconomicCapitalRatio": 4.9874077872328435
},
"2023": {
"obs_EconomicCapitalRatio": 3.9996069884808416
},
"2024": {
"obs_EconomicCapitalRatio": 3.0209663872592287
},
"2025": {
"obs_EconomicCapitalRatio": 3.0134479613948315
}
},
"0001803901": {
"2021": {
"obs_EconomicCapitalRatio": 2.3239919326101237
},
"2022": {
"obs_EconomicCapitalRatio": 1.1649813946676386
}
},
"0001818331": {
"2021": {
"obs_EconomicCapitalRatio": 3.031702783280354
},
"2022": {
"obs_EconomicCapitalRatio": 0.2650382635460216
},
"2023": {
"obs_EconomicCapitalRatio": 0.2340008975350877
},
"2024": {
"obs_EconomicCapitalRatio": 7.1433325795924105
},
"2025": {
"obs_EconomicCapitalRatio": 10.607580330133818
}
},
"0001822359": {
"2021": {
"obs_EconomicCapitalRatio": 4.529492069938443
},
"2022": {
"obs_EconomicCapitalRatio": 2.771063189488642
},
"2023": {
"obs_EconomicCapitalRatio": 1.6728383727412641
},
"2024": {
"obs_EconomicCapitalRatio": 1.4843694887626384
},
"2025": {
"obs_EconomicCapitalRatio": 0.5634025375829321
}
},
"0001834376": {
"2021": {
"obs_EconomicCapitalRatio": 1.9802948402224156
},
"2022": {
"obs_EconomicCapitalRatio": 2.439532779220166
},
"2023": {
"obs_EconomicCapitalRatio": 1.8744085157804056
},
"2024": {
"obs_EconomicCapitalRatio": 1.3621909662118414
}
},
"0001773751": {
"2021": {
"obs_EconomicCapitalRatio": 4.971853684184344
},
"2022": {
"obs_EconomicCapitalRatio": 6.128488895753875
},
"2023": {
"obs_EconomicCapitalRatio": 6.554674754785222
},
"2024": {
"obs_EconomicCapitalRatio": 12.126553207078992
},
"2025": {
"obs_EconomicCapitalRatio": 4.04039885819204
}
},
"0001870940": {
"2021": {
"obs_EconomicCapitalRatio": 5.033081838177257
},
"2022": {
"obs_EconomicCapitalRatio": 1.132782907988652
},
"2023": {
"obs_EconomicCapitalRatio": 2.5947989753230587
},
"2024": {
"obs_EconomicCapitalRatio": 1.8671046483783382
}
},
"0001534969": {
"2021": {
"obs_EconomicCapitalRatio": 2.8842820361801325
},
"2022": {
"obs_EconomicCapitalRatio": 0.5713512984391965
},
"2023": {
"obs_EconomicCapitalRatio": 3.1922358214415856
}
},
"0001822479": {
"2021": {
"obs_EconomicCapitalRatio": 2.6314647506130555
},
"2022": {
"obs_EconomicCapitalRatio": 0.7794445581652086
},
"2023": {
"obs_EconomicCapitalRatio": 1.6169003077959527
},
"2024": {
"obs_EconomicCapitalRatio": 1.317382776714733
},
"2025": {
"obs_EconomicCapitalRatio": 1.6819107661299355
}
},
"0001831097": {
"2021": {
"obs_EconomicCapitalRatio": 10.135987542140258
},
"2022": {
"obs_EconomicCapitalRatio": 5.716884020987739
},
"2023": {
"obs_EconomicCapitalRatio": 3.6117017245510086
},
"2024": {
"obs_EconomicCapitalRatio": 0.5237840028274809
},
"2025": {
"obs_EconomicCapitalRatio": 0.2429987445135107
}
},
"0001844392": {
"2021": {
"obs_EconomicCapitalRatio": 3.102693963604072
},
"2022": {
"obs_EconomicCapitalRatio": 0.36018627065159414
},
"2024": {
"obs_EconomicCapitalRatio": 0.5451364493905979
},
"2025": {
"obs_EconomicCapitalRatio": 0.3728897696807099
}
},
"0001832511": {
"2022": {
"obs_EconomicCapitalRatio": 0.14225887468579412
},
"2023": {
"obs_EconomicCapitalRatio": 0.21200771759380008
},
"2024": {
"obs_EconomicCapitalRatio": 0.045389475358619244
}
},
"0001892316": {
"2023": {
"obs_EconomicCapitalRatio": 110.39054612853406
},
"2024": {
"obs_EconomicCapitalRatio": 94.60058336986788
}
},
"0001635077": {
"2022": {
"obs_EconomicCapitalRatio": 0.0
},
"2023": {
"obs_EconomicCapitalRatio": 0.0
},
"2024": {
"obs_EconomicCapitalRatio": 0.0
},
"2025": {
"obs_EconomicCapitalRatio": 0.5450667778424255
}
},
"0001803737": {
"2022": {
"obs_EconomicCapitalRatio": 0.5721263204730309
},
"2023": {
"obs_EconomicCapitalRatio": 0.4928465005438502
},
"2024": {
"obs_EconomicCapitalRatio": 0.4077090775440418
},
"2025": {
"obs_EconomicCapitalRatio": 0.5377770193692863
}
},
"0001826667": {
"2023": {
"obs_EconomicCapitalRatio": 5.747039577983446
},
"2024": {
"obs_EconomicCapitalRatio": 3.6673040258093965
},
"2025": {
"obs_EconomicCapitalRatio": 6.744892845411586
}
},
"0001965040": {
"2023": {
"obs_EconomicCapitalRatio": 0.8853775922144298
},
"2024": {
"obs_EconomicCapitalRatio": 0.5806666737511045
},
"2025": {
"obs_EconomicCapitalRatio": 0.6601762335313033
}
},
"0001938046": {
"2023": {
"obs_EconomicCapitalRatio": 7.485743735641145
},
"2024": {
"obs_EconomicCapitalRatio": 0.7342890394360521
},
"2025": {
"obs_EconomicCapitalRatio": 1.2366752765702367
}
},
"0001699031": {
"2024": {
"obs_EconomicCapitalRatio": 0.36247445601460876
},
"2025": {
"obs_EconomicCapitalRatio": 2.141226559604184
}
},
"0001960262": {
"2024": {
"obs_EconomicCapitalRatio": 20.758484759101325
}
}
}
}